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Abstract
Disrupted-In-Schizophrenia 1 (DISCI) and Disrupted-In-Schizophrenia 2 (.DISC2)
have been identified as novel candidate genes for psychiatric illness through analysis
of a t(l;l 1 )(q42.1 ;ql4.3) translocation which segregates with schizophrenia and
other major psychiatric illness in a large Scottish family. The DISC locus at lq42 has
been independently implicated in psychiatric illness in multiple populations. DISCI
encodes a novel protein with the potential to interact with many cellular proteins and
is likely to act as a molecular scaffold with wide ranging cellular functions. DISC2 is
a putative non-coding RNA gene located antisense to DISCI and may play a role in
regulation ofDISCI expression.
This PhD thesis investigates the molecular basis of disease pathogenesis in the
t(l;l 1) family as a result of disruption of DISCI and DISC2, providing evidence for
reduced expression of DISCI within translocation carriers. This refutes previous
conjecture of the existence of an abnormal truncated DISCI protein resulting from
the translocation. These data support a disease model ofDISCI haploinsufficiency as
the direct cause of illness in this family, which is further investigated using RNA
interference technology. DISCI knock-down demonstrates that DISCI may function
in multiple diverse cellular pathways with implications for cAMP signal
transduction, cell cycle progression and apoptosis.
The complex biology of the DISCI protein is highlighted by the demonstration of
isoform specific sub-cellular localisation which may result in isoform specific
protein-protein interactions. Furthermore DISCI is shown to be dynamically
regulated during neuronal differentiation of embryonic stem cells.
The DISC2 gene has been successfully extended to its likely 5' end and novel
splicing has been uncovered. This data provides a platform on which to take forward
the functional characterisation of DISC2 including the current hypothesis that it
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1.1 Schizophrenia - History, phenotype and phenomenology
1.1.1 What is schizophrenia?
"At first it was as if parts of my brain "awoke" which had been dormant, and I
became interested in a wide assortment ofpeople, events, places and ideas which
normally would make no impression on me... The walk of a stranger on the street
could be a "sign " to me which I must interpret. Every face in the windows of a
passing streetcar would be engraved on my mind, all of them concentrating on me
and trying to pass me some sort ofmessage. " (Norma McDonald, 1960)
Schizophrenia is a complex and debilitating mental illness. The term schizophrenia,
meaning split mind, was coined by Eugen Bleuler in the early 20lh century. This term
has replaced dementia praecox, the original classification of functional psychosis by
Emil Kraepelin in the late 19th century {Frith and Johnstone, 2003). These functional
psychoses were so called as they had no apparent structural basis, although Kraepelin
believed it to be only a matter of time before an underlying neuropathology would be
uncovered. Even today however, psychiatrists and researchers alike are still
searching for the underlying biological basis of schizophrenia.
Unlike many medical conditions schizophrenia is not an illness you have but rather
an illness 'you are' and which affects all aspects of one's personality. Schizophrenic
patients are aware of their difference and are tormented and frightened by the
symptoms of the illness, which can be either positive (abnormally present) or
negative (abnormally absent). The psychotic (or positive) symptoms of the illness are
most easily treated using antipsychotic medication albeit still with a high number of
non-responders to medication. These symptoms include hallucinations, delusions and
possible physical aggression in response to these. Hallucinations are false
perceptions and many schizophrenia sufferers experience both visual and auditory
hallucinations. Patients often report hearing voices which command the patient to
carry out disturbing actions.
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"Those voices commanded me to do, and made me believe a number offalse and
terrible things... I refused to obey these voices on several occasions, when by obeying
them I was afraid oftaking away the life ofmy attendants... " (John Perceval, 1838)
Visual hallucinations are also common and distressing for schizophrenia sufferers. In
one case a 19 year old woman reported watching in the mirror as her face changed
into that of a rabbit with ears and whiskers (Case 240, Frith and Johnstone 2003).
Further to this, patients also hold false beliefs (delusions), often of a persecutory
nature believing that they are being pursued, that people are controlling their
thoughts or putting thoughts into their heads. It is not surprising that patients
experience anxiety and fury and can respond aggressively to these symptoms. Many
of these psychotic symptoms are treatable using anti-psychotic medication; however
the emotional (or negative) symptoms of this illness are not as easily treated. These
negative symptoms include social withdrawal, lack of emotional responsiveness,
apathy and general hopelessness ('Schizophrenia is there an answer?' National
Institute ofMental Health, 1972).
'...they do not bear the same affection towards their parents and relatives; they
become unfeeling to kindness, and careless of reproof...As their apathy increases,
they are negligent of their dress and inattentive to personal cleanliness..' (John
Haslam, 1809)
These symptoms are just as distressing for patients as the vivid hallucinations and
torturous delusions and this is represented by an increase in the rates of self-harming
and suicide amongst schizophrenia sufferers (Frith and Johnstone, 2003).
"I felt all this tumult of madness-all this stark, lonely living which is worse than
death-and the pain, futility and hopelessness of it all-and the endlessness, the
eternity. "(Lara Jefferson, 1964)
"My fate when I reflect upon it is the most horrible one can conceive of. I cannot
picture anything more frightful than for a well-endowed cultivated human being to
live through his own gradual deterioration fully aware of it all the time" (statement
ofan 18 year old boy quoted by Sir Aubrey Lewis in 1967)
In addition to psychotic and emotional symptoms patients often exhibit cognitive
impairments and movement disorders (Hall et al. 2005). Cognitive impairments in
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schizophrenia often exist prior to the onset of psychotic or emotional symptoms and
may be an underlying hallmark of the illness. It is obvious that schizophrenia is a
phenotypically complex illness and not every patient will exhibit the same spectrum
or severity of symptoms. Diagnosis of schizophrenia is a difficult task and
standardised diagnostic criteria have therefore been employed to ensure conformity.
The most widely used are the Diagnostic and Statistical Manual (DSM-IV) of the
American Psychiatric Association and the World Health Organisation International
Classification of Disease (ICD-10) (Frith and Johnstone 2003).
Although subtle brain abnormalities have been reported in the brains of
schizophrenic individuals there are currently no diagnostic pathological markers for
schizophrenia. Recently however, with the development of new imaging
technologies there has been much research invested in this area. Researchers are
attempting to identify endophenotypes that may give insights into to the pathogenesis
of illness or serve as physiological markers of illness.
Although the symptoms described in this section are clearly severe it must be
remembered that schizophrenia is a spectrum disorder with the nature and severity of
symptoms differing between individuals. One interesting question is whether it is
possible to extend this spectrum into the normal population? Most people at some
time in their lives experience periods of extreme stress or anxiety or may even
experience mild psychotic episodes, but without receiving a diagnosis of psychiatric
illness. Therefore those who do receive a psychiatric diagnosis may represent the
extreme end of a normal spectrum of behavioural, cognitive and emotional function.
1.1.2 Structural and cognitive abnormalities in schizophrenia
The human brain consists of the brainstem, the cerebellum and the cerebral cortex
(divided into two hemispheres). Each cerebral hemisphere contains four lobes of
disparate function. The parietal lobe performs essential roles in touch, spatial
awareness and attention; the occipital lobe is the main visual centre of the brain; the
temporal lobe (which contains the hippocampus and the amygdala) is important for
language, emotion, hearing, object recognition and memory; finally the frontal lobe
is responsible for problem solving, planning and decision making. The brain also
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contains four fluid filled ventricles, two of which are called lateral ventricles (one in
each cerebral hemisphere), a third ventricle which lies between the cerebral
hemispheres and a fourth ventricle between the cerebellum and the brain stem (Frith
and Johnstone 2003). Figures 1.1 depicts these key brain regions in a simplified
format. Image A in this figure represents a structural MRI scan ofmy brain with all
the visible brain structures labelled. Sub-groups of these structures are represented in
the simplified diagrams B, C and D. Malfunction of some of these brain structures
has been implicated in schizophrenia and will be discussed below.
Although there is no defining neuropathology for schizophrenia there have been
numerous reports of subtle abnormalities of brain structure and function in
schizophrenic individuals. Reductions in brain volume and weight have been
reported in addition to enlargement of the ventricles (Harrison and Weinberger,
2005, Harrison 1999, Wright et al. 2000). Structural abnormalities have mainly been
associated with hippocampal, frontal and temporal lobe structures in addition to the
thalamus and some whiter matter (axons and dendrites) defects (Hall et al. 2005,
Harrison and Weinberger, 2005). Histologically there is evidence for impairments in
neuronal migration, survival and connectivity during brain development which stems
from observations of aberrantly located and clustered neurons and reductions in
certain neuronal populations (Harrison and Weinberger, 2005).
Impaired brain function is likely to be related to cognitive defects observed in
schizophrenic individuals. One process reportedly impaired in schizophrenia is
executive function, which is the ability to apply strategy to perform or solve a given
task (Frith and Johnstone, 2003). Executive function is the responsibility of the
frontal lobe and indeed prefrontal cortex dysfunction seems to be a consistent
abnormality present in schizophrenic individuals (Winterer and Weinberger 2004).
Schizophrenic patients also perform poorly on memory recognition tests, which has
been shown to be associated with smaller hippocampal volume and abnormal
hippocampal activation within the temporal lobe region (Weiss et al. 2004, Heckers
2001).
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Defects in electrical activity reflecting abnormal attention and working memory are
consistently reported in schizophrenic individuals. The P300 event related potential
is an electrophysiological measurement of brain activity associated with a specific
stimulus or response and is representative of cortical processing (Patel and Azzam,
2005, Linden 2005). Reduced amplitude and increased latency of the P300 is a
regular finding amongst schizophrenics. Family studies have reported deficits in
P300 ERP in schizophrenics and their unaffected relatives compared to normal
controls (.Davenport et al. 2006, Bharath et al 2000). Studies involving
schizophrenics, unaffected siblings and unrelated controls have also reported
differences in various sub-components of this P300 ERP between siblings (affected
and unaffected) and controls although the specific brain regions contributing to the
P300 deficit seen in schizophrenia are still debatable (Winterer et al. 2003, Turetsky
et al. 2000). The fact that P300 abnormalities are detected in healthy siblings of
schizophrenic patients indicates that although reduced P300 amplitude may be a
genetically controlled trait marker of schizophrenia, indicating underlying defects in
cortical function, it is not a definite indicator of illness.
The P300 ERP is just one of many electrophysiological measures that have been
studied in schizophrenia. Many other electroencephalography (EEG) recordings have
demonstrated aberrant cortical activation and a general deterioration in connectivity
and functional organisation of the schizophrenic brain (Hajos 2006). In addition to
the attention deficits associated with reduced P300, defects in neuronal-network
oscillations and diminished information processing (auditory-gating deficits,
mismatch negativity deficits) have also been reported (Hajos 2006). Understanding
the relationship between neuronal-network oscillations and attention/information
processing will be crucial to understanding the biological basis of schizophrenia.
It is important to note than many structural and functional defects associated with
schizophrenia precede the onset of symptoms and are also present in unaffected
relatives suggesting that these are underlying developmental defects most likely
resulting from genetic predisposition to schizophrenia. In addition neuropathological
abnormalities do not correlate well with severity or duration of illness and
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schizophrenia does not appear to follow a progressive or degenerative course
providing further support for a neurodevelopmental basis to schizophrenia (Harrison
1999). However a recent study of childhood early-onset schizophrenia suggests that
there may be a progressive loss of grey matter in the parietal and frontal cortices
during early adolescence, which eventually extends to the temporal cortex following
puberty and the onset of clinical symptoms (Thompson et al. 2001).
1.1.3 Neurochemical abnormalities of schizophrenia
The ability of natural and synthetic drugs to re-produce schizophrenia like symptoms
in normal individuals has resulted in a number of neurochemical theories. Current
thinking supports a neurodevelopmental basis for schizophrenia that results in
secondary signalling abnormalities. It is still unknown which of the major
neurochemical signalling pathways is responsible for producing the spectrum of
symptoms associated with schizophrenia; however there is a growing belief that
multiple interacting pathways are disrupted.
For many years the prevailing hypothesis has been that a disruption in dopamine
signalling in the brain produces the psychosis associated with schizophrenia. This is
not surprising considering the ability of dopamine agonists such as amphetamines to
produce schizophrenia-like psychotic symptoms in normal individuals and the fact
that all typical antipsychotic drugs alleviate psychosis by antagonising the dopamine
system. Dopamine is thought to mediate reward prediction and motivational salience,
a process whereby neutral events and representations become attention-grabbing and
capture thought and behaviour (Berridge and Robinson 1998, Kapur 2004). This has
parallels with the heightened perceptual experiences of schizophrenic individuals
making dopamine an attractive schizophrenia candidate signalling pathway.
However, upregulation of dopamine within the brains of schizophrenic individuals
has not yet been demonstrated {Frith and Johnstone 2003). Furthermore, not all
patients respond to dopamine blockade suggesting there are other signaling elements
to consider.
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Recent studies of dopamine signalling suggest that it is important for maintaining the
balance of glutamate (excitatory) and GABA (gamma-aminobutyric acid, inhibitory)
neurotransmission in the prefrontal cortex (Winterer and Weinberger 2004). To upset
this balance may result in over-alertness and unstable attention potentially
manifesting as hallucinations. This failure to focus prefrontal activity may result in
cognitive deficits such as have been reported for schizophrenia (Winterer and
Weinberger 2004).
Glutamate signalling has also been implicated in the generation of schizophrenia-like
psychosis. Phencyclidine (PCP) acts on glutamine receptors and produces many
schizophrenic like symptoms including delusions, hallucinations, incoherence,
paranoia and catatonia. Similarly ketamine, an NMDA (glutamate) receptor
antagonist, can produce schizophrenic-like hallucinations and delusions (Frith and
Johnstone 2003). This has resulted in an NMDA hypofunction hypothesis for
schizophrenia. There is strong genetic evidence implicating the glutamate signalling
pathway in schizophrenia (Collier and Li 2003). Neuregulin 1 is a strong
schizophrenia candidate gene which is involved in regulating the expression and
kinetics of NMDA glutamate receptors and also impacts on inhibitory
neurotransmission via GABA signalling (Moghaddam 2003, Harrison and
Weinberger 2005).
It is clear with both the glutamate and the dopamine hypotheses that neither pathway
alone can account for all the complex symptoms associated with schizophrenia.
Furthermore, extensive cross-talk between the major signalling pathways of the brain
implies that abnormalities in one signalling pathway will undoubtedly have wider
implications for neurochemical signalling. It is therefore important to identify the
genetic factors that underlie the abnormal development of the schizophrenic brain,
and hence where these signalling defects are born, if the pathological mechanism of
schizophrenia is to be understood.
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1.1.4 Mitochondrial dysfunction in schizophrenia
The mitochondrion is an important organelle whose main role is to meet the energy
demands of the cell in the form of adenosine triphosphate (ATP) produced by the
process of oxidative phosphorylation. However, the mitochondrion is also important
in the biogenesis of other important cellular components such as amino acids and
nucleotides and plays an important role in programmed cell death (Attardi and
Schatz 1988, Green and Reed 1998). The mitochondrion is particularly important for
brain function due to the high energy demands of this organ. The human brain uses
approximately 20% of the body's energy which is staggering considering that the
brain accounts for only 2% of total body weight (.Drubach 2000). 75% of the brain's
energy is consumed by signalling processes related to information processing
(.Attwell and Gibb 2005).
Each mitochondrion contains its own genome of approximately 16.5kb which
contains 37 genes encoding its own transcription, translation and protein synthesis
systems (Schon 2000). The mitochondrial genome is responsible for producing
polypeptide components of the oxidative phosphorylation system required for ATP
production. Unlike the nuclear genome the mitochondrial genome does not undergo
recombination and lacks efficient repair mechanisms to eradicate accumulating
mutations which results in many mitochondrial diseases, mostly associated with the
brain (Wallace 1999, Schon 2000). Many proteins required for the normal
functioning of the mitochondria are encoded within the nuclear genome. Mutations
in nuclear genes may therefore also affect mitochondria biogenesis (Schon 2000).
Mitochondrial dysfunction is a process implicated in Parkinson's disease where it is
thought that inappropriately sequestered dopamine may result in oxidative stress
leading to cell damage and neurodegeneration (Gluck and Zeevalk 2004). Dopamine
is a cytotoxic molecule and has been shown to inhibit respiration of isolated brain
mitochondria and actively induce damage along with other mitochondrial toxins
(Boada et al 2000, Moy et al. 2000). Under normal physiological conditions
dopamine is sequestered in vesicles which eliminates the cytotoxicity; however
under conditions where dopamine levels are increased (e.g. amphetamine challenge)
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dopamine derivatives are up-regulated within the cytosol where they may exert toxic
effects (Mosharov et al. 2003). Dopamine has been shown to reduce ATP production
in cultured human neuroblastoma cells which is thought to result from inhibition of
mitochondrial respiration via mitochondrial Complex I, a complex which has been
shown to be altered in the prefrontal cortex of schizophrenic brains (Ben-Shachar et
al. 2004, Karry et al. 2004). Inhibition of ATP production occurs at dopamine
concentrations which are non-toxic to neuroblastoma cell viability (Ben-Shachar et
al. 2004). This is an interesting finding as it suggests that dopamine may cause
mitochondrial dysfunction without overt cellular toxicity such that mitochondrial
dysfunction and cellular degeneration are not inextricably linked. Furthermore
Complex I deficiency, which may be a factor in schizophrenia, is a common cause of
mitochondrial encephalomyopathy and presents as severe brain dysfunction (Schon
2000).
Microarray studies have been carried out looking at metabolic gene expression in
schizophrenia. These microarray studies are complicated by factors such as brain pFl
which have been shown to affect mitochondrial gene expression {Li et al. 2004).
Despite this, changes in mitochondrial gene expression in schizophrenia are still
observed even when brain pH is accounted for (Iwamoto et al. 2005). These genes
tend to be down-regulated and are involved in many aspects of mitochondrial
function including respiration, transcription, membrane function and transport to
name a few. One additional caveat is that medication used to treat the symptoms of
psychiatric illness can cause mitochondrial toxicity {Iwamoto et al. 2005). Indeed
analysis of mitochondrial gene expression in bipolar disorder suggests that many of
these changes in expression can be accounted for by medication although some
changes are still evident in medication-free patients {Iwamoto et al. 2005). It is likely
that the effects of medication on post-mortem gene expression in schizophrenia
would be similar to those reported for bipolar disorder. Therefore, although there is
evidence for changes in the expression of mitochondrial related genes in
schizophrenia, confounding factors make conclusions hard to come by and much
more work is required to uncover the mechanism of mitochondrial dysfunction in
schizophrenia.
10
In addition to global changes in gene expression, specific mitochondrial DNA
(mtDNA) sequence variants have been associated with schizophrenia. Marchbcinks et
al. 2003 have identified a sequence variation in the mtDNA that was significantly
more common in schizophrenics that control subjects. This specific variant resulted
in a non-conservative amino acid substitution in the ND4 subunit of NADH-
ubiquinone reductase (also known as Complex I) and was associated with increased
oxidative stress in schizophrenia (Marchbanks et al. 2003). Further mtDNA variants
have been identified in mother-parent offspring pairs showing maternal transmission
of schizophrenia. Five substitutions were identified all of which were absent in 95
control subjects. Three of these variants were non-conservative such that they may
affect the structure or function of cytochrome c oxidase, ATP synthase and NADFI-
ubiquinone oxidoreductase (Martorell et al. 2006).
Although the precise nature of mitochondrial dysfunction in schizophrenia in not
known, studies of gene expression, oxidative phosphorylation and mtDNA sequence
variation all point to a mitochondrial dysfunction phenotype that is associated with
schizophrenia. Further pathological studies have reported abnormalities in the
number and morphology of mitochondria within schizophrenic brains (Ben-Shachar
2002). It is unclear how these defects are caused and whether they are the cause or
result of illness; however many diseases of the mitochondria affect the brain and
present with variable and complex phenotypes comparable to schizophrenia.
1.2 The molecular genetic basis of schizophrenia
1.2.1 Heritability and Heterogeneity
Schizophrenia is a complex genetic illness with a lifetime risk of approximately 1%
within the general population. Schizophrenia is highly heritable with rates of
inheritance increasing with the degree of relatedness to an individual. There is an
approximate 10 fold increase in risk to individuals with a first degree relative
affected by schizophrenia (Owen and O'Donovan 2002). For example, the relative
risk of developing schizophrenia for an individual with an affected sibling is 9%, the
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risk for dizygotic twins ranges from 0-28% and for monozygotic twins the risk is
between 41% and 65%. Schizophrenia is a highly heritable disorder, with heritability
representing a measure of the amount of phenotypic variance that can be attributed to
genetic effects (Cardno and McGuffin, 2002). The risk values for schizophrenia
correlate to an estimated heritability of 80-85% (Owen and O'Donovan 2002).
Furthermore adoption studies provide supportive evidence that this increased risk is
due to an increase in the number of shared genes and not due to shared
environmental factors (Owen and O'Donovan 2002).
If schizophrenia was purely a genetic illness the concordance rate for MZ twins
would be expected to be 100%, rather the concordance rate is -50% suggesting that a
component of the risk for developing schizophrenia must come from other factors,
presumably environmental and epigenetic. A myriad of environmental factors have
been associated with schizophrenia including exposure to infectious agents, season of
birth, adverse or stressful life events, nutrition and substance abuse (Frith and
Johnstone 2003). Epigenetic modification ofDNA is also becoming a popular theory
in the field of schizophrenia. Epigenetic changes are alterations to the functional state
of the DNA which can alter gene expression. These changes can also be modified by
the environment and hormonal state of the body such that the effects of the
epigenetic modification may change during a person's lifetime (Petronis 2004).
There is no experimental data to substantiate the theory of an epigenetic basis to
schizophrenia but it is entirely probable that environmental and epigenetic as well as
stochastic cellular events will impact upon predisposing genetic alterations ultimately
leading to the pathogenesis of schizophrenia.
1.2.2 Finding genes in a gene-pool - linkage and association
Schizophrenia exhibits a complex non-mendelian pattern of inheritance and is likely
to be an oligogenic or polygenic disorder, or even a mixture of both. Numerous
linkage and association studies have been carried out with the hope of identifying
positional or functional candidate genes. Unfortunately, both association and linkage
studies encounter interpretation problems, as positive results are generally
ambiguous and difficult to replicate, as would be expected with a complex illness.
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Despite this, there have recently been several convincing reports of replicated
linkage and association which identify potential genetic susceptibility loci on several
chromosomes. Some exciting candidate genes which are emerging from these studies
are discussed in the subsequent section.
1.2.2.1 The schizophrenia candidates
DTNBP1
The Dystrobrevin-Binding Protein 1 (.Dysbindin, DTNBP1) gene is located on
chromosome 6p22.3. Originally identified by Straub and colleagues in 2002,
dysbindin is an interesting candidate gene for schizophrenia as it is known to be
expressed in the axon terminals of adult mouse brains and may be important for
normal synaptic function (Benson et. al. 2001, Harrison & Owen 2003). Although
extensively replicated in a number of populations, the haplotypes and alleles
associated with schizophrenia have been very different between the studies
(Harrison and Weinberger 2005). No causative allele has been identified although
some single nucleotide polymorphisms (SNPs) have been associated with
intermediate cognitive phenotypes, including IQ, episodic and working memory
(.Harrison and Weinberger 2005).
Dysbindin is associated with the dystrophin-associated protein complex present
within the postsynaptic density (PSD) (Benson et al. 2001). Here it is thought to
function in trafficking and tethering of neurotransmitter receptors and other proteins
(.Harrison and Weinberger 2005). Dysbindin mRNA (post-mortem zn-situ) and
protein (immunohistochemistry in post-mortem brains) is decreased in brains of
some schizophrenic individuals (Weickert et al. 2004, Talbot et al 2004).
Furthermore, over-expression or suppression of dysbindin expression has been
shown to impact on pre-synaptic protein expression and glutamate release by cortical
neurons in culture (Numakawa et al. 2004). Therefore alterations in dysbindin




Neuregulin 1 (NRG1) is located on chromosome 8p. NRG1 was initially identified as
a schizophrenia candidate gene by a genome wide scan and fine mapping study in an
Icelandic population (Stefansson et al. 2002). A highly significant association to a 7
marker haplotype within the 5' region of the gene was reported (Stefansson et al.
2002). Albeit with some allelic heterogeneity, this association has been replicated in
2 UK populations, 4 Chinese populations and 1 Irish population {Harrison and
Weinberger 2005). A recent meta-analysis of case-control association studies of the
NRG1 gene has also reported significant associations of markers within this 5'
haplotype in Caucasian and Asian populations {Li et al. 2006).
No functional variant in the NRG1 gene has been identified for schizophrenia;
however it is likely that associated variants may affect gene expression or splicing.
There is evidence for an imbalance in the type of NRG1 isoforms (by qRT-PCR)
present in postmortem brains of schizophrenics with the type I isoform being up-
regulated in cases versus control brains {Law et al. 2006, Hashimoto et al. 2004,
Harrison and Weinberger 2005). Furthermore altered expression of NRG1 isoforms
have been reportedly associated with disease-associated polymorphisms from the
original 5' haplotype identified by Stefansson et al. 2002 {Law et al. 2006). In
addition, a variant in the promoter region of the NRG1 gene, which has been
associated with higher expression levels of NRG1 type IV, has been further
associated with decreased cortical activation, decreased premorbid IQ and increased
psychotic symptoms in schizophrenia {Hall et al. 2006, Law et al. 2006).
NRG1 has a multiplicity of functions all of which may be important in the aetiology
of schizophrenia, including acting as a glial growth factor and also playing a role in
neuronal migration and myelination and modulation of NMDA receptor signalling
{Collier & Li 2003, Michailov et al. 2004, Gu et al. 2005). NRG1 also has a role in
inducing expression of nicotinic acetylcholine receptors {Yang et al. 2005, Liu et al.
2001). Nicotine has been found to improve sensory gating deficits in schizophrenic
patients and their relatives and a7 nACh agonists improve amphetamine induced
sensory gating in rats {Hajos 2006). In this respect it is interesting that a high
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proportion of individuals with schizophrenia smoke and that a worldwide meta¬
analysis has indicated a positive association between smoking and schizophrenia (de
Leon and Diaz 2005). Smoking may be a form of self-medication for schizophrenia
sufferers.
COMT andPRODH
Two further genes of interest have been identified from chromosomal region 22ql 1,
Catechol-O-Methyl Transferase (COMT) and Proline Dehydrogenase (PRODH).
Both of these genes are present within the region of chromosome 22 that is deleted in
patients with velocardiofacial syndrome. VCFS patients present with learning
abnormalities and schizophrenia-like psychosis among other symptoms (.Murphy
2002). COMT has a direct role in the metabolism of dopamine and other catechols
and is expressed abundantly in neurons of the hippocampus and prefrontal cortex
suggesting it is an ideal candidate gene for schizophrenia (.Harrison and Weinberger
2005).
Unlike many of the other schizophrenia candidate genes the COMT gene shows
association of a functional SNP with schizophrenia. The nature of this SNP is such
that it alters the enzymatic activity of the protein with functional consequences for
the metabolism of dopamine (Collier and Li 2003, Harrison and Weinberger 2005).
This SNP replaces a high activity valine allele at position 158 with a low activity
methionine allele (vall58met) (Lotta et al. 1995, Lachman et al. 1996). Clear
association of either allele with schizophrenia has not been demonstrated due a high
number of negative studies; however the higher activity COMT-valine allele has
shown association with poorer prefrontal cortical function (Harrison and Weinberger
2005). This would seem counterintuitive considering the original dopamine
hypothesis predicts higher dopamine levels as the cause of illness but perhaps COMT
has a more important role in cognitive impairments associated with schizophrenia
rather than the psychotic aspects. Other non-functional alleles within the COMT gene
have also been implicated in schizophrenia although they are not well replicated and
contradictory studies of mRNA and protein levels of COMT in the brains of
schizophrenics only complicates the picture further (.Harrison and Weinberger
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2005). Although the genetic association of the COMT gene with schizophrenia is
complex the function of this gene and the functional implications of the associated
SNPs suggest that COMT is indeed an important mediator of dopamine signalling in
the brain with significant implications for schizophrenia. It is postulated that there is
an 'optimum' level of dopamine signalling in the brain and current thinking suggests
that the COMT Val/Met polymorphism may have a positive or negative effect in a
given individual, depending on their intrinsic levels of dopamine signalling. This
intrinsic dopamine signalling level ('set-point') is likely to be determined by
additional genetic factors and the effect of the Val/Met COMT polymorphism will
vary between individuals depending on whether they lie above or below the
'optimum' dopamine signalling level.
Proline dehydrogenase (PRODH2) is contained within the same 22ql 1 region
deleted in VCFS as the COMT gene. Although statistical association for this gene is
weak PRODH knockout mice show prepulse inhibition (PPI) deficits and decreases
in glutamate and GABA in selected brain regions {Gogos et al. 1999, Harrison and
Weinberger 2005).
Other candidate genes
G72 is a novel primate gene located within chromosomal region 13q22-34 and was
initially reported as a candidate gene for schizophrenia due to its association with
schizophrenia in French-Canadian and Russian populations (Chumakov et. al. 2002).
G72 is of unknown function but has a predicted interaction with D-aminoacid
Oxidase (DAAO), an activator of the NMDA receptor. Association has been
confirmed three times for G72 and the original SNP identified by Chumakov et al.
has been shown to be associated with some cognitive and physiological impairments
seen in schizophrenia {Harrison and Weinberger 2005).
The RGS4 (Regulator of G-protein signalling 4) gene located on chromosome 1 q21 -
22 is involved in neuronal differentiation and has been implicated in schizophrenia
by microarray {Mimics et al. 2001b) and weakly by association {Harrison and
Weinberger 2005).
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GRM3 is a type II metabotropic glutamate receptor which has shown association
with schizophrenia in German, Japanese, and American populations (Harrison and
Weinberger 2005). Extended analyses have provided evidence of association for an
intron 2 variant with characteristic cognitive impairments of schizophrenia (Egan et
al. 2004).
Glutamate decarboxylase (GAD67) is a synthesising enzyme for GABA, the
neurotransmitter of inhibitory interneurons. This synthesising enzyme is reportedly
reduced in a specific subset of GABA containing neurons in the prefrontal cortex of
schizophrenics (.Hashimoto et al. 2003).
Other groups of genes implicated in the schizophrenia disease process by studies of
gene expression include genes involved in the regulation of presynaptic function,
oligodendrocyte/myelin-related genes and metabolic enzymes (Mimics et al. 2000,
Mimics 2001a, Katsel et al. 2005, Vawter et al. 2004). In addition, expression of
genes involved in protein turnover, cytoskeletal dynamics, mitochondrial oxidative
energy metabolism, neurite outgrowth and synaptic plasticity has been reportedly
reduced in laser-captured dentate granule neurons of the hippocampus {Altar et al.
2005).
Genetic studies have clearly identified many candidate genes for schizophrenia.
Many of these candidates highlight processes that may be involved in pathogenesis
of illness but the founding genetic defect is still not clear. It seems more likely that
this is a genetically heterogeneous illness and that there is no one founding mutation
but rather a mixed bag of genes, each contributing to the risk for developing
schizophrenia. Furthermore, although these studies may highlight important genes
and pathways, the disease mechanism remains enigmatic. With the exception of
COMT and NRG1 functional variants within theses genes remain to be identified.
Therefore further research is needed to elucidate the mechanism of action of
potential candidates.
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One candidate schizophrenia gene, which is the main subject of this thesis, is DISCI.
Unlike the previously discussed genes DISCI was identified using a cytogenetics
approach. Cytogenetics uses labelled chromosomal probes to identify chromosomal
abnormalities such as deletions, duplications, inversions or translocations by
fluorescent in-situ hybridisation (FISH). Cytogenetics is a very powerful tool when
tackling complex diseases because it has the power to identify rare mutations with
major effect. Furthermore these studies can pinpoint the exact genes that are
disrupted. Cytogenetic studies are generally confined to a few pedigrees and results
may not represent the cause of illness in the general population, especially with such
a complex illness as schizophrenia. Nevertheless, isolation of single gene defects is
extremely helpful in understanding the pathogenesis of illness. This appears to be the
case for the DISCI gene, originally identified in one pedigree, but with additional
research has now come to be one of the most promising schizophrenia candidate
genes to date. Subsequent sections discuss the identification of DISCI and our
current understanding of its potential role in the biology of schizophrenia.
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1.3 The t(1; 11) translocation
1.3.1. The t(1;11) family
The t(l;ll) family is so named as a result of an inherited balanced translocation
between chromosomes l and 11 {St.Clair et al. 1990). It is a large Scottish pedigree
which was first identified in 1970 {Jacobs et al. 1970) and has been under
investigation for more than 30 years. Within this family the t( 1; 11 )(q42.1 ,q 14.3)
balanced chromosomal translocation segregates with major psychiatric illness
including schizophrenia, bipolar disorder and major depression {Blackwood et al.
2001). Figure 1.3 adapted from Blackwood et al. 2001, shows family members
whose carrier status has been determined and their associated psychiatric diagnoses.
It is noted that some family members without the translocation present with minor
psychiatric diagnoses such as alcoholism and minor depression; however all severe
psychiatric illness is restricted to carriers of the translocation.
Linkage studies on this family produced a highly significant LOD score of 7.1 when
cases of schizophrenia, bipolar disorder or recurrent major depression were all
considered as affected. Linkage analysis with the most severe psychiatric diagnosis
of schizophrenia also produced a significant LOD score of 3.6 {Blackwood et al.
2001). In linkage analysis LOD stands for the logio of the odds score for linkage. In
the case of the t(l; 11) family the odds score for linkage is a measure of the likelihood
that major psychiatric illness and the t( 1; 11) translocation will segregate by chance
as opposed to being linked. A LOD score of 3 equates to 1:1000 (103) odds against
the linkage between the clinical phenotype and the translocation occurring by
chance. Therefore in this family a LOD score of 7.1 equates to >1:10,000,000 odds
against observing the linkage between major psychiatric diagnosis and the t( 1; 11)
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All family members have an IQ within the normal range as determined by the
National Adult Reading Test. Furthermore, the translocation does not appear to
associate with either neurological or developmental abnormalities. Interestingly
however, the translocation does associate with reduced amplitude of the auditory
P300 Event Related Potential (ERP) in both affected and unaffected translocation
carriers (Blackwood et al 2001). The P300 ERP is an electrophysiological
measurement using electroencephalography (EEG). It is a measurement of brain
activity associated with a specific stimulus or response and is representative of
cortical processing (Patel and Azzam 2005, Linden 2005). Normal P300 ERPs
typically appear 300 to 400ms post stimulus and range in amplitude from 5 to 20 pV.
For t(1; 11) family members with a normal karyotype the latency and amplitude of
the P300 ERP were within the normal range with mean values of at 338.3ms and
12.1pV respectively. In contrast family members possessing the translocation
recorded P300 ERPs with increased latency averaging 366.2ms and significantly
reduced amplitude with a mean value of 6.8pV (Blackwood et al. 2001). These
values were similarly reduced in unaffected and affected individuals, therefore the
reduction in P300 amplitude observed in this family appears to be a marker of
schizophrenia susceptibility conferred by the t( 1; 11) translocation. Reduced P300
amplitudes reflect abnormal neural functions in carriers of the t( 1; 11) translocation.
As discussed previously these defects in electrical brain activity are likely to
represent abnormal attention and working memory deficits in these family members.
1.3.2. Candidate genes within the t(1;11) breakpoint regions
The translocation breakpoints on chromosome 1 and 11 have been studied in detail.
No major sequence rearrangements are found at the breakpoint on the derived 11
chromosome and there are no genes disrupted in this region (.Millar et al. 2000).
However with position effects of translocations ranging as far as 1.3Mb from the
breakpoint it is possible that the chromosome 11 breakpoint may alter expression of
the surrounding genes (Velagaleti et al. 2005). Indeed three genes lie in close
proximity to the breakpoint on chromosome 11, the metabotropic glutamate receptor
GRM5, NAALADase II and Tyrosinase (Semple et al. 2001, Devon et al. 1997, Petit
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et al. 1999). As discussed below, these genes have been previously implicated in
schizophrenia.
GRM5 (mGluR5) is a modulator of NMDA signalling and maps to 11 q 14 >850kb
centromeric to the chromosome 11 breakpoint (Devon and Porteous 1997). Due to its
role in NMDA signalling mGluR5 is a good biological candidate gene for
schizophrenia. mGluR5 knockout mice show deficits in pre-pulse inhibition (PPI), a
deficit that is also induced by NMDA antagonists and often reported in schizophrenic
patients (Kinney et al. 2003). It has been suggested that enhancement of mGluR5
activity may produce anti-psychotic effects in rodents and mGluR5 antagonists have
been shown to impair long term potentiation and induce working memory deficits,
two other characteristic features of schizophrenia (Pietraszek et al. 2006).
There is limited genetic evidence to support the involvement of mGluR5 in
schizophrenia. A Case-control association of microsatellite markers within the
mG/uR5 gene revealed significant association between a novel intragenic marker and
schizophrenia (p = 0.046) (Devon et al. 2001). No other such associations have been
reported for mGluR5. Despite being a good biological candidate gene the mechanism
by which mGluR5 interacts with NMDA receptor signalling to either alleviate or
exacerbate psychotic symptoms is not well understood and impaired mGluR5
function alone is not sufficient to induce these symptoms. Furthermore, strong
statistical evidence for mGluR5 as a candidate schizophrenia gene is lacking.
NAALADase II is more commonly known as glutamate carboxypeptidase II (GCP
II). It is a membrane-bound metallopeptidase responsible for cleavage of N-
acetylaspartylglutamate (NAAG) to N-acetylaspartate (NAA) and glutamate
(Robinson et al. 1987, Slusher et al. 1990). NAAG is the most abundant
neuropeptide in the human brain and has been linked immunocytochemically to
glutamatergic pyramidal neurons of the hippocampus and cerebral cortex. (Neale et
al. 2000, Passani et al. 1997). Post-mortem studies report alterations in GCP II
mRNA and enzymatic activity in the hippocampus and prefrontal cortex of
schizophrenic brains (Tsai et al. 1995, Ghose et al. 2004). Studies of the involvement
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of GCP II in schizophrenia are limited and there is currently no genetic evidence to
support GCP II as a general candidate schizophrenia gene.
Tyrosinase maps 1.2Mb centromeric to the llql4.3 breakpoint (Petit et al. 1999). It
is an interesting candidate gene for schizophrenia due to its role in the metabolism of
catecholamines. In the brain tyrosinase acts as a melanin synthesising enzyme which
has been shown to have protective effects against dopamine induced neurotoxicity. It
exerts its protective effect by oxidising dopamine (DA) and dopamine quinones
(DAQ) to produce stable melanin (Miyazaki et al. 2006). This is a potentially
important step in regulating intracellular DA levels as DA is a cytotoxic molecule
that auto-oxidizes to form DAQ and reactive oxygen species contributing to cellular
oxidative stress. DAQ are highly toxic as they bind and inactivate molecules crucial
for the function of DA neurons including the DA transporter and tyrosine
hydroxylase, the rate-limiting enzyme in the production of catecholamine
neurotransmitters (Whitehead et al. 2001, Kuhn et al. 1999). Furthermore, inhibition
of tyrosinase increases DA-induced cell death (Higashi et al. 2000) and tyrosinase
null mice are more vulnerable to metamphetamine induced neurotoxicity (Miyazaki
et al. 2006).
Although chromosome 11 q harbours possible schizophrenia candidate genes in order
for them to be involved in pathogenesis of schizophrenia in the t( 1; 11) family long
range position effects of up to 1.2Mb would have to occur as none of the above
genes are in the immediate vicinity of the breakpoint. Although extensive studies
have not been carried out there is no evidence that expression of these genes is
altered by the t(l;l 1) translocation segregating in this family.
On chromosome lq42.1 however the translocation directly disrupts two novel genes
which have been named Disrupted-In-Schizophrenia 1 and 2 (Millar et al. 2000).
DISCI was identified from mRNA sequence overlapping the derived chromosome 1
breakpoint (accession number AB007926). This novel gene was found to be 6913nt
in length (accession no. AF222980) and encodes a novel protein of 854 amino acids
(Millar et al. 2000). The second gene, DISC2, was identified from expressed
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sequence tags surrounding the chromosome 1 breakpoint region (accession no.
AF222981). This gene is expressed in the reverse orientation to DISCI and is likely
to represent a natural anti-sense non-coding RNA gene (Millar et al. 2000). The full
extent of this gene remains to be characterised.
Just 5'of DISCI lies the gene TRAX which although not directly disrupted may be
altered by position effects as a result of the translocation. However protein
expression studies demonstrate that this is unlikely to be the case as TRAX protein
expression remains the same in translocation and non-translocation cell lines from
this family {Millar et al. 2005b).
The t( 1; 11) family represents a rare resource for identifying candidate genes for
psychiatric illness as the translocation itself appears to be the direct cause of illness.
Furthermore the translocation pinpoints the region of interest and suggests that
disruption of the novel genes, DISCI and DISC2, is the primary event leading to
illness in later life. These genes are discussed in detail in introductory sections 1.4-
1.5 and 1.6 respectively.
1.4 The DISC1 gene
1.4.1 Independent genetic evidence implicates DISC1 in
psychiatric illness
The l q region of chromosome 1 has been implicated in susceptibility to psychiatric
illness in a number of genetic studies {Brzustowicz et al. 2000, Gurling et al. 2001
Macgregor et al. 2004, Curtis et al. 2003, Hamshere et al. 2005).
The first independent genetic evidence directly implicating the DISCI gene as a
schizophrenia susceptibility gene came from a genome wide screen of an internal
Finnish isolate {Hovatta et al. 1999). This isolate had a particularly enriched risk for
developing schizophrenia with a lifetime prevalence of 3.2% compared to 1.1% in
the general Finnish population {Hovatta et al. 1999). The most significant region
identified in this study was chromosomal region lq.32.2-q41 producing a pairwise
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LOD score of 3.82 when schizophrenia and schizoaffective disorder were considered
affected (Hovatta et al. 1999). Fine-mapping of this region in a second large
population-based study of the Finnish population identified positive linkage to an
intragenic marker of DISCI (Ekelund et al. 2001). This intragenic DISCI marker is
in close proximity to the t( 1; 11) breakpoint region residing within intron 9 of the
DISCI gene. These original findings have since been replicated in a further
independent Finnish population (.Ekelund et al. 2004).
An additional association study of the Finnish population implicates
undertransmission of a haplotype of DISCI spanning intron 1 to exon 2 in
susceptibility to schizophrenia in females only (Hennah et al. 2003). Under¬
transmission of this haplotype has been confirmed in an independent study of a North
American population with schizoaffective disorder patients (Hodgkinson et al. 2004).
Hodgkinson et al. provided further evidence for association of additional DISCI
markers with susceptibility to schizophrenia, schizoaffective and bipolar disorder,
including a nonsynonymous Leucine to Phenylalanine amino-acid substitution at
position 607 (Hodgkinson et al. 2004). The functional consequences of this
polymorphism are unknown but magnetic resonance imaging suggests the Phe allele
may be associated with reduced grey matter volume and increased psychotic
symptoms (Malhotra et al. 2006).
Hwu et al. also reported linkage of another chromosome lq marker, D1S251, with
schizophrenia, schizoaffective and additional psychotic disorders in a Taiwanese
population (Hwu et al. 2003). This marker lies upstream of DISCI between the
DISCI and TRAX genes. The TRAX/DISC1 region has been further implicated in
both bipolar and schizophrenia in the Scottish population (Thomson et al. 2005b).
This study provides evidence that the DISCI gene is a susceptibility factor for
psychiatric illness in the general Scottish population and not just in the t( 1; 11)
family.
Interestingly the idea that DISCI may contribute to risk for psychiatric illness in a
sex-dependent manner as originally suggested by the Finnish group (.Hennah et al.
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2003) is supported by other studies demonstrating sex-dependent associations
between DISCI and schizophrenia in a Han-Chinese population and DISCI and
bipolar disorder in the Scottish population (Chen et al. 2006, Thomson et al. 2005b).
Recently a study of a North American family with schizophrenia and schizoaffective
disorder reported an association between a frame-shift mutation within the DISCI
gene and these psychiatric diagnoses (Sachs et al. 2005). The frame-shift mutation
did not however unequivocally segregate with illness and it now appears that a study
of schizophrenia in a UK and Irish population has identified this same mutation in
control subjects but not in schizophrenic subjects (Green et al. 2006). This questions
the relevance of this mutation in the development of psychiatric illness.
In summary positive linkage and associations between the lq region of chromosome
1 and the DISCI gene itself have been reported with respect to schizophrenia,
schizoaffective and bipolar disorder in multiple populations including, British, Irish,
North America, Finnish, Han-Chinese, Icelandic and Taiwanese.
Of course in spite of these positive findings there are also a number of negative
findings which do not support these linkage and association data (Levinson et al.
2002, Kockelkorn et al. 2004, Zhang et al. 2005, Wilson-Annan et al. 1997, Devon et
al. 2001). Two of these studies within the Scottish population use only 2
microsatellite markers and 5 SNPs respectively to determine an association between
DISCI and psychiatric illness (Wilson-Annan et al. 1997, Devon et al. 2001).
Considering the small number of markers tested it is likely that these studies did not
possess the power to detect associations that may have been present. The more recent
association study on the Scottish population by Thomson et al. first constructed a
linkage disequilibrium map of the DISCI region such that informative markers could
be chosen to cover the entire gene region and this study did find positive associations
for the DISCI gene and psychiatric illness (Thompson et al. 2005b).
Two of the other studies which reported negative findings with respect to association
of DISCI and schizophrenia came from the Japanese population (Kockelkorn et al.
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2004, Zhang et al. 2005). It is possible that DISCI is not a major genetic risk factor
for schizophrenia within the Japanese population despite the positive findings in
many additional populations. Of interest however, one recent study within the
Japanese population has reported significant associations for DISCI with major
depression (.Hashimoto et al. 2006). Whilst this study also reported association with
schizophrenia the association was weak (p = 0.0496); however upon analysis of
gender effects a stronger association was determined between DISCI and male
schizophrenic subjects, albeit for a different SNP.
As schizophrenia is a complex illness with multiple interacting genetic factors it is
unlikely that the same genetic risk variants will be present in all populations. It is
likely that this genetic heterogeneity is accountable for failure to replicate linkage to
the lq42 region in a large study of affected sib pairs (Levinson et al. 2002,
Macgregor et al. 2002).
Although the genetic evidence implicating DISCI in psychiatric illness is now
considered to be strong these studies have implicated various regions along the
length of the DISCI gene; these are depicted in figure 1.4.A. With the exception of
the t( 1; 11) translocation these studies have yet to identify a disease causing variant
that affects the function of DISCI. Although these variants are not deemed to be
disease causing, some have been associated with measures of cognitive performance
in affected individuals and therefore are likely to be markers for underlying
functional variants in the DISCI gene. Alternatively they may represent synonymous
disease causing variants similar to the NRG1 polymorphisms that alter expression of
various NRG1 isoforms (Law et al. 2006).
A non-conservative SNP (Ser704Cys) within the DISCI gene has recently been
associated with schizophrenia in a population of schizophrenic patients of American-
European ancestry (Callicott et al. 2005). This SNP results in substitution of a serine
allele with a cysteine within exon 11 of the DISCI gene. The serine allele of this
SNP was seen to be overtransmitted in schizophrenic patients compared to controls.
Furthermore this serine variant was associated with reduced grey matter volume
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within the left hippocampal formation in healthy individuals in addition to abnormal
hippocampal activation (using fMRI) during tests of cognitive function (Callicott et
al. 2005). The serine allele was also associated with minor cognitive abnormalities
and reduced levels of N-acetylaspartate (NAA) within the left hippocampal
formation of schizophrenic individuals (Callicott et al. 2005). The impact of the
Ser704Cys substitution on DISCI function is unknown and again may merely be a
marker of an underlying causative variant within the DISCI gene. What is very
interesting about this particular study is that they examine the effects of the DISCI
variant in healthy subjects and provide evidence that variation in DISCI may alter
brain structure and function in otherwise healthy individuals.
This same Ser704Cys allelic variation has recently been studied within the Scottish
population with respect to normal cognitive ageing in healthy individuals. Cognitive
function was assessed in a cohort of individuals at the ages of 11 and 79. This study
found that there was no direct effect ofDISCI genotype on cognitive function at age
11 although by age 79 there was sex-dependent DISCI genotype effect on cognitive
function with females homozygous for the Cys allele performing relatively poorer
than males of the same genotype (Thomson et al. 2005a). Again this study highlights
the importance of DISCI in cognitive function in healthy individuals; however this
study reports that the Cys allele is associated with cognitive deficits rather than the
Ser allele from the Callicott study. This Ser704Cys SNP has also been associated
with severity of delusions within schizophrenic patients (DeRosse et al. 2006).
The previously reported HEP3 haplotype originally associated with schizophrenia in
the Finnish population (Hennah et al. 2003) has also been associated with impaired
visual attention and working memory in a subset of individuals used in the initial
association study. In fact this haplotype proved more significantly associated with
these cognitive traits than schizophrenia and again some deficits were also seen in
unaffected individuals, further supporting DISC Is role in cognitive function (Hennah
et al. 2005).
Additional associations of the HEP1 haplotype and a rare haplotype derived from the
HEP2/HEP3 haplotypes (from the Hennah et al. 2003 study), have further been
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reported with reduced grey matter density and impairments in long-term and spatial
memory in a twin based study of the Finnish population (Cannon et al. 2005).
A recent study has further confirmed the association between DISCI and
schizophrenia in a second Taiwanese population and also demonstrated sustained
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1.4.2 DISC1 gene structure and evolution
The DISCI gene spans ~400kb of genomic DNA and consists of 13 exons producing
a full length transcript of approximately 7.5kb in length (Millar et al. 2000).
Comparative genomics reveals conservation of DISCI genomic sequence in mouse
(Mus musculus), zebrafish (Danio rerio) and pufferfish (Fugu rubripes) and RT-PCR
confirms the presence of DISCI cDNA sequences (Taylor et al. 2003). The genomic
structure of mammalian DISCI differs from pufferfish and zebrafish, which lack
exon 9a of mammalian DISCI and possess an additional exon 11a that appears to
have been lost in mammalian DISCI homologues. Intron 12 of human DISCI is of
the rare AT/AC type and is conserved between human, mouse and pufferfish (.Millar
et al. 2001, Taylor et al. 2003, Ma et al. 2002).
Mammalian DISCI produces 4 alternative splice isoforms denoted Long (L, full
length, exons 1-13, EMBL:Af222950), Long variant (Lv, excludes distal 66
nucleotides of exon 11, EMBL:AB007926), Short (S isoform, uses an alternative
3'UTR in intron 9 (exon 9a) EMBL:AJ06177) and Extremely short (Es isoform,
terminates transcription two intronic codons after exon 3 EMBL: AJ506178) (Taylor
et al. 2003).
DISCI also shows intergenic splicing with its neighbouring gene TRAX (translin-
associated factor X). This splicing event produces novel fusion transcripts, although
translation of these transcripts is yet to be documented (.Millar et al. 2000). The
TRAX gene produces a 33kDa protein that binds to Translin (Aoki et al. 1997).
Translin is an RNA binding protein with potential involvement in dendritic mRNA
translation, an important process necessary for synaptic plasticity (Muramatsu et al.
1998, Pfeiffer and Huber 2006).
The full length DISCI transcript is translated into a protein of 854 amino acids that is
predicted to consist of a globular N-terminal region and a C-terminal region (Millar
et al. 2000). The N-terminal region contains a nuclear localisation signal (Taylor et
al. 2003) and the C-terminal region contains conserved leucine zipper and coiled-coil
motifs likely to be required for DISCI protein-protein interactions {Millar et al.
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2001, Millar et al. 2000). The mouse ortholog, Disci, also contains this nuclear
localisation signal, leucine zippers and coiled coil domains suggesting they are of
functional importance (Ma et al. 2002). The protein structure ofDISCI is such that it
possesses the ability to bind a multiplicity of protein interactors and therefore is a
likely molecular scaffold protein.
The t(l;l 1) translocation disrupts the DISCI gene within intron 8 resulting in the 3'
end translocating to chromosome 11. If the disrupted DISCI allele on chromosome 1
was transcribed it may produce a truncated transcript that hypothetically could
produce a C-terminally truncated protein lacking many of the coiled coil domains
necessary for DISCI protein interactions.
1.4.3 DISC1 gene expression in mammals
1.4.3.1 DISC1 expression in brain
Initial Northern blotting experiments revealed that DISCI mRNA is expressed in
many adult human tissues (heart, brain, placenta, kidney and pancreas). DISCI
appears to be most highly expressed in human heart and brain with DISCI transcripts
detected in multiple brain regions (Millar et al. 2000). In recent years much work has
been carried out to define more clearly the regions of DISCI expression using the
mouse, rat and monkey as more accessible systems. These studies aimed to
investigate the role of DISCI in brain function and development and with
schizophrenia being increasingly thought of as a neurodevelopmental disorder these
studies are necessary to sustain this current thinking.
Northern blotting of adult mouse tissues detects Disci expression in heart, brain,
kidney and testis (Ma et al. 2002). In concordance with human data, the highest
expression level was detected in heart tissues. Northern blotting in rat also reveals
heart to be the highest expressing tissue (Ma et al. 2002). In situ hybridisation of
adult mouse brain tissue demonstrated high Disci expression in the dentate gyrus of
the hippocampus in addition to low expression in many additional tissues including
the cerebellum, cerebral cortex, ammon's horn and olfactory bulbs. Very low
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expression was also detected within the paraventricular and arcuate nuclei of the
hypothalamus and amygdala {Ma et al. 2002). A further study of rodent Disci
demonstrated expression within hippocampal, cortical, cerebellar and olfactory
neurons of rat brains {Miyoshi et al. 2003).
Subsequent in situ studies for DISCI in brains of adult African Green Monkeys also
revealed widespread expression including the lateral septum and dentate gyrus of the
hippocampus and lower expression within the cerebral cortex, amygdala, cerebellum,
paraventricular hypothalamus and the interpenduncular and subthalamic nuclei
{Austin et al. 2003).
Thus, the most consistent observation common to rodent and primates is prominent
expression in the dentate gyrus. This is an interesting finding considering the
neurodevelopmental abnormalities of the hippocampus implicated in schizophrenia.
The cerebral cortex and the cerebellum also express DISCI in these three species
whilst other regions of expression differ. Although this may be due to differences in
experimental methods, including the library used to isolate the DISCI probe and the
isoforms of DISCI detected by each probe it is also possible that DISCI performs
distinct functions in rodent brains to that of the primate brain.
Attempts to determine a developmental expression profile for Disci have shown that
Disci is expressed in the hippocampus throughout mouse brain development from
embryonic day 14 to postnatal day 21. Disci appears to be expressed more
prominently in amnion's horn at birth but this expression diminishes during postnatal
stages in favour of increased expression in the dentate gyrus. Disci expression is
seen in cortical neurons and interneurons at the time of neuronal birth and migration
{Austin et al. 2004). The finding that Disci is expressed throughout brain
development is further supported by expression studies of the DISCI protein in the
developing mouse brain (Schurov et al. 2004). This study demonstrated DISCI
expression in similar limbic brain regions to the mRNA studies. DISCI expressing
cells were neuronal in nature, both excitatory and inhibitory. Furthermore, a lOOkDa
DISCI isoform demonstrated dynamic expression during mouse brain development
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with most prominent expression at embryonic day 13.5 and postnatal day 35, which
correspond to periods of active neurogenesis and puberty respectively (Schurov et al.
2004).
DISCI is well placed for a role in schizophrenia considering its widespread
expression in the brain and prominent expression in the hippocampus and other
limbic brain regions. Hippocampal function has been implicated in schizophrenia and
hippocampal lesions in rodents and primates can lead to neuropsychological defects
including cognitive, locomotor and behavioural abnormalities similar to those
reported in schizophrenia (Bachevalier et al. 1999, Swerdlow et al. 2001, Lipska
2004, Marquis et al. 2006).
Although the expression ofDISCI in the brain is most intriguing due to the nature of
illness caused by disruption by the translocation (i.e. severe psychiatric illness),
DISCI has also been seen to be highly expressed in heart tissue from human, mouse
and rat, and therefore may play additional important functions in other locations.
1.4.3.2 Sub-cellular DISC1 expression in cultured cells
Using cell culture techniques, exogenous and endogenous DISCI protein expression
has been studied in detail in many mammalian cell types, including primary cells and
established cell lines. DISCI has a very varied expression pattern occupying many
sub-cellular locations including the cytoplasm, cytoskeleton, nucleus, mitochondria
and centrosome (Ozeki et al. 2003, Morris et al. 2003, Miyoshi et al. 2004, Brandon
et al. 2004, James et al. 2004, Brandon et al. 2005, Kamiya et al. 2005, Ogawa et al.
2005, Millar et al. 2005a). These sites of DISCI expression are depicted in figure
1.4.B and will be discussed in more detail in relation to the function of DISCI in
subsequent sections.
Similar to studies of DISCI expression in brain tissues a number of these studies
using cell lines have demonstrated changes in DISCI expression which are related to
neuronal differentiation. DISCI expression is seen to be augmented in differentiating
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rodent neuronal (PC 12) cells and coincides with movement of the DISCI protein
from cytoplasmic puncta into neurite-like processes (Ozeki et al. 2003). A similar
change is DISCI distribution has been reported using a human neuroblastoma cell
line (SH-SY5Y) {James et al. 2004). Furthermore, in cultured rat hippocampal
neurons DISCI expression has been localised in growth cones {Miyoshi et al. 2003).
Studies of DISCI interacting proteins should give insights into the many potential
functions of DISCI within each sub-cellular compartment and hopefully will enable
us to understand the role of DISCI in the mammalian brain and how it may













Figure 1.4.B. DISC1 has been shown to be expressed in multiple sub-cellular locations
within mammalian cells. These locations which are depicted here include the
mitochondrion, the nucleus, the centrosome and the cytoplasm (in particular the
perinuclear region).
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1.5 DISC1 function and protein interactions
1.5.1 DISC1 yeast two-hybrid studies
To date, seven yeast two-hybrid screens have been carried out with the aim of
identifying DISCI interacting proteins {Millar et al. 2003, Morris et al. 2003,
Miyoshi et al. 2003, Ozeki et al. 2003, Miyoshi 2004, Brandon et al. 2004, Camargo
et al. 2006). The yeast two-hybrid study by Millar et al. uncovered 21 potential
interactors by screening human (adult and foetal) brain libraries. The proteins
identified were from multiple sub-cellular compartments including the cytosol,
centrosome, golgi, nucleus, cell membrane and the mitochondria. Seven of the clones
identified in this screen produced very strong interactions with DISCI. Of these
seven proteins, two are centrosomal proteins (NUDE and NUDEL (NudE-like), one
protein localises to both the centrosome and the golgi (AKAP9), one additional golgi
protein (GM130) was also amongst the strong interactors and three further
cytosolic/nuclear proteins were identified (ATF4, GRIPAPI, ARHGEF11). If these
proteins represent true DISCI interactors then DISCI is clearly a multi-functional
protein.
Additional yeast two-hybrid studies also identified ATF4 and NUDEL as potential
DISCI interactors {Morris et al. 2003, Ozeki et al. 2003, Brandon et al. 2004). These
studies suggest that DISCI may play important roles in transcriptional regulation
within the nucleus/cytosol through interactions with ATF4, and also at the
centrosome via interactions with NUDEL. Two additional yeast two-hybrid studies
again using human brain cDNA libraries identified a further centrosomal protein
kendrin/pericentrin-B {Miyoshi et al. 2004) and FEZ1 (fasciculation and elongation
protein zeta-1), a protein involved in axonal outgrowth and fasciculation {Miyoshi et
al. 2003).
Most recently a study of the DISCI interactome has been published {Camargo et al.
2006). This study utilised a yeast two-hybrid system to identify and categorise
DISCI interactors into functional networks. This study strongly supports the multi-
functionality of the DISCI protein, with DISCI protein:protein interactions
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postulated to pay a role in many biological processes including biogenesis and
organisation of the cytoskeleton, mRNA and protein synthesis, cell cycle and cell
division and intracellular transport and signalling. The majority of interactions
presented within this interactome however are yet to be confirmed experimentally.
1.5.2 DISC1 at the centrosome
The centrosome represents the microtubule organising centre (MTOC) of
mammalian cells, a highly complex organelle that functions to nucleate and organise
microtubules. Published literature suggests that more than 100 regulatory proteins
localise to the centrosome, creating a hub of activity and a control centre for multiple
diverse cellular functions (Doxsey et al. 2005). Coiled coil domains, as seen in
DISCI, are common to many of the regulatory proteins that localise to centrosomes.
The centrosome has a key role in cell cycle progression and neuronal migration both
of which will be discussed in more detail in the following sections. In addition, the
centrosome acts as a centre of proteolytic activity with components of the ubiquitin-
proteosome degradation pathway (UPD pathway) concentrated here. This pathway is
important for mediating many cellular processes including cellular differentiation,
stress response, neurotransmission and apoptosis (Badano et al. 2005). Furthermore
the centrosomal UPD pathway has been implicated in Parkinson's disease
(Nussbaum and Ellis 2003, Badano et al. 2005).
1.5.2.1 The centrosome in cell cycle progression
Centrosomes have a critical role in cell cycle progression and mitosis. The
mammalian cell cycle consists of four stages, Gi, S phase, G2 and M phase, in
addition to a Go stage in which cells remain quiescent. M phase is the stage at which
cells undergo mitosis. Mitosis itself has 7 progressive stages, Interphase, Prophase,
Prometaphase, Metaphase, Anaphase, Telophase and Cytokinesis. During interphase
the DNA replicates and centrioles are duplicated; this replicated DNA and the
associated proteins condense to form visible chromosomes during prophase; the
microtubule cytoskeleton disassembles leaving free building blocks of tubulin to
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generate the mitotic spindle which forms during prometaphase; once the mitotic
spindle is formed sister chromatids attach via associated protein bundles which form
the kinetochore; these chromosome are then aligned at the centre of the cell during
metaphase to form the metaphase plate; once the chromosomes are in the correct
alignment anaphase commences, during which the spindle fibres of the mitotic
spindle shorten and the sister chromatids become separated; this process continues
into telophase, the point at which the chromatids arrive at opposite poles of the
mitotic spindle ready for cytokinesis; an actin ring then contracts in the region of the
metaphase plate producing two daughter cells which re-organise a new microtubule
cytoskeleton before beginning the whole process again (Sullivan 2006
http://www. cellsalive.com/mitosis.html).
The cell cycle is an intricate process into which multiple checkpoints are
incorporated. These checkpoints monitor the cells size and environment as well as
DNA replication and alignment of chromosomes during metaphase. Cells that evade
checkpoint controls are harmful to the organism as they may accumulate mutations
due to errors during DNA replication or produce chromosomal abnormalities due to
misalignment of chromosomes. A comprehensive review of the cell cycle and its
regulation is beyond the scope of this introduction, but some salient features will be
mentioned.
Accumulation ofmany regulatory proteins at the centrosome has been documented to
be important for cell cycle progression; some of these are known regulators of the
cell cycle whereas others have a less well defined role. These regulatory proteins and
protein complexes include Cdkl-cycB, Aurora-A kinase, Polo kinase, Pericentrin
B/Kendrin, AKAP450-PKA, y-tubulin and Pericentrin-yTuRC (Prigozhina et al.
2004, Kramer et al. 2004, Zimmerman et al. 2004, Hirota et al. 2003, Keryer et al.
2003, Marumoto et al. 2003, Gillingham and Munro 2000, Lee et al. 1998). These
proteins have importance not least for entry into mitosis from G2 but also for the
transition between Gi to S phase, cytokinesis and mitotic exit (Doxsey et al. 2005).
Consistent with these data, removal of whole centrosomes by microsurgery results in
mitotic defects (Hinchcliffe et al. 2001, Khodjakov and Rieder 2001). Centrosomes
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may also play a role in responding to genotoxic stress by inducing mitotic
catastrophe, a process whereby mitotic division of aberrant cells fails providing a
mechanism of eliminating these cells from the normal cycling population (Doxsey et
al. 2005).
1.5.2.2 The centrosome in nuclear migration and nucleokinesis
Neuronal migration occurs as a stepwise process. In the first instance the migrating
neurons extend a leading process (neurite) in response to chemoattractants or
chemorepellants. This is then followed by translocation of the centrosome into the
leading process, followed by the nucleus and retraction of the trailing process (Tsai
and Gleeson 2005). It is postulated that the centrosome plays a role in determining
the direction ofmigration and in nuclear translocation into the leading process, which
is termed nucleokinesis (Badano et al. 2005). Some of the key players in this process
are components of a conserved nuclear migration pathway, including LIS 1, NUDEL
and Cytoplasmic Dynein.
Nudel (NudE-like or Ndell) is the mammalian homologue of the Aspergdlus
nidulans nudE gene. NudE is known to interact with nudF, which is homologous to
mammalian Lisl (Xiang et al. 1995, Efimov and Morris 2000). The nudF and nudE
genes were so named as they were initially identified as nuclear distribution mutants
(nud mutants). The nudF and nudE genes are important components of the nuclear
migration pathway in A. nidulans. A. nidulans is a multinucleate filamentous fungi
and this nuclear migration pathway is essential for nuclei to migrate towards the
hyphal tip of the growing fungal colony (Morris 2000). Cytoplasmic dynein is
another important component of this nuclear migration pathway as it was also
identified as a nud mutant, nudA, in A. nidulans (Morris 2000). Mammalian
homologues LIS1 and NUDEL also interact with cytoplasmic dynein and recently
there has been much research aiming to elucidate the individual functions and the
mechanism of interaction of these proteins (Niethammer et al. 2000, Sasaki et al.
2000).
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One current model of nuclear migration proposes that the nucleus is attached to the
microtubule network via LIS1 at the centrosome and a microtubule stabilising
protein DCX at the nucleus. The ability of NUDEL and Dynein to bind LIS1 then
provides a means for dynein, a molecular motor protein involved in retrograde
movement along microtubules, to move the nucleus towards the centrosome, located
in the leading process of the migrating neuron (Badano et al. 2005). This model
proposes that NUDEL, LIS1 and Dynein interactions link the nucleus, centrosome
and microtubule network making nucleokinesis possible. Research in this area is now
providing evidence in support of such a model some ofwhich is outlined below.
LIS1 is known to play an important role in neuronal migration in mammals as
mutations in the Lisl gene result in lissencephaly, a developmental brain disorder
resulting in smooth cerebral surface and disorganisation of cortical layers due to an
arrest in neuronal migration {Reiner et al. 1993, Dobyns et al. 1993, Lo Nigro et al.
1997). LIS1 and NUDEL are highly co-expressed during neuronal development and
a direct interaction between these two proteins has been observed by yeast two-
hybrid screening and co-immunoprecipitation {Niethammer et al. 2000, Sasaki et al.
2000). The NUDEL/LIS1 interaction may be particularly important in neuronal
migration as point mutations in the Lisl gene which affect its interaction with
NUDEL have been found in human patients with lissencephaly {Lo Nigro et al. 1997,
Sasaki et al. 2000). As nuclear migration is an important feature of neuronal
migration the roles of NUDEL and LIS1 in this process may explain the neuronal
migration defects seen in lissencephaly.
Microtubule dynamics are also an important feature of neuronal migration as nuclear
translocation requires a close association of the nucleus with the microtubule
organising centre (MTOC or centrosome) {Morris 2000, Tsai and Gleeson. 2005).
NUDEL and LIS1 have been localised to the centrosome in developing neurons and
therefore it is plausible that they may play a role in the nucleokinesis aspect of
neuronal migration {Niethammer et al. 2000, Sasaki et al. 2000).
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Cytoplasmic dynein is a multi-subunit protein complex consisting of heavy,
intermediate and light chains. Both LIS1 and NUDEL can bind directly to
cytoplasmic dynein heavy chain (Sasaki et al. 2000). Cytoplasmic dynein heavy
chain also possesses an intrinsic ATPase activity and homo-dimers of LIS 1 have
been shown to regulate this ATPase activity of cytoplasmic dynein (Smith et al.
2000, Mesngon et al. 2006). Furthermore, NUDEL is required to facilitate this
interaction between LIS1 and cytoplasmic dynein and in budding yeast it has been
demonstrated that this NUDEL/LIS1 interaction is necessary to target dynein to
microtubule ends (Shu et al. 2004, Li et al. 2005).
To examine the effects of disrupting this conserved nuclear migration pathway Shu et
al. performed RNA interference to reduce expression of all three components.
Migrating neurons that have been treated using RNAi to silence any of the three
components of this nuclear migration pathway (NUDEL, LIS1 or Dynein) produce
neuronal migratory defects (Shu et al. 2004). Furthermore, in the subset of RNAi
treated neurons that have not migrated correctly there is a reported increase in the
distance between the nucleus and the centrosome. This suggests that translocation of
the nucleus into the leading process of the migrating neuron may be affected (Shu et
al. 2004). Indeed these neurons are seen to complete the first stage of migration
correctly by extending an outgrowing neurite, but the distance that the nucleus
travels is much shorter than in control neurons (Shu et al. 2004). It appears to be the
case that neurons cannot migrate successfully unless this nuclear migration pathway
is fully functional as all three components are necessary in order for neurons to
migrate and position correctly. Although Shu et al. did not report changes in
neuroblast proliferation, reductions in LIS1 have previously been shown to result in
increased programmed cell death and decreased neuroblast proliferation (Gambello
et al. 2003). Therefore it is possible that some neuronal migratory defects may also
result from a decrease in the numbers of viable neurons.
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1.5.2.3 DISC1 interacts with components of a conserved nuclear
migration pathway and plays a role in neuronal migration
Yeast two-hybrid studies identified NUDEL as a robust DISCI interacting protein.
This NUDEL-DISC1 interaction has been confirmed by co-immunoprecipitation and
immunofluorescence experiments (Brandon et al. 2004, Kamiya et al. 2005). DISCI
has been found to co-exist with NUDEL as part of a neurodevelopmentally regulated
macromolecular complex in mouse brain lysates (Brandon et al. 2004). DISCI has
also been shown to bind LIS 1, suggesting the existence of a DISC1/NUDEL/LIS1
multi-subunit complex (Brandon et al. 2004). NUDEL and LIS1 are established
evolutionarily conserved interactors but this new data proposing DISCI as a third
component of this macromolecular complex gives exciting clues as to the potential
functions of DISCI.
LIS1 has dose-dependent effects on neuronal migration and haploinsufficiency of the
Lis1 gene is sufficient to perturb neuronal migration and give rise to lissencephaly
(.Reiner et al. 1993, Lo Nigro et al. 1997, Gambello et al. 2003). It is conceivable that
if DISCI functions in the same pathway as LIS1, that haploinsufficiency for full
length DISCI as seen in the t( 1; 11) family may also produce defects in nuclear
translocation and hence neuronal migration. This is an attractive hypothesis as
schizophrenia is considered to be a disorder of mis-connectivity resulting from
aberrant neuronal migration (Harrison and Weinberger 2005).
A recent study by Kamiya et al. 2005 has demonstrated that in addition to NUDEL
and LIS1, DISCI also co-immunoprecipitates with y-tubulin, Dynactin (pl50glucd)
and Dynein intermediate chain (Dyn IC) providing further evidence that it may play
a role in the nuclear migration pathway. However this data is contradictory to data
published previously. Brandon et al. 2004 showed that DISCI and LIS1 indeed
interact either in a direct manner or indirectly via DISCI binding to NUDEL;
however this study reported that DISC 1 does not immunoprecipitate y-tubulin or any
other Dynein related proteins.
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Despite this contradictory data, which may be due to methodological differences, it is
interesting that DISCI may function as part of the conserved LISl/NUDEL/Dynein
nuclear migration pathway. Kamiya et al 2005. performed RNA interference
experiments to reduce DISCI levels in the developing mouse brain, similar to the
Lis1/Nudel/Dynein RNAi experiments by Shu et al. 2004. These experiments aimed
to address the role of DISCI in neuronal migration. Kamiya et al. 2005 delivered
DISCI shRNA into developing mouse brains by in utero electroporation at
embryonic day 14. They found that reducing DISCI levels resulted in a severe
neuronal migration defect by postnatal day 2, with neuronal migration 'virtually
inhibited' following RNAi for DISCI. Furthermore examination of the orientation of
neurons that did migrate, at postnatal day 14, showed that these neurons were
malpositioned and had reduced dendritic outgrowth. Similar to the Shu et al. 2004
study Kamiya et al. 2005 also measured the distance between the nucleus and
centrosome in migrating neurons which had received DISCI shRNA and found that
the distance between the nucleus and the centrosome was significantly increased
relative to control neurons at embryonic day 18.5. Intriguingly Kamiya et al. 2005
demonstrate similar neuronal migration defects in mice transfected in utero with a
hypothetical 'mutant' C-terminally truncated DISCI protein that could theoretically
be produced by the t(l; 11) translocation.
Extended analyses demonstrate that this 'mutant' DISCI protein disrupts the P-
tubulin microtubule network, fails to immunoprecipitate LIS1, NUDEL or Dynein
and causes re-distribution of these proteins from the centrosome. The authors suggest
that interaction between the full length (wild-type) DISCI and the 'mutant' DISCI
via a self-association domain results in less available full length DISCI, due to
mislocalisation. The authors imply that the 'mutant' DISCI acts in a dominant-
negative manner; however mislocalisation of DISCI by 'mutant' DISCI would also
mimic a haploinsufficient phenotype as less DISCI is available for protein
interactions (Porteous and Millar, 2006). Although the specific mechanism is
debatable this 'mutant' DISCI protein is postulated to affect the ability of full length
DISCI to interact with LIS 1, NUDEL and Dynein in the correct sub-cellular location
and hence results in inhibition of neuronal migration. These neuronal migratory
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defects during embryonic brain development are proposed by Kamiya et al. 2005 to
explain the high incidence of psychiatric illness in the t(l;l 1) family.
Although the experimental design of this study is impressive, certain aspects of the
study are not clear. The authors describe the use of a 'strong suppressor' of DISCI
(referred to as RNAi #1). The authors use co-transfection of exogenous DISCI and
shRNA constructs to determine the levels of protein knockdown by western blotting.
Refer to figure 1.5.A (Figure 5 (a) Kamiya et al 2005). From this exogenous DISCI
knockdown (upper panel) they infer that RNAi #1 has 'strong suppression' of
DISCI, although the same cannot be said for the levels of endogenous knockdown
seen in the bottom panel of this figure. This study does not state which antibody has
been used to detect DISCI. Previously this group has produced DISCI N-terminal
and C-terminal antibodies which detect both lOOkDa DISCI and 75kDa DISCI in
PC 12 cells (Ozeki et al. 2003). Ozeki et al. state that differentiating PC 12 cells have
augmented DISCI expression in comparison to undifferentiated cells, with both
lOOkDa and 75kDa isoforms detectable. In this study Kamiya et al. 2005 are
examining DISCI knockdown in differentiating PC 12 cells however it is not clear
whether the 75kDa isoform of DISCI is detected or indeed knocked down as the
only the lOOkDa DISCI band is shown by western blotting.
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Figure 1.5.A. (Figure 5 (a) from Kamiya et al. 2005). In this diagram the upper panel shows
DISC1 knockdown induced by co-transfection of exogenous DISC1 and DISC1 shRNA
constructs. The lower panel shows DISC1 RNAi induced knockdown of the endogenous
protein.
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These levels of DISCI knockdown would not be sufficient to analyse RNAi
phenotypes at a cell population level; however Kamiya et al. 2005 have managed to
show endogenous DISCI knockdown on an individual cell basis by













Figure 1.5.B. (Figure S2 (a) from Kamiya et al. 2005). This figure depicts knockdown of
DISC1 by immunofluorescence following RNAi. The 'strong suppressor' #1 does indeed
result in reduced DISC1 protein levels in transfected cells.
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The in utero electroporation experiments of DISCI shRNA into developing mouse
brains demonstrated that the strong suppressor RNAi #1 inhibited almost all neuronal
migration and construct RNAi #2 produced a weaker inhibition. In addition the
distance between the nucleus and the centrosome in transfected neurons, that had
managed to migrate, was significantly increased in comparison to control neurons.
Surprisingly however the distance was generally greater in migrating neurons that
received the RNAi #2 'weak' construct than in those that had received the RNAi #1
'strong' construct.
To summarise the study, Kamiya et al. 2005 has shown that RNAi for DISCI
produces migratory defects similar to that of over-expressing 'mutant' DISCI (see
also Ozeki et al. 2003). Extended analysis of the over-expression of 'mutant' DISCI
shows disruption of the microtubule network and perturbations in the accumulation
ofNUDEL and LIS 1 at the centrosome. The suggestion from the RNAi work is that
this neuronal migration defect is a secondary effect resulting from defects in
nucleokinesis. The authors draw parallels between the phenotypes obtained using
RNAi and that of over-expression of 'mutant' DISCI and Kamiya et al. 2005 place a
lot of emphasis on the adverse effects of the 'mutant' DISCI protein on the
LISl/NUDEL/Dynein pathway. However, production of this truncated protein has
never been demonstrated in individuals possessing the t( 1; 11) translocation. This
should not detract from the RNAi work, which clearly has exciting implications for
the role of DISCI in neuronal migration. The RNAi generated neuronal migration
phenotypes reported in this paper are exciting as DISCI haploinsufficiency is the
potential disease mechanism operating within the t(l;l 1) family.
To date, Kamiya et al. 2005 are alone in their observations of endogenous DISCI at
the centrosome. Over-expression studies have however demonstrated the existence of
DISCI at the centrosome (Morris et al. 2003, Miyoshi et al. 2004, Millar et al.
2005a). Clearly additional work needs to be carried out to characterise the multiple
potential sub-cellular locations of endogenous DISCI.
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1.5.3 DISC1 at the mitochondria
In addition to the centrosome another prominent site of DISC l expressions appears
to be the mitochondrion (James et. al. 2004). Mitochondrial dysfunction has been
implicated in schizophrenia (Ben-Shachar, 2000). Key functions of the
mitochondrion such as oxidative phosphorylation and calcium homeostasis are
important for synaptic plasticity and the role of the mitochondrion in apoptosis is
essential for normal brain development (.Ben-Shachar, 2002). Apoptosis is important
to limit and mould cortical connectivity in the developing brain affecting neural
precursor cells, immature neurons and synapse-bearing neurons {Morilak et al. 2000,
Roth and D'Sa, 2001). In particular apoptosis related to the mitochondrial
apoptosome appears to be important and mitochondria isolated from immature neural
precursors are more sensitive to apoptosis induction than those of mature neurons
{Roth andD 'Sa, 2001, Polster et al 2003).
DISCI has been shown to interact by yeast two-hybrid assay with mitofilin (IMMT),
a protein present within the inner mitochondrial membrane (.Millar et. al. 2003). The
function of IMMT is currently unknown and lends no clues to the potential role of
DISCI in the mitochondrion. Further evidence shows that mitochondrially located
DISCI is resistant to trypsin digestion which is consistent with DISCI being located
within the mitochondrion or within the mitochondrial membrane {James et al. 2004).
Currently there are two clues to functions that DISCI may perform at the
mitochondria. Firstly, over-expression of DISCI results in a mitochondrial ring
phenotype suggesting that DISCI may be involved in mitochondrial fission and
fusion {Millar et al. 2005a). Secondly, recent data demonstrating an interaction
between 71kDa DISCI and Phosphodiesterase type 4B suggests that DISCI may be
involved in cAMP signalling at the mitochondria {Millar et al. 2005b). Considering
the implications of mitochondrial dysfunction in schizophrenia, it will be of great
interest to further examine the role ofDISCI at the mitochondria.
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1.5.4 DISC1; A molecular bridge linking components of the cAMP
signalling pathway?
1.5.4.1 Compartmentalisation of cAMP signalling
Cyclic AMP (cAMP) is a signalling molecule which transduces the primary signals
of hormones and neurotransmitters interacting with their cognate membrane bound
receptors. Cyclic AMP is synthesised by adenylate cyclases and is coupled to
receptor signalling at the membrane. Membrane bound signals are transduced via
cAMP to activate Protein kinase A (PKA), which subsequently phosphorylates
downstream target genes, thus eliciting a signal transduction cascade. Following this
signalling cascade cAMP is degraded to 5'AMP by locally expressed
phosphodiesterases thus re-setting baseline cAMP signals within the cell (Beavo and
Brunton 2002, Houslay and Adams 2003). Sub-cellular targeting of PKA and other
regulatory proteins to specific sites of action is an essential feature of the cAMP
signalling cascade. Protein kinase A is trafficked and anchored at specific sub¬
cellular locations by molecular scaffold proteins called A-Kinase Anchor Proteins
(AKAPs) (Feliciello et at. 2001). There are numerous AKAP proteins each with the
ability to bind PKA but which localise to independent sub-cellular locations thus
providing a mechanism to compartmentalise cAMP signalling (Colledge and Scott
1999, Diviani and Scott 2001).
Cyclic AMP signalling has implications for psychiatric illness and related brain
disorders as it plays an important role in learning and memory. The
phosphodiesterase responsible for degrading cAMP was first identified by genetic
screening for learning and memory defects in Drosophila (Dudai et al. 1976, Chen et
al. 1986). As aforementioned, cAMP potentiates signals by activating PKA; PKA
acts by phosphorylating CREB, a transcription factor that then goes on to elicit
transcription of downstream genes. Genes transcribed by CREB have been
implicated in long term potentiation and CREB mutant mice produce deficits in LTP,
learning and memory (Bauman et al. 2004).
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1.5.4.2 DISC1 interacts with components of the cAMP signalling
pathway
A yeast two-hybrid study for DISCI originally identified AKAP9 as a putative
interacting protein (Millar et al. 2003). AKAP9 is a multiply spliced gene which
encodes multiple protein isoforms (Keryer et al. 1993, Lin et al. 1998, Schmidt et al.
1999, Takahashi et al. 1999). The largest isoform produced from this gene,
AKAP450, is located predominantly at the centrosome; however its protein alias CG-
NAP (Centrosome- and golgi-localised PKN-associated protein) is so named because
it has been documented to exist at the centrosome and golgi apparatus (Witczak et al.
1999, Takahashi et al. 1999). AKAP450/CG-NAP is reported to localise to the
centrosome in interphase cells, at the mitotic spindle poles in metaphase cells and
additionally at the cell midbody during telophase and cytokinesis (Takahashi et al.
1999). AKAP450/CG-NAP will subsequently be referred to as AKAP450.
The dynamic localisation of AKAP450 at the centrosome during mitosis suggests
that it may play a role in cell cycle progression. Indeed it has been demonstrated that
perturbation of AKAP450s role at the centrosome produces defects in the cell
division cycle (Keryer et al. 2003). The centrosomal targeting domain of AKAP450,
the PACT domain, has been localised to the C-terminus of the protein (Gillingham
and Munro, 2000). By exogenously expressing the PACT domain of AKAP450
Keryer et al. 2003 demonstrated displacement of endogenous AKAP450 and PKA
type II from the centrosome. This manifested as defects in centriole duplication and a
block in cell cycle progression (Keryer et al. 2003). Core components of the
centrioles and centrosome, were not found to be affected in this study in the same
manner as PKA type II suggesting that cAMP signalling at the centrosome is
important for cell cycle progression.
Recently a member of the type 4 phosphodiesterase gene family, PDE4D3, has been
shown to be phosphorylated by PKA type II and to co-localise and interact with
AKAP450 at the centrosome (McCahill et al. 2005). Type 4 phosphodiesterases
specifically inactivate cellular cAMP helping to maintain intracellular cAMP
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gradients (Houslay and Adams, 2003). This particular AKAP/PKA/PDE complex
may be of particular importance at the centrosome and in cell cycle progression.
Furthermore PDE4D3 has recently been shown to bind DISCI using a co-
transfection followed by immunoprecipitation approach (Millar et al. 2005b) and
AKAP450 has previously been identified as a putative DISCI interactor by yeast
two-hybrid screening (Millar et al. 2003). AKAP450 is known to bind PKA type II
and localise it to the centrosome (Keryer et al. 2003) and has also been shown to
bind PDE4D3 at the centrosome (McCahill et al. 2005). This suggests a potential
AKAP mediated mechanism for regulating the interaction between PDE4D3 and
PKA type II at the centrosome, with DISCI potentially playing a role in this process.
DISCI has a documented role in binding to type 4 phosphodiesterases but the only
interaction studied in detail is that of DISCI and PDE4B1 at the mitochondrion
(Millar et al. 2005b). The proposed interaction between DISCI and PDE4B1 is one
whereby DISCI binds and renders PDE4B1 inactive until such time as PDE4B1
becomes phosphorylated and undergoes a conformational change resulting in release
of DISCI. This proposed mechanism would maintain PDE4B1 in an inactive state,
thus blocking hydrolysis of cAMP, until such time as PKA, perhaps delivered by a
mitochondrial AKAP, can release the inhibition of DISCI upon PDE4B, resulting in
hydrolysis of cAMP. These protein interactions create an auto-regulatory loop for
maintaining intracellular gradients of cAMP at the mitochondrion. These processes
are common throughout the cell and specific combinations of PKA, PDEs, AKAPs
and potentially DISCI, present in specific sub-cellular compartments, may function
to regulate local cAMP gradients.
Therefore as DISC1/PDE4B1 is to the mitochondrion, so DISC1/PDE4D3 may be to
the centrosome. But the question remains as to whether DISCI, or specific isoforms
ofDISCI, are expressed in such a compartmentalised manner?
There is support for DISCI interaction with additional centrosomal proteins from
work by Miyoshi et al. who identified the protein kendrin (also known as Pericentrin-
B) as a putative DISCI interactor by yeast two-hybrid screening (Miyoshi et al.
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2004). The DISCl/Kendrin interaction was confirmed in cultured cells by
immunoprecipitation and immunofluorescent co-localisation. Furthermore this
interaction was deemed necessary to localise DISCI at the centrosome (Miyoshi et
al. 2004). Kendrin is a large centrosomal protein which exhibits restrictive
localisation to the poles of the mitotic spindle during mitosis (Flory et al. 2000).
Kendrin co-localises with Pericentrin and y-tubulin at the poles of the mitotic spindle
and is postulated to play a role in microtubule nucleation during spindle formation
{Flory et al. 2000).
Interestingly kendrin has been shown to interact with AKAP450 in vivo and to form
complexes with AKAP450, y-tubulin and one of the yTuRC proteins, necessary to
nucleate microtubules during mitotic spindle formation {Takahashi et al. 2002). It
was also reported that disrupting this complex formation inhibited microtubule
nucleation from isolated centrosomes suggesting that AKAP450 and kendrin may
provide a mechanism for anchoring yTuRC to the centrosome (Takahashi et al.
2002). The fact that DISCI may form complexes with either or all of these proteins
indirectly implicates DISCI in cAMP signalling and mitosis.
Although DISCI has been shown to co-localise to the centrosome when over-
expressed {Morris et al. 2003, Miyoshi et al. 2004, Millar et al. 2005a), only one of
three studies of endogenous DISCI have localised DISCI to the centrosome, whilst
the other studies place DISCI predominantly at the mitochondria {Brandon et al.
2004, James et al. 2004, Kamiya et al. 2005). Therefore the potential for DISCI
interactions at the centrosome is tantalising but further demonstration of endogenous
DISCI at the centrosome is needed to substantiate the current speculations.
1.6 The DISC2 gene
1.6.1 DISC2; Gene structure, evolution and expression
With DISCI emerging as an important candidate gene involved in the aetiology of
schizophrenia it will be imperative to understand how DISCI is regulated within the
cell. One gene, which could be of paramount importance in regulation of DISCI, is
DISC2. DISC2 is also disrupted by the t( 1; 11) translocation and as such may also
have important implications for schizophrenia. DISC2 is located on the opposite
strand to DISCI and is transcribed in a distal to proximal orientation thus
representing a natural antisense transcript partially overlapping DISCI (Millar et al.
2000).
To date 15kb of DISC2 sequence has been published (AF222981, Millar et al. 2000).
This sequence encompasses one large exon, with the 3' end residing within intron 8
of the DISCI gene; the 5' end of this gene remains uncharacterised (Millar et al
2000, Taylor et al. 2003) and is hypothesised to lie within intron 9 of DISCI. This is
a very large intron of approximately 150kb in length in humans. Furthermore, the
large size of this intron appears to be conserved across species with mouse Disci
intron 9 being approximately 51 kb (Ma et al. 2002). This suggests that intron 9
sequence is functionally important in some manner, possibly because it harbours the
DISC2 gene; however no species conservation has been detected for DISC2 (Taylor
et al. 2003).
Detailed analysis of the known DISC2 sequence has identified the longest open
reading frame as 57 codons in length, with the context of the putative start codon
unlikely to initiate translation (Taylor 2001, PhD Thesis). Therefore DISC2 is
presumed to be a non-coding RNA gene. Expression of this gene has been reported
in human heart where it appears to produce multiple splice isoforms (Millar et al.
2000)
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1.6.2 Genetic evidence supporting DISC2 as a schizophrenia
candidate gene
Although the genetic evidence for DISCI is strong with many positive linkage and
associations across the length of the gene, these studies do not rule out DISC2 as a
candidate gene. In fact none of these genetic studies can discriminate between DISCI
and DISC2 in terms of positive linkage and association because at best linkage
studies define only a region of interest, and association studies identify markers that
are in linkage disequilibrium with the causative mutation and not necessarily the
actual disease casing variant. Furthermore many of these positive studies report
markers that are within the DISC2 gene region (Hennah et al. 2003, Hodgkinson et
al. 2004, Ekelund et al. 2001, Ekelund et al. 2004, Cannon et al. 2005). Therefore
DISC2 represents an important schizophrenia candidate gene in its own right. See
figure 1.4.A which depicts these linkage and association data within the DISCI gene.
It is difficult to hypothesise how disruption of the DISC2 gene is relevant to
psychiatric illness as the gene is not fully characterised. One possibility however is
that as a non-coding RNA gene DISC2 functions to regulate the expression of its
cognate sense partner DISCI. This and other functional possibilities are discussed in
the following sections.
1.6.3 Non-coding RNA molecules and antisense gene regulation
The central dogma states that DNA gives rise to RNA which gives rise to protein.
However we now know that this is not necessarily the case and that not all RNA
gives rise to protein, nor does RNA need to code for protein to possess functionality.
It has become apparent in recent years that non-coding RNA molecules, many of
which are produced from antisense transcripts, are more widespread within the
human genome than initially thought. Indeed non-coding RNA molecules are some
of the most important regulatory molecules in the cell and are absolutely required for
normal transcription and translation. Since the completion of the human genome
project it has become evident that an organism's complexity cannot alone be
attributed to the number of protein-coding genes it possesses {International Human
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Genome sequencing Consortium, 2004). Paradoxically it appears that the more
complex the organism, the less of its genome actually codes for protein (Szymanski
and Barciszewski 2002). For example 86% of the genome of Escherichia Coli codes
for protein whereas only 29% of the genome of Arabidopsis Thaliana codes for
protein and perhaps even more strikingly, only 1.4% of the human genome codes for
protein {Szymanski and Barciszewski, 2002). There must therefore be something
other than proteins contributing to the complexity of the eukaryotic genome. This
complexity is potentially derived from the multitude of non-coding RNAs present
within the human transcriptome. Non-coding RNAs make up approximately 50-75%
of the eukaryotic transcriptome {Szymanski and Barciszewski 2002). These non-
coding RNAs include familiar housekeeping RNA molecules involved in the
translation of genetic information, RNA editing, RNA processing and other
ribonucleoprotein particles {Eddy 2001, Szymanski and Barciszewski, 2006). Other
non-coding RNAs are considered regulatory RNAs and perform various important
functions including X-chromosome inactivation {Xist RNA), X-dosage compensation
{roXl/roX2 in drosophila) and genetic imprinting {H19, Air) {Eddy 1999, Szymanski
and Barciszewski 2006). Normal gene expression would not be possible without
these regulatory RNA molecules.
A sub-group of putative regulatory RNA molecules that are becoming increasingly
interesting are natural antisense transcripts (NATs), of which DISC2 is one.
Naturally occurring antisense RNAs have been well documented in prokaryotes
where they are important in carrying out a multiplicity of functions including
regulation of transcription and replication {Inouye, 1988). To date in-silico
approaches have identified more than 2500 human NATs with 1600 of these
analysed and predicted to be true {Yelin et. al. 2003). Many important genes are
known to have associated NATs; these include genes involved in regulation of
development, cell-cycle, apoptosis and translation {Vanhee-Brossollet & Vaquero,
1998).
There are a variety of ways in which antisense RNA molecules can regulate their
cognate sense mRNA. They may regulate the expression of sense mRNAs at the
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level of transcription via competition for regulatory factors, or through physically
hindering the progress of transcription, either topologically or by being transcribed
themselves {Munroe and Zhu, 2006). They may also regulate sense gene expression
post-transcriptionally by binding and blocking regulatory binding sites in the sense
mRNA. This can potentially regulate any step in RNA processing including
translation, polyadenylation, splicing, transport or even degradation (.Munroe and
Zhu, 2006).
Moreover sense:antisense dsRNAs can also result in activation of cellular siRNA-
related pathways. The consequences of this can be two-fold. Firstly dsRNA duplexes
may be subject to RNA editing, which can result in a change in coding potential,
nuclear retention or cytoplasmic degradation (Kumar and Carmichael, 1998). The
second mechanism for dealing with dsRNA is that of RNA interference. This is a
mechanism whereby dsRNA duplexes are chopped up to produce short interfering
RNAs which target homologous mRNA sequences for degradation and can also
function to recruit chromatin remodelling factors to the endogenous gene region, thus
silencing transcription (Hannon, 2002). Although this is a possible mechanism for
controlling sense gene expression, and chemical siRNAs are routinely used to
experimentally reduce gene expression, natural antisense transcripts have not yet
been shown to produce siRNAs via dsRNA formation with their cognate sense
mRNA {Munroe and Zhu, 2006).
The mechanisms of antisense mediated gene regulation discussed so far involve
antisense:sense binding within the nucleus; however antisense gene regulation may
also occur in-trans, i.e. in the cytoplasm. The mechanics of this are currently
unknown although they may be similar to that of microRNAs, which regulate the
translation ofmessenger RNAs in the cytoplasm (Bartel 2004).
To date the importance of non-coding RNA genes has been underestimated and they
have been overlooked in favour of protein coding genes; however antisense
transcription within the human genome is a very worthy topic for further research as
many natural antisense transcripts have been implicated in the pathogenesis of
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disease. Of particular interest in relation to psychiatric illness is their implication in
neurological disorders.
Several non-coding RNAs have recently been implicated in neurological diseases.
Nemes et. al. 2000 reported a triplet repeat expansion in the human m-antisense
RNA SCA8 that causes spinocerebellar ataxia, a neurodegenerative disorder
involving the purkinje neurons of the cerebellum. The SCA8 antisense RNA is
thought also to control the sense gene KLHLF, however a mechanism for this is yet
to be described (Nemes et. al. 2000). Angelman and Prader-Willi syndrome are
neurobehavioural disorders largely caused by deletions/mutations within the 15ql 1-
15ql3 chromosomal region but have also been associated with defects in imprinting,
regulation or expression of non-coding RNA molecules at this chromosomal locus
(Costa, 2005). Furthermore decreased expression of another small non-coding RNA
molecule, BC200 has been associated with Alzheimer's disease (Costa, 2005).
Considering the large repertoire of currently known non-coding RNA molecules and
the fact the there are likely to be many more to come, we are beginning to appreciate
the complex nature of the human genome. It appears that proteins are no longer the
centre of the cellular universe as originally thought....
"Biologists should not deceive themselves with the thought that some new class of
molecules, ofcomparable importance to proteins, remains to be discovered. This
seems highly unlikely. " Francis Crick 1958
....Rather it now appears that RNA itself possesses multifunctionality which is
required to orchestrate a diversity of molecular interactions within eukaryotic cells.
Figure 1.6 taken from Costa 2005 depicts this scenario where RNA represents the
central hub integrating complex cellular networks. Considering the obvious
importance of 'non-coding' RNA molecules, it is an exciting possibility that DISC2
functions as a non-coding RNA molecule. The fact that it is antisense to DISCI
opens up the possibility that it may act as a riboregulator ofDISCI, and therefore it is
plausible that disruption of DISC2 might have a role in the pathological mechanism
of schizophrenia by dysregulation of DISCI. It may also be the case however that
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DISC2 functions independently of DISCI and that its function may be independently
important in the pathology of schizophrenia.
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1.7 PhD Aims
The aims of this PhD were fourfold;
• To elucidate the disease mechanism operating within the t( 1; 11) family.
This has been a topic of much controversy in recent years. I aim to uncover the
disease mechanism by examining whether the t( 1; 11) results in production of an
abnormal DISCI protein with aberrant cellular functions or whether the translocation
affects gene transcription such that overall levels ofDISCI are reduced.
• To clarify sites of DISCI sub-cellular localisation.
Many studies have examined the sites of DISCI protein expression within
mammalian cells. These studies have produced conflicting results; however it is
becoming apparent that DISCI occupies multiple sub-cellular locations. I aim to
explore this in more depth and examine if this localisation is isoform specific.
• To examine cellular phenotypes resulting from DISCI RNA interference.
The biological functions ofDISCI are not well understood; however considering that
it has multiple interacting protein partners these functions are likely to be wide
ranging. I aim to utilise RNA interference to elucidate further the functions of the
DISCI protein.
• To further characterise the DISC2 gene.
DISC2 has been overlooked to date in favour of DISCI which is promising to be a
very exciting candidate gene for psychiatric illness. However considering the genetic
evidence and the nature of DISC2 as a non-coding RNA gene, it remains a worthy
gene deserving of further exploration. As a start I aim to characterise the gene
structure further by identifying the 5' end ofDISC2 and hopefully shed some light on
the effects of the t( 1; 11) on this gene.
Benjamin Franklin once said that one should "either write something worth reading
or do something worth writing". I hope that in the context of these experiments and





This chapter details the experimental procedures used throughout this PhD thesis.
Additional details concerning solutions and reagents can be found in Appendix II.
Protocols were developed from Sambrook et a!. 1989 unless otherwise specified.
2.2. Mammalian cell culture
2.2.1 Cell lines and growth conditions
All mammalian cells were classified as containment level 1 and were manipulated
using Envair Bio2+ Class II Safety Cabinets. Cells were grown under humid
conditions (37°C, 5% Carbon Dioxide) in the appropriate growth medium. T.25, T.75
and T.175 tissue culture flasks with filter caps were used to maintain cell cultures
(CellStar®, Greiner Bio-One). Details of cell lines and growth conditions can be
found in table 2.2.A at the end of this section.
2.2.1.1 Feeding and passage of adherent cells
Cell medium was replenished every 3-4 days as required. Cells were passaged at 70-
90% confluency. To do this, growth medium was aspirated using a sterile glass
pipette and cells were washed in D-PBS (GIBCO®) to remove any remaining serum.
Cells were incubated with a 1:1 solution of versene plus trypsin (GIBCO) at 37°C to
lift them from the flask surface. The versene:trypsin solution was inactivated by
adding an equal volume of growth medium containing 10% fetal bovine serum
serum. Cells were centrifuged gently at lOOOrpm for 5 minutes (CR312 Jouan
centrifuge) at room temperature and then re-seeded into new medium. Cells were re-
seeded at 1 in 10 to 1 in 50 dilutions.
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2.2.1.2 Feeding and passage of suspension cells
Lymphoblastoid cell lines derived from the t( 1; 11) family members were grown in
suspension in upright T.75 tissue culture flasks. Cells were maintained by feeding
every 3-4 days (25-50ml medium). It is recommended that lymphoblastoid cell
cultures be maintained at a density of 3-9 x 104 cells per ml (www.ecacc.org.uk). If
the cells were to be used for protein or RNA extraction the media was replenished
daily for 3-4 days prior to harvesting. Healthy lymphoblastoid cells grow in floating
aggregates which settle at the bottom of the tissue culture flask. To replenish medium
or passage cells the flasks were removed from the incubator into the tissue culture
hood with minimum agitation to avoid disrupting the cell aggregates. The medium
was removed using a sterile glass pipette. The medium was then either replenished or
to split the cells an appropriate volume of cells was removed and placed into a new
flask of fresh medium. Once in fresh medium cells were agitated to dissociate
clumps and promote growth.
2.2.1.3 Preparation and recovery of cell stocks
To prepare frozen cell stocks an appropriate amount of cells (4-9 xlO6-
lymphoblastoid cells or 1-2 x 106-adherent cells) were centrifuged for 5 minutes at
lOOOrpm. Cell pellets were resuspended in 1ml of cell freezing medium (Appendix
II) and placed in a CryoTube™ (NUNC™). Cells were frozen slowly using a Cryo
1°C freezing container (NALGENE). The freezing chamber is filled with 100%
ethanol or propan-2-ol and the CryoTube is placed in the holder provided. This was
stored at -70°C overnight. Using this container the cells are frozen slowly at a rate of
-1 °C /minute. The cells can then be placed for long term storage in liquid nitrogen.
Frozen cells were recovered by thawing quickly at 37°C and placing into a T.25
tissue culture flask with 5mls of growth medium. Cells were incubated overnight at
37°C, 5% C02 to recover and adhere. Following this, cells were given fresh medium
and grown as normal.
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2.2.2 Haemocytometer counting to determine cell number
The haemocytometer (improved Neubar) was prepared by cleaning with 70%
ethanol. A coverslip was placed over the haemocytometer chamber. Cells were
trypsinised as normal and resuspended in fresh growth medium. Confluent cell
suspensions were diluted 1 in 10 for counting. Each chamber of the haemocytometer
was filled by capillary action using a pasteur pipette to place a drop of the cell
suspension at the chambers edge. A minimum of four 1mm squares (divided into 16
smaller squares) were counted and the average cell number was calculated. This
represents the number of cells x 104/ml.
2.2.3 Chemical transfection ofmammalian cell lines
2.2.3.1 Transfection of adherent cells using Lipofectamine™ 2000
Cells were transfected in 6 or 12 well COSTAR® flat bottom plates. Cells were pre-
plated 24-48 hours prior to transfection. If cells were to be used for
immunofluorescence they were pre-plated onto 16mm glass coverslips into 12-well
plates (typically lxl05 cells per well). For RNA and Protein applications cells were
transfected at approximately 70-80% confluency.
Lipofectamine2000™ transfection conditions
12-well plate 6-well plate






Final plating volume 1ml 2ml
To perform the transfection, LF2000 (Invitrogen), siRNA (Ambion®, Table 2.2.B)
or DNA were diluted in Opti-MEM® 1 reduced serum medium (GIBCO) according
to the manufacturers instructions. Transfection complexes were added dropwise to
the cells and normal growth medium was added to make up the final volume.
62
2.2.3.2 Transfection of adherent cells using siPORT-Amine
siPORT™ Amine (Ambion) is a polyamine reagent that was used specifically for
transfection ofHEK293 cells. 24 hours prior to transfection, cells were plated in 6 or
12-well plates at a density of l-2xl05 per well respectively. Cells were plated onto
16mm glass coverslips in 12-well plates for immunofluorescence purposes.
siPORT™ Amine transfection conditions
Reagent 12-well plate 6-well plate






Final plating volume 1ml 2ml
DNA, siRNA and siPORT™ were diluted in Opti-MEM 1 according to the
manufacturers instructions. The complexes were added dropwise to the cells and
normal growth medium was added to make up the final reaction volume.
2.2.3.3 Reverse transfection of adherent cells using siPORT-Amine
Reverse transfection involves transfecting cells in suspension before plating. The
conditions for transfection are the same as those in section 2.2.3.2, however
complexes are added to the empty wells of the tissue culture plate and then an
appropriate number of cells are overlaid in normal growth medium. This method is
advantageous in that no pre-plating of cells is required. Furthermore there is a greater
cell surface area available for transfection as the cells are in suspension. Cell
suspensions should not be prepared more than lhr in advance of plating and should
be kept at 37°C at all times.
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2.3 Preparation of nucleic acids
These following techniques were used to isolate DNA for use in PCR (polymerase
chain reaction) and mammalian cell transfection. RNA preparations were used for
cDNA synthesis and RT-PCR (reverse transcriptase PCR).
2.3.1 DNA isolation from mammalian cells
Total DNA was isolated from human cultured cells using the DNeasy® Tissue kit
(QIAGEN). A maximum of 5xl06 cells were used. In brief, cells were lysed using
proteinase K; ethanol was added to the lysate, which was then applied to a spin
column with a specialised silica-gel membrane that binds the DNA. Contaminants
were removed by washing the column and the DNA was then eluted. DNA was
eluted twice using 2 x 200pl volumes of AE buffer provided. For a detailed protocol
refer to instruction manual QIAGEN #69504. Isolated DNA was stored temporarily
at 4°C or at -20°C for long term storage.
2.3.2 Quantification of DNA
2.3.2.1 Quantification of DNA using a spectrophotometer
DNA concentration was determined by measuring the absorbance of the sample at
260nm. This reading (OD26o) was then used to calculate the concentration of the
DNA sample. DNA was diluted 1:100 and lOOpl of dilute DNA was placed in a
quartz cuvette with a 10mm path length. The absorbance was measured using the
GeneQuant spectrophotometer and the following calculation was used to determine
the DNA concentration. Conversion factors are listed in section 2.3.7.1.
• OD26o x conversion factor x dilution factor = concentration pg/ml
2.3.2.2 Quantification of DNA by agarose gel electrophoresis
To quantify DNA by gel electrophoresis lpl ofDNA sample (lpl DNA + 8pi H20 +
lpl 10X Orange G loading buffer) was run alongside 500ng of XHindlll (lOpl @
50ng/ul. Invitrogen) molecular weight marker. The DNA concentration was deduced
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by comparing the band intensity of the unknown DNA sample to band intensity of
the kHindlll marker.
2.3.3 Extraction of total RNA from mammalian cells
Total RNA was isolated using the RNeasy® Mini kit (QIAGEN #74104) according
to the manufacturer's instructions. In brief, mammalian cell cultures were harvested
and centrifuged at 1000 rpm for 5 minutes (< lxlO7 cells). Cell pellets were lysed by
vortexing in an appropriate volume of lysis buffer and homogenised using a 20-
guage needle. 70% ethanol was added to the lysate and this was applied to an
RNeasy mini column. The RNA binds to a silica-gel membrane in the mini column.
The membrane was then washed to remove contaminants before elution of RNA in
nuclease free water. All procedures were performed at room temperature. These
RNA preparations were subject to DNase treatment to remove any contaminating
DNA.
2.3.4 Isolation ofmRNA from mammalian cells
To isolate mRNA from cultured mammalian cells the Poly(A)Pure™ mRNA
purification kit was used (Ambion). This kit is ideal for procedures where unspliced
or partially spliced RNA is problematic. This kit specifically isolates polyadenylated
RNA by hybridisation to Oligo(dT) cellulose. This kit requires high cell numbers in
comparison to kits that isolate total RNA. A minimum of 5xl06 cells and a maximum
of 200 x 106 cells were used for each mRNA isolation. The procedure briefly entails,
cell lysis, lysate dilution, incubation with Oligo(dT) cellulose to bind polyA RNA,
washing to remove non-specifically bound ribosomal RNA and other contaminants
followed by elution of the polyA RNA. For a detailed protocol refer to instruction
manual Ambion #1915.
2.3.5 RNA storage and stabilisation
If cell pellets were not used immediately for isolation of RNA they were either
frozen on dry ice and stored at -70°C or alternatively, the cells were stored in
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KNAlater® stabilisation reagent (Ambion). To store cells in KNAlater cells were
centrifuged for 5 minutes at lOOOrpm. These pellets were washed and resuspended in
lOOpl of phosphate buffered saline (PBS). 5 to 10 volumes of RNAlater stabilisation
reagent was then added to the cell suspension. These cells were stored at 4°C for up
to 4 weeks or placed at -70°C for long term storage. For a detailed protocol refer to
the manufacturer's instructions (Ambion #7020).
2.3.6 DNase treatment of RNA
These procedures were used to remove genomic DNA contamination that may exist
in RNA isolated from mammalian cells.
2.3.6.1 DNase I treatment and phenol/chloroform extraction of RNA
RNA was incubated with DNase I to remove genomic DNA and the RNA was then
recovered by phenol/chloroform extraction and overnight precipitation in
isopropanol. This procedure was performed as follows.
DNAse treatment lpgRNA
lpl DNase I (Roche, 10 U/pl)
lpl RNase Inhibitors (Roche, 40 U/pl)
X pi sterile water
50 pi reaction volume - 37°C for 30 minutes
Phenol/Chloroform extraction
• Add 50pl Phenol + 50pl Chloroform to reaction mixture, vortex well
and centrifuge at 13,000rpm for 2 minutes (This step separates the
aqueous layer containing the nucleic acids from the insoluble protein
layer).
• Remove the aqueous (top) layer; to this add 50pl chloroform, vortex
and centrifuge as before.
• Keep aqueous layer.
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RNA precipitation To the aqueous layer from the phenol/chloroform
extraction add,
1/10th volume Ammonium Acetate
2.5 volumes 100% ethanol
2pi glycogen
• Precipitate RNA overnight at -20°C.
• Recover RNA by centrifugation > 12,000rpm for 20 minutes.
This procedure is time consuming and requires the use of harmful substances.
Therefore a safer and quicker method using the TURBO DNA-^fee™ kit was
subsequently used (Ambion #1907).
2.3.6.2 TURBO DNase treatment of RNA
TURBO DNase has a higher affinity for DNA than DNase I with 350% greater
catalytic activity. TURBO DNase is incubated with RNA in an optimised reaction
buffer for 30 minutes at 37°C. The DNase is then removed using a DNase
inactivation reagent, which also remove divalent cations from the RNA sample. The
DNase inactivation reagent requires a 2 minutes incubation step followed by a 1.5
minute centrifugation step. The RNA supernatant is then recovered. For a detailed
protocol refer to instruction manual (Ambion #1907).
2.3.7 Quantification ofRNA
2.3.7.1 Quantification of RNA using a spectrophotometer
To determine RNA concentration, extracted RNA was diluted 1:50 to 1:100 in
RNAse free water. lOOpl of each dilution was placed in a quartz cuvette with a
10mm path length. The absorbance at 260nm (OD260) of each RNA dilution was
determined by spectrophotometry using the GeneQuant RNA/DNA calculator
(Pharmacia). The following conversion factors were used to determined RNA or
DNA concentration.
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An OD260 unit of 1 equates to the
following nucleic acid concentration
Double stranded DNA 50pg/ml
Single stranded RNA 40pg/ml
Single stranded DNA 35pg/ml
Single Stranded oligo 20pg/ml
*Values taken from Bioreference.net
The following calculation was used to determine RNA concentration; OD260 x 40 x
dilution factor = RNA concentration in pg/ml
2.3.7.2 Quantification of RNA using the Agilent 2100 Bioanalyser
The Agilent Bioanalyser was used to determine the quality and purity of extracted
RNA. To analyse samples the Agilent RNA 6000 Nano kit was used, lpl of neat
RNA is sufficient to determine concentration and quality of extracted RNA. For
details refer to the Agilent user manuals at www.chem.agilent.com.
2.3.8 Preparation of complementary DNA (cDNA)
This method was used to make cDNA for use as a template in non-quantitative and
real-time PCR techniques. cDNA was made by reverse-transcription of mammalian
RNA using the 1st Strand cDNA Synthesis Kit for RT-PCR (AMV) (Roche). This
method produces single stranded RNA using AMV reverse transcriptase. A typical
cDNA synthesis reaction is shown below.
cDNA Synthesis Reaction
Volume Reagent Final concentration
2pi 1 OX Reaction Buffer IX
4pl 25mM Magnesium Chloride 5mM
2pi lOmMdNTPs ImM
2pi Random Primers p(dN)6 3.2pg
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lpl RNase Inhibitor 50 units
0.8pl AMV Reverse transcriptase 20 units
Xpl Total RNA, or
PolyA RNA
< 1 |ig total RNA
1 OOng PolyA RNA
Xpl Sterile Water
Final Reaction Volume = 20pl
A master mix containing the appropriate reagents was prepared, mixed and
centrifuged before aliquoting into 0.5ml RNase free thin walled tubes. The reactions
were then cycled on a thermal cycler (Peltier PTC-225) as shown below.
Thermal cycling of cDNA synthesis reactions
25°C 10 minutes Primer Annealing





For all cDNA reactions a negative control reaction was prepared alongside which
contained RNA but no reverse transcriptase enzyme. This was to ensure no DNA
contamination exists in the RNA preparations that may interfere with downstream
PCR applications. Negative controls containing distilled water plus reverse
transcriptase were also prepared to ensure all reagents were free of contamination.
To ascertain if the cDNA synthesis was successful all samples were assayed for
amplification of Glyceraldehyde-6-phosphate Dehydrogenase (GAPDH) by PCR.
PCR products were analysed by agarose gel electrophoresis.
2.3.9 DNA isolation from agarose gels
This gel extraction method was used to isolate PCR products for the purposes of
cloning or sequencing. PCR products were extracted from low melting point (LMP)
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agarose gels using the QIAquick Gel Extraction kit (Qiagen, #28704) according to
the manufacturers' instructions. In brief gel slices containing the desired PCR
product are dissolved at 50°C in an appropriate buffer. An appropriate volume of
isopropanol is added and the mixture is then applied to a spin column where the
DNA binds to a silica membrane. After impurities are washed away (e.g. salt and
agarose) the DNA is eluted and ready for use.
2.4 Amplification of nucleic acids
2.4.1 Non-quantitative Polymerase Chain Reaction (PCR)
Gene expression was measured non-quantitatively using a Thermo-Start® DNA
polymerase (Abgene®, cat # AB-0908/a). This enzyme is thermostable and requires
a high temperature activation step to begin the reaction, thus increasing the
stringency of the PCR reaction and eliminating non-specific priming. Details of the
PCR reaction mix and thermal profile of the reaction are given below.
Recipe for a single PCR reaction mixture
2pl 10X Thermo-Start reaction buffer
1.2pl 25mM Magnesium Chloride
0.5pl lOmM dNTPs (SIGMA)
0.1 pi Thermo-Start DNA polymerase
75-1OOng Forward Primer
75-100ng Reverse Primer
~lpl Template DNA Template amount depends on source and concentration
Add distilled water to a make the final reaction volume 20pl
Thermal Profile of a typical PCR
95 °C 15 minutes Enzyme activation step, 1 cycle
Foil owed by 36 cycles
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94 °C 20 seconds DNA denaturation step
Tm °C 30 seconds Annealing Temperature of Primers
72 °C 30-60 seconds Extension step for 500bp-lKb product
Followed by
72 °C 10 minutes Final extension
4 °C Hold
If annealing temperatures of primers were not closely matched a touchdown program
was used for amplification. A typical touchdown PCR thermal profile is given below.
Thermal Profile of a touchdown PCR
95 °C 15 minutes Enzyme activation step, 1 cycle
Followed by 6 cycles
94 °C 20 seconds DNA denaturation step
70 °C 30 seconds
Highest annealing temperature
-2 °C per cycle
Fol lowed by 29 cycles
94 °C 20 seconds DNA denaturation
60 °C 30seconds Lowest annealing temperature
72 °C 30-60 seconds Extension step for 500bp-lKb product
Followed by
72 °C 10 minutes Final extension
4 °C Hold
Details of primers including sequences and annealing temperatures are listed in table




Allele-specific PCR was carried out for DISC2 SNP rsl535530. Forward and reverse
primers were designed with the 3' base representing the polymorphic nucleotide as
shown below.
SNP rsl535530 surrounding sequence ttccattcA/Ggtttgcca
G Allele primers J3 Forward tattagcaaacacaggttgagacag
J10 Reverse caggtgccttggcaaacC
A Allele primers J3 Forward tattagcaaacacaggttgagacag
J11 Reverse caggtgccttggcaaacT
Allelic specificity of the primers was optimised by a gradient PCR program the
details ofwhich are shown below.
Thermal Profile of a Gradient PCR
95 °C 15 minutes Enzyme activation step, 1 cycle
Followed by 36 cycles
94 °C 20 seconds DNA denaturation step
62 °C to 72 °C 30 seconds
Temperature varies across the PCR block. Each
sample anneals at a different temperature and the
optimum annealing temperature can be
determined.
72 °C 30-60 seconds Extension step for 500bp-lKb product
Followed by
72 °C 10 minutes Final extension
4 °C Hold
Allele-specific PCR was carried out by nested PCR. Initially primers were used to
amplify the region containing the SNP and this product was used as the template for
the allele-specific PCR. ThermoStart DNA polymerase was used to carry out this
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PCR reaction. All primer sequences and conditions are listed in table 2.4. PCRs were
performed on a Peltier gradient thermal cycler (PTC-225, MJ Research).
2.4.3 Quantitative Real-Time PCR
Gene expression was measured quantitatively with SYBR® Green Real-Time PCR
using the MyiQ™ Single-Colour Real-Time PCR Detection System (Bio-Rad
laboratories Ltd. Cat# 170-9740). This technique calculates relative gene expression
compared to a control by measuring fluorescence of a SYBR® Green dye which is
incorporated into the DNA during amplification.
PCR master mix (iQ™ SYBR® Green Supermix cat# 170-8882) was obtained from
Bio-Rad Laboratories, Ltd. Real-time PCR Primer sequences are listed in table 2.4.
Glyceraldehyde-3 -phosphate Dehydrogenase (GAPDH), Glucose-6-phosphate
dehydrogenase (G6PD) and Human Phosphofructokinase (hPFKm) reference genes
were amplified to facilitate normalisation. Details of the PCR reaction mix and
thermal profile are listed below.
Recipe for a single qRT-PCR reaction mixture
7.5pl 2X iQ™ SYBR Green Supermix
75-1OOng Forward and Reverse Primers
3pi Template Single stranded cDNA, 1:3 dilution
dILO to final volume of 15pl
Thermal Profile of a typical RT-PCR reaction
95 °C 3 minutes 1 cycle
Followed by 40 cycles
95 °C 10 seconds DNA denaturation
66 °C 30 seconds Primer annealing
72 °C 45 seconds Extension
Followed ?y melt curve analysis
55 °C 10 seconds +0.5 °C per cycle for 80 cycles
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Melt curve analysis was carried out to ensure primer specificity. All samples were
tested a minimum of three times. Each primer set had an internal standard curve to
determine primer efficiencies'. Dilutions of pooled cDNAs were used as standards.
Each curve consisted of four dilutions, Neat, 1:10, 1:100 and 1:1000. Relative gene
expression levels were determined using the MyiQ™ Real-Time PCR detection
system optical software system version 1.0 (Bio-Rad Laboratories, Ltd.).
2.4.4 Rapid Amplification ofcDNA Ends (RACE)
This technique was used to isolate the 5' end of the novel DISC2 gene. The
FirstChoice™ RNA-Ligase-Mediated (RLM) RACE kit (Ambion) was used. This
particular protocol uses a cDNA library that has been enriched for mRNAs
containing true 5' ends. Gene specific primers for DISC2 were generated (see table
2.4) and used to amplify a human heart RACE ready cDNA library according to the
manufacturer's protocol. SUPER TAQ plus (HT Biotechnology) and Thermostart
Taq (Abgene) were tested with this protocol. Both enzymes generated products. I
routinely used Thermostart Taq as this enzyme is compatible with PCR cloning of
RACE products if necessary. For these experiments however PCR direct sequencing
was chosen as the optimum method for sequencing products. To do this RACE
products were excised from a low melting point gel and purified and sequenced as
previously described.
75




DISC2 nested PCR primers (see chapter 8)
DISC2 forward J5 (outer) AAAATGCTCAAGACCTTGCC 62°C
67°CDISC2 reverse J6 (outer) CTGTTGGTGTTGAGTTCCAGG
DISC2 forward J3 (inner) TATTAGCAAACACAGGTTGAGACAG 67°C
65°CDISC2 reverse J4 (inner) AAAAAGCTGGGAAGTGTTAAAGAAG
DISC2 Allele-specific primers (SNP rs1535530, see chapter 8)
DISC2 forward J3 TATTAGCAAACACAGGTTGAGACAG
66°CG allele reverse J10 CAGGTGCCTTGGCAAACC
A allele reverse J11 CAGGTGCCTTGGCAAACT
DISC2 intron 9 primers (See chapter 8)
Primer pair 1 forward J25 TGACCCAGCCTCAGGTATTC
TD 70-60°C
Primer pair 1 reverse J26 CAGAGAAGGGGCAGTTGAAG
Primer pair 2 forward J27 AAAAGGCATAAATGAAAGGGC
TD 70-60°C
Primer pair 2 reverse J28 GAAAGGGAGGAGGTGAGGAG
Primer pair 3 forward J29 CGCAGCCACATAAAGAAATG
TD 70-60°C
Primer pair 3 reverse J30 CTTCCCCTATTCTGCTTCCC
Primer pair 4 forward J31 GCGAATAGCCAGGTTTGAAG
TD 70-60°C
Primer pair 4 reverse J32 TGAGTGTGCAAGACAGGAGG
Primer pair 5 forward J33 CAGAGCCGCAGAGAAGAGAC
TD 70-60°C
Primer pair 5 reverse J34 GTGCTTTCAGAGATCAGGGG
Primer pair 6 forward J35 CTAGCTGATGCAGGAGGAGG
TD 70-60°C
Primer pair 6 reverse J36 TTTTGGACAGGCTGATTTCC








DISC2 RACE Primers (see chapter 8)
RACE outer J26 CAGAGAAGGGGCAGTTGAAG
60°C
RACE inner J26 CCTAATTCTTGGCACAGTCTCA
DISC1 Primers (see chapter 3)... continues onto next page
Exon 2 forward J14 GAACGTGGAGAAGCAGAAGG
66°C
Exon 2 reverse J15 CAGAGAACTGGAGGAGCCAG
Exon 4-6 forward J43 AGCCTGCACTTTCAACTTCC 66°C
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Exon 4-6 reverse J44 AGTTGCTGCTCTTGCTCCTC
Exon 9 forward J37 AGAGAGAGAAGGGCTGGAGG
66°C
Exon 9 reverse J38 GTCTCCTGGTGCTCCACTTC
Exon 11-12 forward J39 CAGGGGAAGCCTGTCTGTAG
66°C
Exon 11-12 reverse J40 TGGATTGCTGTGTGAAGTTG
Intron 10-11 forward J54 ACAGAATCTTAGCTAATCACCATGC
66°C








G6PD A forward ATCTTGGTGTACACGGCCTC
66°C
G6PD B reverse CAACCACATCTCCTCCCTGT
All primers were designed using Primer 3 software (SDSC Biology Workbench)
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2.5 Agarose gel electrophoresis
Stock solutions for this section are detailed in Appendix II. Standard agarose gels of
1-1.5% were used to separate fragments of size 0.2-0.5 kb and 0.8-1% gels were used
to resolve fragments of size 0.5kb or greater. Gels were prepared and run using IX
Tris-Acetate buffer. Samples were loaded using 10X Orange buffer (Appendix II).
Electrophoresis was carried out using Hybaid Electro-4 gel tanks. Voltage applied
(usually 80-100V) creates an electric current causing the DNA to migrate through the
agarose from the cathode (-ve) to the anode (+ve) due to the negatively charged
phosphate backbone of the DNA.
DNA was stained with Ethidium Bromide (0.5pg/ml molten agarose, SIGMA) or
SYBR Safe™ (lpl/lOOml molten agarose, Invitrogen™ #SS33102). Fragments were
visualised using a UV transilluminator (Thistle Scientific) with the aid of a uvidoc
(Uvitec, DOC-CF08.XD). The molecular weight of each fragment was determined
by comparing its mobility to a 1Kb DNA ladder (Invitrogen) or a /.Hindlll
(Invitrogen, Appendix II) marker for larger fragments of up to 23Kb in size.
DNA fragments were also run on low melting point (LMP) agarose gels to allow for
recovery of the DNA after electrophoresis. LMP agarose gels were prepared using
IX TAE and usually run at 80V.
2.6 Sequencing of DNA
DNA templates for sequencing consisted mainly of PCR products. All DNA for
sequencing was checked by agarose gel electrophoresis before sequencing was
carried out. In some cases (e.g. multiple PCR products in the same reaction) the
DNA was gel extracted before use in sequencing procedures.
2.6.1 Preparation of sequencing templates
Sequencing templates were prepared by one of three methods; the gel extraction
method has been previously described; the other two methods, drop dialysis and
ExoSAP-IT treatment, are described below.
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2.6.1.1 Drop dialysis of DNA
DNA derived from extraction or PCR procedures may contain excess salts or
detergents which can inhibit sequencing reactions. Problematic sequencing can
usually be resolved by removing these inhibitors using a microdialysis procedure. To
dialyse DNA 0.025pm MF-Millipore™ membrane filters were used (MLLIPORE).
The 25mm membranes were placed floating on a petri-dish of distilled water (shiny
surface upwards). After allowing the membrane to wet for about 5 minutes a small
volume of DNA was then pipetted onto the membrane and left for lhour. The DNA
is removed with a pipette and ready for use. This method is adapted from Silhavy et
al. 1984.
2.6.1.2 ExoSAP-IT treatment of DNA
ExoSAP-IT™ (GE Healthcare) contains exonuclease I and alkaline shrimp
phosphatase which effectively removes all excess primers and dNTPs before
sequencing. 5pi of PCR product was incubated with lpl of ExoSAP-IT™ on a
thermal cycler for 30 minutes at 37°C followed by 30 minutes at 80°C.
2.6.2 PCR direct sequencing
Sequencing reactions were carried out in lOpl volumes using BigDye® Terminator
Ready Reaction Mix v3.1 as detailed below.
BigDye v3.1 Sequencing Reaction
lpl 2.5X Ready Reaction Mix (final concentration 0.25X)
1.5pl 5X sequencing buffer (final concentration 0.75X)
1.5- lOng PCR product (usually -lpl of treated PCR reaction)
25ng Forward and Reverse sequencing primers
dHiO to make final volume lOpl
Sequencing reactions were performed using a Peltier PTC-225 thermal cycler. The
thermal profile of the sequencing reaction is detailed below.
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Thermal Profile ofBD v3.1 sequencing reaction
96°C 1 minute, 1 cycle





2.6.3 Ethanol/EDTA precipitation of sequencing reactions
After sequencing, DNA was precipitated by adding 2.5pl of 125mM EDTA and 30pi
100% Ethanol. This was mixed and incubated at room temperature for 15 minutes
followed by centrifugation at 13,000rpm for 20 minutes. All ethanol was removed
and a further 30pi of 70% ethanol was added. This was centrifuged at 4°C for 5
minutes and again all ethanol was removed. After air-drying samples were stored at -
20°C until they were analysed. Samples were analysed using Applied Biosystems
3730 DNA Analyser and sequences examined using the CONSED (Gordon et al.
1998) or Chromas (version 1.45, McCarthy C. 1996) analysis software.
2.7 Analysis of protein expression
2.7.1 Protein lysate preparation from cultured mammalian cells
To prepare lysates, cultured cells were harvested as previously described. Cells were
pelleted at 4°C, at 1000-2000rpm for 5minutes and pellets were washed once in PBS.
Pellets were resuspended in an appropriate amount of RIPA buffer with complete
protease inhibitors (Roche, Appendix II). Typically, pellets recovered from 12 or 6
well plates were resuspended in 30-50pl of RIPA buffer and pellets from 10cm
dishes were resuspended in 100-500pl RIPA buffer depending on cell density at time
of harvest. Pellets were resuspended by pipetting followed by sonication in ice for 5-
10 seconds at (2 microns, peak-to-peak) using an MSC Sonicator. Lysates were
stored at -70°C until use.
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2.7.2 Determining protein concentration
The Bio-Rad Protein Assay (Bio-Rad Laboratories) was used to determine the
concentration of protein lysates. The manufacturers' protocol was modified to
perform reactions in 1.5ml eppendorfs. 25pl of a 1:10 dilution of each protein sample
was made in distilled water (2.5pi lysate + 22.5pi water). 6 protein standards were
prepared in a 25pl volume as shown below.
Concentration pi of protein standard Distilled water
Standard 1 = 0.2 mg/ml 2.5 22.5
Standard 2 = 0.4 mg/ml 5 20
Standard 3 = 0.6 mg/ml 7.5 17.5
Standard 4 = 0.8 mg/ml 10 15
Standard 5 = 1.0 mg/ml 12.5 12.5
Standard 6 = 1.5 mg/ml 18.25 6.75
For the protein assay 125pl of Bio-Rad Reagent A was added to each sample and
standard followed by 1ml of Bio-Rad Reagent B. The reactions were allowed to
develop for 15-30 minutes in darkness and the absorbance of each was measured at
750nm in plastic cuvettes (1cm path length, Fisherbrand). A standard curve was
created using Microsoft Excel by plotting concentration (x-axis) Vs absorbance (y-
axis) of each standard. Unknown concentrations were deduced from this using the
equation of the line.
2.7.3 One dimension SDS-Polyacrylamide gel electrophoresis
2.7.3.1 Gel preparation
SDS-PAGE resolving gels of 8-15% polyacrylamide were prepared using 30%
Acrylamide/Bis solution (Bio-Rad Laboratories). 25% Ammonium persulfate
solution (Sigma) and TEMED (Sigma) were used to catalyze polymerisation. Eligh
porosity stacking gels of 4% polyacrylamide were used for loading samples. Gels
were cast 1mm thick using the Mini-PROTEAN 3 electrophoresis system casting
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module (Bio-Rad Laboratories). Gel preparation methods were adapted from
Molecular Cloning, Sambrook et al. 1989.
2.7.3.2 SDS-PAGE sample preparation
Protein lysates were prepared for electrophoresis using Laemmli sample buffer
(Appendix II) containing detergent (20% Sodium Dodecyl Sulphate solution). DTT
(Dithiothreitol) was used as a reducing agent in protein sample preparation.
Typically, 10-30pg of protein lysate was prepared in 15-30pl volume. A typical
lysate preparation is shown below.
20pg protein lysate
10 pi 2x Laemmli PSB
2 ul 1M DTT
Distilled water to final volume of 20 pi
Samples were heated at 70-100°C for 5 minutes to dissociate polypeptide subunits
before loading on SDS-Polyacrylamide gels. Samples were either run on homemade
polyacrylamide gels or pre-cast gradient polyacrylamide gels.
2.7.3.3 Bio-Rad Acrylamide/Bis gel electrophoresis
Protein electrophoresis was carried out using the discontinuous Tris-Glycine Buffer
system (10X Tris/Glycine buffer, Bio-Rad Laboratories). The Mini-PROTEAN 3 gel
tank system (Bio-Rad laboratories) was used for electrophoresis. After boiling,
protein samples were loaded into the wells of the stacking gel and run at 50 volts (V)
(Bio-Rad PowerPac3000) until the protein samples had passed through the resolving
gel interface. The voltage was then increased to 100-150V. 15pl of protein standard
was loaded alongside samples to determine polypeptide sizes. The two protein
standards used for the purposes of these experiments were the Precision Plus
Protein™ standard (Bio-Rad Laboratories) and SeeBlue™ plus2 pre-stained standard
(Invitrogen).
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2.7.3.4 Pre-cast gradient gei electrophoresis
Electrophoresis was carried out using NuPAGE® Novex Tris-Acetate 3-8% gradient
gels (Invitrogen). This method was used to achieve good resolution of the three
DISCI protein isoforms of between 75 and 71kDa in size. Pre-cast gels were run
using the XCell SureLock™ gel tank (Invitrogen). 500mls ofNuPAGE Tris-Acetate
SDS running buffer (Invitrogen) was used to fill the upper and lower chambers and
protein samples were loaded. The samples were run at 150V for approximately 1-
1.5hrs. Current was applied using the Bio-Rad PowerPac300. Typically, the
SeeBlue™ Plus2 pre-stained standard was run alongside samples to allow size
determination.
2.7.4 Two dimension SDS-Polyacrylamide gel electrophoresis
Two-dimension (2D) gel electrophoresis separates proteins based on their isoelectric
point (pi) in the first dimension and on their size in the second dimension. This
system allows clear resolution of proteins very close in size which may not be
resolved using one-dimensional electrophoresis.
For the purposes of these experiments 2D gels were run using the ZOOM®
IPGRunner™ System (Invitrogen). Approximately lOOug of lysate was mixed with
rehydration buffer (RB) to a final volume of 155pi. This lysate mixture was loaded
into a channel of the IPGRunner cassette and a ZOOM strip was slotted into each
channel with the sample (acidic end (+) of the strip is inserted first). ZOOM strips
are thin strips of polyacrylamide gel containing an immobilised pH gradient (IPG
strips). These strips allow for isoelectric focusing (IEF) of protein samples.
Isoelectric focusing separates proteins depending on their pi.
Once all the samples were loaded the cassette was sealed and incubated on the bench
overnight. This procedure serves to solubilise and denature the proteins and also to
rehydrate the IPG strips before IEF. The strips used in these experiments contained a
wide non-linear pH gradient ranging from pH 3-10. IEF was performed using a
PowerEase®500 power pack (Invitrogen) for 4 hours at 500V (0.5 Watts per strip,
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ImAmp per strip). Following focusing the IPG strips can be stored at -70°C until
ready for second dimension SDS-PAGE.
Immediately prior to SDS-PAGE the IPG strips were equilibrated in NuPAGE®
LDS sample buffer (Invitrogen). The strips were equilibrated for 15 minutes in LDS
buffer containing NuPAGE sample reducing agent (Invitrogen) followed by 15
minutes in LDS buffer containing an alkylating solution (ProteoPrep™
iodoacetamide, Sigma). The IPG strips were then inserted into NuPAGE Novex 4-
12% Bis-Tris ZOOM gels (Invitrogen). One IPG strip was inserted into the well of
each ZOOM gel and the well was sealed using 400pl of 0.5% agarose solution (made
in IX MES running buffer, Invitrogen). SDS-PAGE was performed at 200V for 50
minutes in IX MES buffer (using the PowerEase®500 power pack). Once completed
the gels were analysed by western blotting.
2.7.5 Fixing/Staining SDS-polyacrylamide gels
These methods were used to fix and stain proteins after electrophoresis. This was
done to determine equal protein loadings as confirmation of successful protein
concentration determination and also to determine successful transfer of proteins
after western blotting.
2.7.5.1 GelCode® Blue staining
After electrophoresis the gels were rinsed 3 times for 15 minutes each in distilled
water followed by 1 hour incubation at room temperature with the protein stain
reagent. Gels were then de-stained in water which removes excess stain and enhances
the protein staining.
2.7.5.2 Coomassie Brilliant Blue staining
Polyacrylamide gels were incubated in coomassie protein stain (Appendix II) for 30
minutes followed by multiple de-stain washes in MethanokAcetic Acid (Appendix
II).
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2.7.6 Drying SDS-polyacrylamide Gels
Polyacrylamide gels can be stored long term after drying. To dry gels they were
placed face down on 1 sheet of saran wrap (Dow chemical company). One piece of
wet Whatman 3MM was placed on top of the gel followed by one piece of dry 3MM.
The gel is place saran side up in a vacuum pump and dried for approximately 1 hour.
It is crucial that the vacuum is not released with the first 30 minutes of drying.
2.7.7 Western Blotting
2.1.1A Immobilising proteins on PVDF membrane - Wet transfer
This system was used to transfer proteins from pre-cast Tris-Acetate gels and 2D
Bis-Tris ZOOM gels onto 0.2pm PVDF membranes (Invitrolon™ PVDF). The
membrane was prepared by soaking briefly in 100% methanol followed by 5-15
minutes equilibration in NuPAGE transfer buffer. The gel was sandwiched with the
PVDF membrane and two pieces of 3MM filter paper, according to the
manufacturers' instructions. This sandwich was placed in the XCell II™ blot module
(Invitrogen) within the XCell SureLock gel tank. The blot module was filled with
NuPAGE transfer buffer and the outer chamber of the tank was filled with water. A
current of 30V was applied for 1 hour using the Bio-Rad PowerPac300.
2.7.7.2 Immobilising proteins on PVDF membrane - Semi-Dry transfer
This system was used to transfer proteins from homemade polyacrylamide gels onto
Hybond-P PVDF membranes optimised for protein transfer (Amersham
Biosciences). After electrophoresis gels were equilibrated three times for 10 minutes
in semi-dry transfer buffer (Appendix II). The membrane was prepared by soaking in
100% methanol, followed by 15 minutes equilibration in transfer buffer. The gel was
placed on top of four pieces of Whatman 3MM filter paper soaked in transfer buffer,
the PVDF membrane was placed over the gel and then four more pieces of soaked
3MM filter paper were used to complete the sandwich. Transfer was carried out at
20V for 1.5 hours using the TRANS-BLOT® semi-dry transfer cell (Bio-Rad
Laboratories) and the Bio-Rad PowerPac300.
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2.7.7.3 PonceauS staining membranes
Ponceau's stain (Appendix II) was used to determine successful protein transfer onto
PVDF membranes. After transfer, membranes were rinsed in distilled water followed
by 5 minutes incubation in PoncauS. Membranes were de-stained in distilled water.
2.7.8 Immunoblotting; Detection of immobilised proteins
Once proteins were immobilised on membranes antibodies were used to detect
specific proteins of interest. Membranes were typically incubated at 4°C overnight in
blocking buffer (PBST or TBST, see Appendix II). Antibodies were diluted
appropriately in PBST/TBST and incubated with membranes overnight at 4°C or for
1 hour at RT. Membranes were washed in PBST/TBST (1 x 15minutes, 3x5
minutes) and incubated with Horseradish Peroxidase (HRP) conjugated secondary
antibodies for 20-30 minutes at RT. Following a second wash stage bound antibodies
were detected by chemiluminescence using ECL plus Western Blotting detection
reagents (Amersham Biosciences). Details of suggested immunoblotting and
detection protocols can be found in user manual RPN2132. For specific antibody
conditions see table 2.7.
2.7.9 Immunofluorescence (IF); Visualisation ofproteins in fixed
cells
Immunofluorescence was used to visualise sub-cellular localisation of proteins in
fixed mammalian cells. Cells were plated on 16mm glass coverslips to enable
microscopic analysis and fixed in 100% methanol or 4% Paraformaldehyde (PFA,
Appendix II) for 10 minutes at room temperature (RT). Cells fixed in PFA require a
further permeabilisation step which was performed using 0.5% Triton-X 100 (in
PBS) for 15 minutes at RT. Cells were incubated in antibody blocking buffer for a
minimum of 15 minutes at RT (Appendix II). For blocking and all subsequent
incubation steps a damp paper towel was placed over the wells inside the plate to
create a humid chamber.
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After blocking cells were incubated with primary antibody (150-200pl, in a 12 well
plate) for 1 hour at RT followed by 3 x 5 minute washes in PBS/BSA (0.02%
solution, Appendix II). Alexa Fluor conjugated secondary antibodies were used to
visualise proteins by fluorescent microscopy. Secondary antibodies were diluted
appropriately in PBS/BSA and incubated for 1 hour at RT. Washes were repeated as
for the primary incubation and coverslips were mounted face down in Mowiol/DAPI
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2.8 FACS analysis (Fluorescence Activated Cell Sorting)
2.8.1 Analysis of cell proliferation using 5'-bromo-2'-deoxyuridine
5-bromo-2'-deoxyuridine (BrdU) incorporation was used as a measure of cell
proliferation. BrdU is a thymidine analogue that becomes incorporated into
replicating DNA. Cells replicate their DNA during S phase of the cell cycle; these
cells can be selectively labelled by pulsing cells with BrdU for short periods of time.
BrdU incorporation was detected by a fluorescein conjugated monoclonal anti-BrdU
antibody using the In Situ Cell Proliferation Kit, FLUOS (Roche). In brief cells were
incubated with 10pM BrdU in normal growth medium for 35-45 minutes. Cells were
then harvested, fixed (Appendix II) and resuspended to yield a singe cell suspension.
The cellular DNA is then denatured, non-specific binding sites are blocked and the
fluorescein conjugated monoclonal anti-BrdU antibody is applied. Cells are then
washed to remove unbound antibody and resuspended for FACS analysis. The
amount and intensity of fluorescein (bound antibody) was determined by flow
cytometry using a BD FACSCalibur by exciting the sample at 488nm. The
percentage of fluroescein positive cells in a BrdU-treated cell population relative to
an untreated population is a direct reflection of the number of dividing cells. This
was quantified using the CellQuest™ software. For detailed experimental protocols
refer to user manual 1-810-740, version 3 (Roche).
2.8.2 Analysis of DNA content to determine cell cycle profile
This assay is based on the principle that cells contain different amounts of DNA
depending on their stage of the cell cycle. Cells which have entered mitosis and are
within the G1 phase will be diploid (2N) as they have not yet replicated their DNA.
After replication (S phase) the cells will be have twice as much DNA (4N) before
dividing to produce two diploid daughter cells. During S phase cells will have an
intermediate DNA content to that of G1 or G2 phase cells. By determining the
cellular DNA content it is possible to calculate the cell cycle profile of a cell
population.
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This technique used propidium iodide (PI, Sigma) incorporation as a measure of total
cellular DNA. In brief cells are harvested by trypsinisation and resuspended in 50pl
of a hypotonic citrate buffer (Appendix II) which causes the cell membrane to
become permeable to PI. To this 225pl of trypsin solution A are added and the cells
are incubated at room temperature for 10 minutes (Appendix II). Following this
162pl of trypsin inhibitor/RNAse A solution B is added and cells are incubated for
10 minutes at room temperature (Appendix II). RNAse A incubation is necessary to
remove dsRNA which would also be stained using PI. Finally 125pl of PI solution C
(Appendix II) is added and the cells are incubated on ice for 10 minutes. References:
Vindelov et al. 1983 A-D.
Cells were assessed using a Coulter® EPICS® XL™ flow cytometer (Beckman
Coulter). The FL3 detector was used to examine PI staining and hence the DNA
content of each cell. DNA histogram plots of FL3 staining were created using the
EXP032™ ADC cytometer software. These histograms were exported to the
MultiCycle DNA Analysis software programme (Phoenix Flow Systems, USA,
www.phnxflow.com) to calculate more accurately the percentage of cells within each
phase of the cell cycle.
2.8.3 Apoptosis assay
Apoptotic cell death was measured in cultured mammalian cells using the Annexin
V-FITC Apoptosis detection kit I (BD Pharmingen™ #556547). This kit takes
advantage of the fact that apoptotic cells translocate the membrane phospholipid
phosphatidylserine (PS) to the outer leaflet of the cell membrane whilst undergoing
programmed cell death. Annexin is a protein capable of binding PS and hence
capable of identifying apoptotic cells. This kit uses Annexin V in conjunction with
propidium iodide (PI) a vital dye that stains DNA in a similar manner to ethidium
bromide. Early apoptotic cells exclude PI whereas necrotic cells and late stage
apoptotic cells take up PI thus enabling the identification of three distinct cell
populations, early apoptotic, late apoptotic and necrotic (or dead) cells.
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To measure apoptosis in a cell population cell culture medium was removed and
spun down to recover any detached cells. The remaining cells were trypsinised and
pooled with any cells collected from the culture medium. Cells were then washed
and resuspended at approximately lxl06cells/ml in binding buffer (provided). lOOpl
of this cell suspension was used for each apoptosis assay and to this 5pi each of
Annexin V-FITC and PI were added. The cells were vortexed gently and incubated at
room temperature in the dark for 15 minutes. 400pl of binding buffer was added to
each test and this was analysed using a Coulter EPICS XL flow cytometer. The FL1
channel was used to detect cells which have bound Annexin V and the FL3 channel
to detect cells that have incorporated PI. Dot plots of FL1 (X axis) versus FL3 (Y
axis) were generated using the EXP032 ADC software. Quadrant statistics were
used to determine the proportion of green, red and double labelled cells.
2.9 PDE4 activity assay
Protein lysates were prepared by resuspending cells in 3T3 lysis buffer (Appendix II)
and lysing on a rotary wheel for 1 hour at 4°C. Lysates were cleared by
ultracentrifugation at 30,000 x g (rcf) for 30 minutes (Beckman optima
ultracentrifuge, TLA100.3 fixed angle rotor). The appropriate concentration of lysate
(as determined by a standard activity curve) is added to PDE Tris buffer (Appendix
II) with and without 20pM of a PDE4 inhibitor rolipram (Sigma) to make a final
reaction volume of 50pl. A negative control containing Tris buffer only should be
included. 50pl of 2pM H -cAMP substrate is added to each reaction (Appendix II).
Samples are incubated at 30°C for 30 minutes to allow the PDE4s to hydrolyse the
H -cAMP substrate to produce 5'AMP, followed by boiling for 2 minutes to stop the
reaction. Samples are cooled for 15 minutes on ice, before adding 25pl snake venom
to each reaction (Sigma, Appendix II). Incubation with snake venom for 10 minutes
at 30°C de-phosphorylates the H -5'AMP product (thus removing its negative
■3
charge). A dowex ion resin is then used to remove the negatively charged H -cAMP
substrate remaining in the reaction (400pl of Dowex Slurry per sample, see
Appendix II). This is incubated for 15 minutes on ice, mixing frequently before
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centrifuging at 13,000rpm for 3 minutes to spin down the resin and bound H -cAMP.
150pl of supernatant was added to 1ml of Ecoscint Scintillation fluid and counted
using a scintillation counter (tritium channel). 50pl of the FE-cAMP substrate is
■3
counted to determine total H counts added to the reaction. PDE4 activity can be
determined by removing the rolipram insensitive (not PDE4) activity from the total
activity. For these experiments total counts (or activity) were graphed as % of control
activity.
2.10 Centrosome isolation from SH-SY5Y cells
Centrosomes were isolated from mammalian cells using a modified version of the
technique published by Moudjou and Bornens, 1998. Some reagents and solutions
are detailed in Appendix II where indicated, others can be obtained from the original
reference. In brief cells were treated with lpg/ml Cytochalasin D and 0.2pM
Nocodazole for 1 hour prior to centrosome isolation (Appendix II). Cells were
trypsinised and pellets washed with TBS Buffer. Cells were recovered and washed
again using TBS 1/10-8% Sucrose buffer. Cells were recovered and resuspended in
TBS 1/10-8% Sucrose and lysis buffer (Appendix II) was added. Lysate was filtered
through a cell strainer and incubated at 4°C for 30 minutes with HEPES and DNase
at final concentrations of 1 OmM and 1 pg/ml respectively.
Lysates were applied to a discontinuous sucrose gradient and ultracentrifuged at
40,000 x g (15,300 rpm) for 1 hour in a Sorvall Ultra Pro 80 (swinging bucket rotor
TH-641) in 14x89mm Beckman centrifuge tubes. Centrosomes settled between 65%
and 50% sucrose using this procedure and were removed using a syringe. This
centrosomal lysate was diluted with four volumes of 20% sucrose and centrifuged at
43,000 rpm for 30 minutes using a Beckman Optima Ultracentrifuge (TLA 100.3
fixed angle rotor) in 13x51mm Beckman centrifuge tubes. Centrosome pellets were
resuspended using 40mM Tris pH 8.0 with 0.3% SDS and stored at -70°C. The
procedure is depicted in figure 2.10.
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■SH-SY5Y cells -40% confluent
■Nocodoazole (0.2|jM) and Cytochalasin D
(1 (jg/ml), (1 hour, 37°C)
■Harvest in PBS and Pellet
■Wash once in 10-50ml TBS Buffer
(1,500rpm, 8 minutes)
■Wash once in 5-50ml TBS 1/10-8%
Sucrose Buffer (1,500rpm, 8 minutes)
■Resuspend in 1-4ml TBS 1/10-8%
Sucrose Buffer
■Lyse by adding 3-16ml Lysis Buffer
■Filter lysate (100pm pore size)


























2.11.1 Single Nucleotide Polymorphism (SNP) selection
The NCBI dbSNP database and the USCS genome browser were used to identify
SNPs in DISCI and DISC2.
2.11.2 Bioinformatics programs













Promoter predictions (Grail, Genscan, FPROM
and TSSG)




Defining the disease mechanism operating in the t(1;11)
family
3.1 Preface
Schizophrenia is a complex disease with multiple genetic factors contributing to
disease aetiology in the general population. The t( 1; 11) family is unique because a
balanced translocation co-segregates through four generations with major psychiatric
illness. We can infer that a gene of major effect has been disrupted which directly
confers susceptibility to illness. This overcomes a huge hurdle in the genetics of
complex diseases as the region of interest is immediately apparent because it is
marked by the translocation. It is still necessary however to elucidate the
consequences of the translocation and the mechanism of disease pathogenesis.
There are two genes disrupted by the translocation. The priority candidate gene in
this family is DISCI, a novel protein coding gene, which is expressed in regions of
the brain implicated in psychiatric illness. There are two disease mechanisms that
could potentially leads to pathogenesis of illness in this family via disruption of
DISCI. The first mechanism assumes production of aberrant DISCI truncated or
fusion proteins. Such putative proteins might arise by one or more of the following
processes. A C-terminally truncated DISCI protein might be produced from the
derived chromosome 1. Such a truncated protein would lack much of the coiled-coil
forming potential of wild type (WT) DISCI and would lose the ability to interact
with many DISCI protein partners. Alternatively the derived chromosome 11 might
lead to the production of an N-terminally truncated DISCI isoform. Such a protein
would be predicted to retain some of the functional capacity of WT DISCI, but
without the N terminal region which is needed for correct sub-cellular localisation of
DISCI (Millar et a!. 2005a). Finally, the possibility of fusion proteins resulting from
juxtaposition of chromosome 1 and chromosome 11 sequences cannot be ruled out.
The downstream consequences any of these scenarios would be that either
truncated/fusion DISCI fails to perform its correct cellular functions and/or may
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acquire abnormal properties with detrimental cellular effects. In order for a
truncated/abnormal protein to be produced it is necessary that transcription occurs on
the derived 1 and 11 chromosomes and that this sequence then becomes translated.
To date there have been no studies investigating this in t(l;l 1) family members.
The second disease mechanism which may operate within the t( 1; 11) family is one of
haploinsufficiency. Haploinsufficiency occurs when a 50% reduction in gene product
(i.e. disruption of one allele) is sufficient to cause a disease phenotype. Family
members possessing the t( 1; 11) translocation have only one intact copy of the DISCI
gene. Haploinsufficiency would explain the co-segregation with illness if there was
no productive expression from the derived chromosome 1 allele. There is evidence to
support this from protein expression studies in a limited number of translocation
carriers. This data suggests that there is a reduction in the levels of DISCI protein in
translocation carriers versus those with a normal karyotype (Millar et al. 2005b). It is
unknown whether this is as a result of ablated transcription from the derived DISCI
allele or a cellular surveillance mechanism which degrades aberrant DISCI
transcripts. It is important to note that the two disease mechanisms mentioned here
are not necessarily mutually exclusive because it is possible that an abnormal protein
may also affect the function of the full length protein. Kamiya et al. have recently
reported that DISCI can dimerise via a self-association domain (Kamiya et al. 2005).
Furthermore in vitro over-expression of the hypothetical C-terminally truncated
DISCI isoform results in disruption of the normal localisation of full length DISCI,
which is postulated to occur via this self-association mechanism (Kamiya et al.
2005).
This chapter presents data from an extensive study of lymphoblastoid cell lines
derived from t(l; 11) family members, which express the DISCI gene. This study
analyses DISCI transcription from the normal and derived alleles and examines the
expression of DISCI at both the mRNA and protein level. It further investigates the
presence of C-terminally or N-Terminally truncated DISCI isoforms and whether
these are likely to contribute to disease pathogenesis in this family.
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3.2 DISC1 transcripts are produced from the derived chromosome
1
3.2.1 DISC1 SNP selection and genotyping
DISCI protein expression in lymphoblastoid cell lines from t( 1; 11) family members
has been previously analysed and no aberrant DISCI isoforms detected (Millar et al.
2005b). The effects of the t(l;l 1) translocation on transcription of this gene has yet
to be investigated. In order to assess transcription from the derived DISCI allele it is
necessary to distinguish it from the full length, wild-type allele. To do so exonic
single nucleotide polymorphisms were identified and genotyped in genomic DNA
isolated from t( 1; 11) lymphoblastoid cell lines. A panel of cell lines possessing both
normal and translocation karyotypes were analysed. Genotypes were determined by
amplifying the region using PCR and subsequent sequencing across the SNP.
SNP rs2492367 located in exon 6 of the DISCI gene was found to be homozygous in
all individuals and therefore not useful for discriminating the DISCI alleles. A
translocation carrier heterozygous for SNP rs3738401 located in DISCI exon 2 was
however available for analysis. Using SNP rs3738401, the A allele is present in all
carriers whereas some non-carriers possess a GG homozygous genotype. This infers
that the A allele of SNP rs3738401 represents the translocated DISCI allele and the
G allele represents the wild-type DISCI allele. As this translocation is inherited and
recombination is repressed in this region of chromosome 1 we can be confident in
this SNPs ability to discriminate between the alleles. Figure 3.2.A depicts the
inheritance of the translocation and thus how it is possible to discriminate the alleles
using this SNP.
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Table 3.2. T(1;11) exonic DISC1 SNP genotyping data
T(1;11)
Cell line status
Forward Reverse Forward Reverse
Genomic rs2492637 exon 6 cDNA rs2492637
N CC CC ND ND
T cc CC ND ND
T CC CC ND ND
ND = Not determined
Genomic rs3738401 exon 2 cDNA rs3738401 exon 2
N GG GG GG GG
T AG AG AG AG
DISC1 SNP genotype
Normal Karyotype x Translocation carrier
Parental genotypes
3
N T T N
G G A A A G
Offspring (F1) genotypes
J
A allele marks the translocation
Figure 3.2.A. Genotyping data for DISC1 exonic SNPs are shown in table 3.2. Below is
a cartoon depicting inheritance of the translocation. The chromosome carrying the
translocation is marked in red. Although the parental genotypes do not distinguish the
allele marking the translocation the presence of an AA translocation carrier and a GG
non-carrier in the F1 generation indicates that the A allele of DISC1 marks the
translocation chromosome.
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3.2.2 Analysis of DISC1 transcripts
To assess whether transcription occurs from the derived DISCI allele, cDNA was
prepared using mRNA isolated from t( 1; 11) lymphoblastoid cell lines that were
heterozygous for SNP rs3738401. The region surrounding this SNP was amplified by
PCR and sequenced in the same manner as for genomic DNA. If mRNAs are
transcribed from both alleles A and G, both alleles should be detected when
sequenced. Products were sequenced in both forward and reverse orientations for
normal and translocation carrying cell lines. Figure 3.2.B shows sequencing
chromatograms obtained from these cell lines. Cell line 74 possesses a normal
karyotype (N) and is homozygous GG for SNP rs3738401. Cell line 94 possesses the
translocation (T) and is heterozygous AG for rs3738401. It is clear that whilst only
the normal G allele is detected from cell line 74 (N), cell line 94 (T) produces
transcripts from both alleles as indicated by the presence of both A and G peaks
(indicated by N) at the position of the SNP. This method of sequencing is indicative
of abnormal transcripts being produced from the derived DISCI allele, however it is
not a quantitative assay so does not have the ability to inform on the relative
abundance of each transcript. Quantitative Real-Time PCR (qRT-PCR) was therefore
carried out on patient lymphoblastoid cell lines in order to determine whether DISCI
levels are affected by the translocation.
Normal homozygous GG Translocation heterozygous AG
90 100
G CG ATG TC TC TC TCG GC CC T TCA
80 90
:gcg atgtctctctcngcccttcag
Figure 3.2.B. This figure shows sequencing chromatograms for DISC1 exon 2 SNP
rs3738401. The normal cell line (74) is homozygous GG for SNP rs3738401 and as
such only the G allele is detected. However, it is clear that both alleles produce a
transcript in the translocation carrying cell line (94) as both A and G SNP alleles are
clearly visible in the chromatogram. This region containing the SNP is blow up on the
right as indicated by the arrows. This data is published in Millar et al. 2005b.
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3.3 Real-Time PCR reports a reduction in DISC1 transcription in
cell lines possessing the t(1;11) translocation
3.3.1 DISC1 primer design
Quantitative Real-Time PCR (qRT-PCR) was carried out to determine the relative
transcript abundance in translocation carriers compared to normal karyotype
controls. Primer pairs for DISCI qRT-PCR were designed within exon 2, spanning
exons 4-6, within exon 9 and spanning exons 11-12. Figure 3.3.A outlines the
location of these primers and the specific transcripts targeted by each pair. In brief,
primers from exon 2 and exons 4-6 were used to amplify DISCI sequence proximal
to the breakpoint region. These will detect transcription from the non-translocated
DISCI allele and also any C-terminally truncated or fusion transcripts produced from
the derived DISCI allele on the derived 1 chromosome. Primers within exon 9 and
exons 11-12 will amplify sequences distal to the translocation breakpoint, which
includes transcripts from the non-translocated DISCI allele and any N-terminally
truncated or fusion transcripts from the derived 11 chromosome.
3.3.2 SYBR green Real-Time PCR design and optimisation
SYBR green Real-Time PCR uses DNA binding dye chemistry during PCR
amplification to quantify the relative transcript abundance. SBYR green is a non-
sequence specific intercalating agent similar to ethidium bromide which emits a
strong fluorescent signal when it becomes incorporated into double stranded DNA
(.Morrison et al. 1998). Incorporation of SYBR green during PCR can be used as a
measure of the amount of transcript being amplified. PCR primers designed for non-
quantitative standard PCR techniques are compatible with this type of qRT-PCR
unlike Taqman technology (Applied Biosystems) which requires specific probes. The
disadvantage of SYBR green qRT-PCR is that optimisation of primers is required on
each template that is to be amplified. This is due to the fact that each primer pair will
amplify DNA with different efficiencies. Primer pairs are described as being 100%
efficient if amplification is exponential. However, few primers will truly amplify all
templates in every cycle. To calculate individual primer pair efficiencies, standard
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curves were constructed using a 4 point dilution curve (1 in 10 dilution series). The
cDNA used to construct standard curves was a pooled cDNA sample consisting of
translocation carriers and normal karyotype cDNA. Ideally primers should be at least
90% efficient and replicate samples should have a correlation coefficient greater than
0.99.
Another area of concern when using DNA binding dyes such as SYBR green is that
these dyes can bind to non-specific amplicons in addition to primer dimers and these
will also emit fluorescent signals. It is necessary to ensure that this non-specific
fluorescence is not confused for a specific signal. To control for this, melt curve
(a.k.a. dissociation curve) analysis was carried out after each amplification. If the
products are specific they should have the same melting temperature and this can be
seen using melt curve analysis. An example of a melt curve plot is shown in figure
3.3.B. Primer dimers, contaminating DNA and non-specific products are easily
detectable if they exist. PCR products were also routinely checked by agarose gel
electrophoresis to ensure specificity of the reactions.
102
DISC1 genomic structure and qRT-PCR primer locations
Exon 2 Exon 4-6
t(1;11) breakpoint
2 3 4 5 6 7 8
V
Exon 9








Figure 3.3.A. This diagram shows the location of DISC1 primers used for quantitative
Real-Time PCR to determine the relative expression of transcripts in t( 1; 11) cell lines
with and without the translocation.
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Figure 3.3.B. Melt curve plots of qRT-PCR primers are shown. Negative controls are
indicated in black and experimental samples are represented using coloured lines.
Specificity of primers is determined by analysing the peaks of the melt curve, which will be
identical for specific products. Peak height is an indication of relative transcript abundance
and does not correlate to specificity however non-specific products generally produce lower
peak heights.
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3.3.3 Relative quantification of DISC1 mRNA levels in t(1;11)
lymphoblastoid cell lines
RNA was extracted from lymphoblastoid cell lines, DNase treated and
complementary DNA (cDNA) synthesised under sterile conditions. All cDNAs were
tested for contaminating genomic DNA before use in qRT-PCR applications (see
chapter 2). A panel of cell lines derived from t( 1; 11) translocation carriers and their
karyotypically normal relatives were examined for their relative levels of DISCI
transcripts. At least two independent RNA samples were used to make cDNA.
DISCI levels were determined both proximal and distal to the translocation using
two sets of primers in each case. Two housekeeping genes were used to normalise
cDNA levels between preparations, Glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) and Human Phosphofructokinase (hPFKm). Relative levels of DISCI
were calculated using the Gene Expression Macro™ (Bio-Rad Laboratories Ltd.).
Algorithms are derived from Vandesompele et al. 2002 and also from the geNorm
website. This macro performs calculations similarly to the delta-delta CT method
modified to incorporate differences in primer efficiencies using the Pfaffl equation
(.Livak and Schmittgen, 2001, Pfaffl et al. 2001). The methodology is outlined in box
3.3.C.
Using SYBR green qRT-PCR, DISCI is seen to be dramatically reduced in
translocation carriers compared to karyotypically normal cell lines (Figure 3.3.D I-
III). This reduction is apparent using primers located in exon 2, exon 4-6 and exon
11-12. The differences in expression between translocation carriers and normal
karyotype controls are significantly different for primers located in exon 2
(**p<0 oi) and for primers spanning exon 4-6 (**p<0.01) of the DISCI gene. P
values were calculated by a two-tailed t-test using mean expression values for each
cell line. Statistical analysis was performed using the Prism software (GraphPad
Software, Inc.).
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Box 3.3.C Methodology for calculating relative gene expression values
After Real-Time PCR amplification each product amplified is assigned a cycle threshold
value. This represents the PCR cycle number at which a particular sample crosses a
defined threshold level. The cycle threshold value is inversely correlated to transcript
abundance (i.e. high abundance transcripts will have a lower cycle threshold than low
abundance transcripts). This value is termed a Ct value and is used to calculate the
relative abundance of each transcript as detailed below.
Primer Efficiency is determined from Relative quantity = primer efficiency (control Ct-sample Ct)
standard curves for each primer pair.
A primer efficiency of 100% = 2 as
there will be twice as much PCR
template after one amplification
cycle. Similarly an efficiency of 90%
= 1.9 and of 120% = 2.20. These
values are used to calculate the
relative quantity. Due to primer
variability It is important to account
for differences in primer efficiencies
when calculating the relative
transcript abundance.
Normalisation factor = (relative qty 1* relative qty N)<1/N)
•If no control sample is defined within the experimental sample set the
sample with the lowest Ct value should be used.
•Relative Qty is calculated for each sample for each gene independently
including reference genes. The relative values of reference genes are
used to calculate a normalisation factor (geometric mean) for each
sample.
•Dividing the relative qty for each sample by the normalisation factor for
each sample gives the un-scaled expression value for each sample in
the experimental gene set.
Relative expression level = Relative quantity / normalisation factor
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The relative DISCI expression values were not as well correlated for primers
spanning exon 11-12. These primers are located close to the 3'UTR of DISCI and
there was difficulty amplifying the 3' end of the gene. These primers were therefore
more difficult to optimise than primers located more N-terminally and required more
cDNA template per reaction. However running end-point qRT-PCR products on
agarose gels revealed that DISCI transcripts are less abundant in translocation
carriers than normal karyotype controls, which is in agreement with primers located
proximal to the translocation breakpoint (Figure 3.3.D (III)).
In contrast, primers designed within exon 9 of DISCI (i.e. distal to the breakpoint)
appeared to indicate an up-regulation of transcription in some t( 1; 11) cell lines
carrying the translocation suggesting the possibility of transcription from the derived
chromosome 11 (Figure 3.3.E). This data was not significant (p>0.05, two-tailed t
test) due a significant difference in the variance of each data set. On examining the
breakpoint region of chromosome 11 using the UCSC genome browser however
three novel expressed sequence tags (ESTs) were found. Two of these ESTs overlap
the breakpoint region and are in the correct orientation to elicit transcription of
derived DISCI sequences (Figure 3.4.A (I)). Albeit, this result is not supported by
primers spanning exon 11-12, which are also distal to the breakpoint. It is unlikely
therefore that this transcript, if real, extends as far as translocated 3'UTR sequence of
DISCI. For this reason the possibility of a stable N-terminally truncated DISCI
transcript or protein in t(l;ll) cell lines is highly unlikely but remains to be
investigated.
There is one other possibility which could account for this apparent transcriptional
up-regulation immediately distal to the breakpoint region. The primers within exon 9
of DISCI are also within the known DISC2 sequence, which overlaps DISCI in the
reverse orientation, therefore these primers could be detecting transcription of DISC2
sequence from the derived chromosome 11. Although this has not been formally
tested future work will incorporate experiments to analyse this.
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In summary, DISCI levels in t( 1; 11) cell lines possessing the translocation are
dramatically reduced in comparison to cell lines possessing a normal karyotype. This
is supported by qRT-PCR data using two primer pairs proximal to the translocation
breakpoint and one primer pair distal to the breakpoint. However, one primer set,
located distally in exon 9 of DISCI, shows apparent up-regulation of DISCI
sequences in some translocation carriers compared to controls. This could be
explained by DISCI transcription initiated from the derived 11 chromosome which
terminates before the derived DISCI 3'UTR, but perhaps more likely reflects
transcription of the anti-sense gene DISC2 from the derived chromosome 11.
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Figure 3.3.D. This figure shows quantitative Real Time PCR DISC1 expression data
from t(1; 11) cell lines. DISC1 expression levels are compared between translocation
carriers (red) and normal karyotype controls (black). Primer proximal to the t(1; 11)
breakpoint show a reduction in DISC1 expression levels (I and II). Scatter plots in the left
panel indicate individual cell lines with replicate values for each and graphs in the right
panel show the group mean and SEM for translocation and control cell lines. This
reduction in DISC1 expression reaches significance as determined by a two-tailed t-test,
**p<0.01 (GraphPad Prism). Primers spanning exon 11-12, distal to the t( 1; 11)
breakpoint, also support this data showing a reduction in DISC1 expression in
translocation carriers as seen by agarose gel electrophoresis following qRT-PCR (III).
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Normal Translocation Normal Translocation
Figure 3.3.E. This figure shows DISC1 qRT-PCR data using SYBR green Real-Time
PCR. DISC1 expression was compared between t(1; 11) cell lines possessing the
translocation and normal karyotype controls. Exon 9 DISC1 primers are located distal to
the translocation breakpoint. The scatter plot on the left shows the individual cell lines
with replicate values for each and the scatter plot on the right shows the group mean
and SEM for translocation and control cell lines. This data indicates up-regulation of
DISC1 expression in some translocation carrying cell lines suggesting there may be
possible transcription of DISC1 sequences on the derived 11 chromosome. This data is
not significant due to the high variance of expression within the translocation data set.
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3.4 The derived chromosome 11 is unlikely to support DISC1
transcription and translation
In light of the apparent up-regulation of transcription distal to the breakpoint it is
necessary to examine the chromosome 11 breakpoint region in detail. The three
novel ESTs found in this region are all orientated towards the centromere and thus
have the potential to elicit transcription of derived DISCI sequences (Figure 3.4.A
(I)). If DISCI sequence is transcribed in this region it could hypothetically produce
an N-terminally truncated DISCI protein isoform provided it is in frame with the
existing EST sequence.
Conceptual translation studies were carried out in silico on juxtaposed DISC1-
chromosome 11 EST sequences using the SIXFRAME translation programme
(SDSC Biology Workbench). This programme translates nucleic acid sequences to
produce six translations. The programme produces three forward translation frames
beginning in the first frame with the first nucleotide of the start codon and then
beginning with the second and then third nucleotide in the subsequent frames.
Similarly it produces three translations using the reverse sequence. These sequences
can then be exported for further analysis using protein analysis software.
Using this programme, D/SCf-chromosome 11 EST fusion sequences produced an
open reading frame of 268 amino acids in length when DISCI was fused to EST
CK000409 (Figure 3.4.A (II)). This open reading frame possesses the final two
coiled coil domains of DISCI. This region of the protein has been reported to be
responsible for interactions with NUDEL and LIS1 (Ozeki et al. 2003, Morris et al.
2003, Brandon et al. 2004). If translated, this could result in a DISCI protein missing
the N-terminal region, but potentially possessing the ability to bind to NUDEL and
LIS1.
DISCI is a multi-compartmentalised protein. The N-terminal globular domain directs
sub-cellular localisation to the nucleus, mitochondria and cytoplasm (Ozeki et al.
2003, Millar et al. 2005a). If this hypothetical N-terminally truncated sequence were
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translated, an abnormal protein possessing some of the functional capacity of WT
DISCI without its ability to localise correctly could be produced.
However, this scenario is considered unlikely for the following reasons. The
penultimate coiled coil domain ofDISCI is encoded by exon 9, for which qRT-PCR
data suggested an up-regulation in translocation cell lines, but the last coiled coil
domain of DISCI is encoded by exons 11 and 12 and qRT-PCR in this region does
not support the theory of DISCI transcription from chromosome 11. Therefore if
DISCI sequences are transcribed from chromosome 11 they are unlikely to extend as
far as exon 11-12 before terminating. Therefore the translocated DISCI sequence is
not likely to be in frame with these ESTs. Nonetheless it is still desirable to
demonstrate the absence of such a truncated protein by examining DISCI protein
lysates from normal and translocation carrying t( 1; 11) cell lines.
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Figure 3.4.A. Examination of the breakpoint region on chromosome 11 revealed three
novel EST sequences correctly orientated to elicit transcription of derived DISC1
sequence (I). Translation studies using SIXFRAME suggest there is a possibility of a
268 amino acid open reading frame (ORF) derived from fused sequences of CK000409
and DISC1. If translated this ORF would possess two of DISCTs coiled coil interaction
domains (II). CK000409 sequence is shown in dark blue, DISC1 sequence is shown in
red, with the coiled coil domains marked in black.
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3.5 There are no detectable truncated DISC1 isoforms in cell lines
possessing the t(1; 11) translocation
3.5.1 One Dimension SDS-PAGE does not detect abnormal DISC1
protein isoforms
The existing DISCI expression data from t( 1; 11) family members has focused solely
on the hypothetical C-terminally truncated DISCI isoform for the valid reason that
over-expression of C-terminally truncated DISCI constructs have been shown to
have detrimental effects on neurite outgrowth and neuronal migration (Ozeki et al.
2003, Kamiya et al. 2005). Current data reports a reduction in DISCI protein levels
in translocation carriers compared to non-translocation cell lines (Millar et al.
2005b). One-dimension SDS-Polyacrylamide gel electrophoresis (SDS-PAGE) using
an antibody designed to the N-terminus of DISCI (R47, see Figure 3.5.A) reports a
reduction in the three alternatively spliced DISCI isoforms of approximately 71-
80kDa in size. Furthermore, studies of a natural polymorphism in mouse Disci
resulting in a premature stop codon in exon 7 resulting in a truncated Disci allele
demonstrated that although DAc/transcript abundance is not altered the predicted C-
terminally truncated protein is not detected suggesting instability of this protein
{Koike et al. 2006). One caveat to this study is that an uncharacterised Disci
antibody was used and therefore further evidence is needed to substantiate these
findings.
Therefore current data does not support the existence of a human C-terminally
truncated DISCI isoform in t(l;l 1) family members. The predicted molecular weight
of this truncated protein is approximately 75kDa. The signal may therefore be
masked by wild-type DISCI isoforms. Moreover the Millar et al 2005b. study has
not addressed the question of an N-terminally truncated DISCI protein that may be
produced from the derived chromosome 11 or the existence of potential t( 1; 11)
fusion proteins. Consequently more evidence is needed to support the current
hypothesis of haploinsufficiency within the t(l ;11) family.
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To further address this issue one (ID) and two (2D) dimension SDS-PAGE was
performed on lysates from t( 1; 11) lymphoblastoid cell lines using N-terminal and C-
terminal DISCI antibodies to determine the presence or absence of aberrant DISCI
protein isoforms.
Lysates from normal and translocation carrying cell lines were initially analysed by
ID western blotting using a C-terminal DISCI antibody (Ogawa et al. 2005). This
antibody detects full length DISCI and the long variant DISCI isoform at
approximately 93-100kDa (Figure 3.5.A). As this antibody is designed to the C-
terminus it should detect any abnormal DISCI isoforms produced from the derived
11 chromosome. Using this antibody there were no detectable N-terminally truncated
DISCI isoforms in t(l;l 1) translocation carriers (Figure 3.5.B).
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Figure 3.5.A. This figures shows the locations of antibodies used to analyse t(1;11)
lysates by one and two dimension SDS-PAGE followed by western blotting.
aDISCI
Figure 3.5.B. This figure shows lysates from t(1; 11) cell lines probed using DISC1 C-
terminal antibody aDISCI. N = Non-translocation/Normal cell lines, T = Translocation
carrying cell lines. There are no IM-terminally truncated isoforms detected by one
dimension SDS-PAGE. Antibody specificity is indicated in the right panel by probing
endogenous DISC1 and FLAG-tagged DISC1 over-expressed in HEK293 cells.
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3.5.2 Two Dimension SDS-PAGE does not detect abnormal DISC1
protein isoforms
Analysis of DISCI protein isoforms was further examined using a two-dimension
SDS-PAGE system (2D-PAGE). This system will address the presence of a C-
terminally truncated DISCI isoform or DISCI fusion proteins possessing the C-
terminal region in t(l;l 1) cell lines. While the C-terminally truncated isoform may be
too similar in size to wild-type DISCI isoforms to be resolved by one-dimension
SDS-PAGE, two-dimension SDS-PAGE resolves proteins based on their isoelectric
point and size, therefore it has the power to resolve proteins with similar molecular
weights.
Lymphoblastoid lysates from t( 1; 11) family members were analysed by western
blotting using N-terminal and C-terminal DISCI antibodies R47 (original antibody
used by Millar et al. 2005b) and aDISCl respectively. Figure 3.5.C presents the
results of 2D western blots using these antibodies. R47 detects three specific protein
spots by 2D western blotting. Two spots are approximately 75kDa in size and are
likely to correspond to DISCI short isoforms. One protein spot is approximately
39kDa in size which could possibly represent the extremely short DISCI isoform
{James et al. 2004). C-terminal aDISCl detects one additional protein spot at
approximately lOOkDa; this is likely to represent the Long or Long Variant DISCI
isoform. There is no difference in DISCI isoforms present in t( 1; 11) cell lines
possessing the translocation and those possessing a normal karyotype.
In summary the N-terminal DISCI antibody R47 does not detect a C-terminally
truncated DISCI isoform by ID or 2D SDS-PAGE in lymphoblastoid cell lines
possessing the t(l;ll) translocation. ID analysis using the aDISCl C-terminal
antibody corroborates this data. Subsequent 2D SDS-PAGE using aDISCl shows
similar DISC 1 isoforms are present in translocation cell lines as in those possessing a
normal karyotype. There is no evidence therefore for the existence of DISCI
truncated isoforms as a result of the t(l ;11) translocation.
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Figure 3.5.C. T(1;11) lysates were probed using N-terminal DISC1 antibody R47 and C-
terminal antibody aDISCl No N-terminally or C-terminally truncated DISC1 isoforms are
detected by two dimension SDS-PAGE. Antibody R47 detects three spots, two of ~75kDa in
size, likely to represent DISC1 short (S) isoforms, and one of ~39kDa which possibly
represents the extremely short (Es) DISC1 isoform. aDISCI detects an additional spot of
~100kDa, likely to represent either L or Lv DISCI With the exception of one of the 75kDa




The data presented in this chapter aims to shed light on the mechanism of disease
pathogenesis in carriers of the t( 1; 11) translocation. The main competing hypotheses
for disease pathogenesis in this family are one of haploinsufficiency for DISCI
versus the production of an abnormal truncated DISCI protein with detrimental
effects on the cell. When cDNAs designed to express the hypothetical truncated
DISCI protein are over-expressed many adverse effects at the level of neuronal
migration and neurite outgrowth have been seen (Kamiya et al. 2005, Ozeki et al.
2003). As a result of this work this C-terminal DISCI truncation has been termed in
some cases the 'disease mutant form of DISCI' (Ozeki et al 2003). While there is no
disputing the phenotypic consequences, it must be remembered that there has been
no human truncated DISCI isoform detected in the translocation carriers from the
t( 1; 11) family. Therefore as far as human disease pathogenesis is concerned the
involvement of a C-terminal truncated DISCI isoform is purely speculative. Until
direct evidence for this protein is observed this protein remains hypothetical. It is
also noted that evidence for a reduction is DISCI protein synthesis in t( 1; 11)
translocation carriers has been reported and therefore the only direct evidence to
come from the t( 1; 11) family supports a haploinsufficiency disease model (Millar et
al. 2005b). This evidence is however limited and alone cannot rule out the presence
of abnormal truncated/fusion proteins.
In order to address these issues an extensive study of DISCI expression was
undertaken using lymphoblastoid cell lines derived from t( 1; 11) family members.
This data reports transcription from the derived DISCI allele on chromosome 1. This
transcription however is unlikely to produce a stable transcript as overall DISCI
mRNA levels are significantly reduced in translocation carriers compared to normal
karyotype controls (a subset of this data is published in Millar et al. 2005b). This
data suggests that transcripts produced from the derived DISCI allele are likely to be
subject to cellular surveillance mechanisms and subsequently degraded.
Primers located distal to the breakpoint spanning exons 11-12 corroborate this data
however one primer pair located distally, within exon 9, shows conversely that some
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t( 1; 11) translocation carriers possess more transcripts than normal cell lines.
Although further evidence is needed to support this up-regulation, this could
potentially be due to either amplification of DISC2 sequences (which also overlaps
this region of DISCI in anti-sense orientation) or DISCI transcription from the
derived allele on chromosome 11. It is considered likely that this up-regulation is a
result of transcription of DISC2 from the derived chromosome 11 for the following
reasons.
Examination of the chromosome 11 breakpoint region revealed novel ESTs with the
potential to drive transcription ofDISCI. However, as the second set of distal DISCI
primers (exonll-12) showed a reduction in DISCI levels in t( 1; 11) carriers, this
transcription does not extend to the translocated 3' DISCI sequence. This suggests
that the translocated sequence may be out of frame with chromosome 11 juxtaposed
sequence, consequently producing a premature stop codon. Furthermore, it is highly
unlikely, that even if this transcript does exist, that this sequence would produce a
stable protein. To this end the absence of truncated/fusion DISCI isoforms has been
confirmed by ID and 2D SDS-PAGE which detects no abnormal DISCI protein
isoforms within translocation carrier cell lines. In conclusion the data presented in
this chapter supports a disease model of haploinsufficiency for DISCI as the most
likely cause of illness in carriers of the t(l;l 1) translocation. This haploinsufficiency
is most probably a result of cellular surveillance mechanisms which degrade
abnormal DISCI transcripts.
However, the DISC2 gene is also disrupted by this translocation, and stable
transcripts may be produced from the derived DISC2 allele. As the function of the
DISC2 gene is currently unknown we can only speculate as to what consequences
disruption of this gene may have. DISC2 represents a putative non-coding RNA gene
antisense to DISCI which may have a role in regulating DISCI expression. It is
important therefore to understand the consequences of the t( 1; 11) translocation on
DISC2 gene expression in addition to studying DISCI. Gene expression analysis of




Isoform specific enrichment of DISC1 at the centrosome
4.1 Preface
Functional studies of the DISCI protein suggest that it occupies multiple sub-cellular
locations and interacts with multiple protein partners. DISCI has been reported to
localise to the nucleus, cytoplasm, mitochondria and centrosome (Table 4.l.A). This
chapter aims to shed some light on the multiple locations of the DISCI protein by
examining isoform specific protein expression in mammalian cells, focusing on
DISC 1 at the centrosome.
DISCI has been shown to bind various centrosomal proteins including NUDEL,
LIS1 and Kendrin/PericentrinB (see introductory section) therefore studies
demonstrating DISCI occupation at the centrosome are not surprising. Three studies
using exogenous over-expressed tagged DISCI have shown co-localisation to the
centrosome (Morris et al. 2003, Miyoshi et al. 2004, and Millar et al. 2005a). All
three studies utilise y-tubulin as a marker of centrosome position. Taken together
these studies have shown that SH-SY5Y (human neuroblastoma) cells, COS7
(African green monkey) cells and HeLa (human epithelial) cells exhibit DISCI
immunoreactivity at the centrosome.
It is possible that over-expressing DISCI at high levels may alter the sub-cellular
distribution profile. Furthermore, using bulky tags such as GFP to label the protein
may hamper localisation to the correct sub-cellular compartment. For these reasons
studies of the endogenous protein are important to substantiate these findings. Two
studies examining endogenous DISC 1 sub-cellular distribution refute the findings of
these over-expressing studies. Brandon et al. 2004 reported that although
endogenous DISCI does interact with the centrosomal proteins LIS1 and NUDEL, it
does not localise to the centrosome. This was demonstrated by non overlapping
immunoreactivities of endogenous DISCI and y-tubulin in SH-SY5Y cells. James et
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al. 2004 also support this finding that endogenous DISCI and y-tubulin do not co-
localise.
There is however one recent study which does support endogenous DISCI
localisation at the centrosome. Kamiya et al. 2005 reported endogenous DISCI to be
co-localised with y-tubulin and an additional centrosomal protein LIS1 in COS7 cells
and mouse cortical neurons.
One complication with these studies of endogenous DISCI is that all three studies
utilised different antibodies to detect the protein. James et al. 2004 used two DISCI
antibodies, one designed to the N-terminus of DISCI, R47, and a C-terminal
antibody R1443/1. These antibodies are known to detect distinct DISCI isoforms
(James et al. 2004). Brandon et al. 2004 used a C-terminal DISCI antibody (D26).
The R47 N-terminal antibody detects all DISCI isoforms, R1443/1 detects major
DISCI isoforms of lOOkDa and 75kDa whereas antibody and D26 detects a 95kDa
DISCI isoform (James et al. 2004, Brandon et al. 2004). Sub-cellular localisation
studies have shown that the N-terminal antibody, R47, detects DISCI at the
mitochondria in SH-SY5Y (James et al. 2004). The C-terminal antibody R1443/1
detects DISCI at the mitochondria and additionally within the cytoplasm in SH-
SY5Y cells whereas the C-terminal antibody D26 detects DISCI mainly in the
perinuclear region in this same cell type (James et al. 2004, Brandon et al. 2004).
Furthermore DISCI R47 has been shown to co-localise with specific mitochondrial
markers (James et al. 2004, Brandon et al. 2005) whereas R1443/1 and D26 detect
additional DISCI isoforms associated with cytoskeletal markers (James et al. 2004,
Brandon et al. 2004). It is likely to be the case that the R47, D26 and R1443/1
antibodies are detecting isoform specific localisation of DISCI to different sub¬
cellular compartments. It is clear from these experiments that the sub-cellular
distribution pattern of DISCI is complex; however none of these antibodies detect
DISC 1 at the centrosome.
122
In the Kamiya et al. study, which did report DISCI localisation at the centrosome,
the authors have not specified which antibody has been used to detect DISCI so we
cannot be sure which DISCI isoforms this antibody is detecting.
Acquisition of a new C-terminal antibody (aDISCl, see table 2.7) has enabled me to
address this issue of DISCI sub-cellular localisation further. These experiments
utilise immunofluorescent techniques in combination with sub-cellular fractionation
to address the issue of isoform specific localisation ofDISCI at the centrosome.
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4.2 Endogenous DISC1 localises to the centrosome
4.2.1 DISC1 Long and Long variant isoforms occupy cytoplasmic
and centrosomal locations
The C-terminal aDISCl antibody exhibits a different affinity for DISCI than either
of the current in house antibodies R47 and R1443/1. Ogawa et al. showed that
aDISCl detects a DISCI doublet at lOOkDa and a single band at 80kDa by
immunoblotting in SH-SY5Y cells (Ogawa et al. 2005). In my hands this antibody
robustly detected the doublet at lOOkDa and occasionally the 80kDa band. This
doublet most likely represents the full length (L) and long variant (Lv) DISCI
isoforms. Although this antibody detects the two long DISCI isoforms, as does the
N-terminal R47 antibody, it does not detect the DISCI triplet at ~75kDa that the R47
N-terminal antibody detects. It will be interesting therefore to compare the sub¬
cellular profiles of the isoforms detected using these two antibodies. This will allow
us to determine if all DISCI isoforms localise to similar sub-cellular compartments
or if the longer isoforms exhibit different sub-cellular patterns to the shorter DISCI
isoforms.
HEK293 and SH-SY5Y cells were processed by immunofluorescence for DISCI
using aDISCl and R47. In agreement with the differences in isoform specificity seen
by immunoblotting, these antibodies detected DISCI immunoreactivity at distinct
sub-cellular locations. R47 detected DISCI at the mitochondria as reported
previously (James et al. 2004). The C-terminal aDISCl antibody however exhibited
a very different pattern of localisation. This antibody did not exhibit a mitochondrial
pattern of localisation but rather a punctate cytoplasmic distribution and a dense spot
in the perinuclear region. On initial observation this perinuclear spot looked likely to
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To examine this localisation further sub-cellular markers were employed.
Mitochondrial marker cytochrome oxidase subunit II (MTC02), Golgi matrix protein
(GM130) and centrosome marker y-tubulin were tested for co-localisation with
DISCI. aDISCl immunoreactivity was found to overlap with y-tubulin in both SH-
SY5Y and HEK293 cells, suggesting that this C-terminal antibody detects a
centrosomal DISCI isoform (Figure 4.2.B and Figure 4.2.C). In dividing SH-SY5Y
cells aDISCl assumes a clear centrosomal location at the poles of the mitotic spindle
(Figure 4.2.C, lower panel). The DISCI isoforms detected using the aDISCl
antibody are distinct from the major DISCI isoforms detected using the DISCI
antibody R47 as they do not co-localise with the mitochondrial cytochrome oxidase
subunit II (Figure 4.2.D, upper panel). DISCI isoforms detected using the R47
antibody mainly co-localise with the mitochondria (Figure 4.2.D, lower panel);
however a small amount of DISCI detected using this antibody occupies a
centrosomal location (Figure 4.2.E).
The golgi matrix protein, GM130, has previously been identified as a putative DISCI
interactor by yeast two-hybrid analysis (.Millar et al. 2003). GM130 showed no co-
localisation with either R47 or aDISCl (Figure 4.2.F (aDISCl/GM130), R47 data
not shown).
Therefore, of the markers tested, the only sub-cellular marker seen to co-localise
with C-terminal DISCI antibody aDISCl is the centrosomal marker y-tubulin. To
confirm this result an additional centrosomal marker was chosen. I decided to
examine aDISCl co-localisation with the centrosomal protein AKAP450 (also
known as CG-NAP, AKAP350 or Yotiao) in SH-SY5Y cells. AKAP450 was chosen
as it was identified previously as a putative DISCI interactor by yeast two-hybrid
analysis (Millar et al. 2003). Figure 4.2.G (A-D) demonstrates the presence of
AKAP450 at the centrosome in SH-SY5Y cells. AKAP450 is known by many
alternative names, including CG-NAP. It was named CG-NAP (Centrosome and
Golgi PKN associated protein) because it can be associated with both the centrosome
and golgi apparatus (Takahashi et al. 1999). Figure 4.2.F1 presents additional images
ofAKAP450 alongside images of GM130 in SH-SY5Y cells. AKAP450 and GM130
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have distinct sub-cellular distribution patterns in this cell type. AKAP450 is localised
at the poles of the mitotic spindle in dividing cells consistent with a centrosomal
location. Furthermore AKAP450 is seen to co-localise with an additional
centrosomal protein, Ninein, in SH-SY5Y cells (Figure 4.2.G (E-H)).
When SH-SY5Y cells were processed by immunofluorescence AKAP450 and
aDISCl immunoreactivity showed strong co-localisation at the centrosome further
confirming the presence of DISCI at the centrosome (Figure 4.2.1). Some additional
co-localisation is seen within the cytoplasm as indicated by arrows in figure 4.2.1
(image H). It is intriguing that these two proteins may interact in additional locations
other than the centrosome. AKAP450 is an A Kinase Anchor Protein which functions
to traffic Protein Kinase A (PKA) to the centrosome (Keryer et al. 2003). It is
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The data obtained from these immunofluorescence microscopy experiments suggest
that the DISCI isoforms detected by the N-terminal R47 antibody are predominantly
mitochondrially located, which is in agreement with previously published data
{James et al. 2004, Brandon et al. 2005). However these experiments also show a
small amount of R47 immunoreactivity at the centrosome, which has not been shown
before. This centrosomal pattern is hard to detect due to the abundance of
mitochondrial DISCI staining which possibly explains why this has not been
reported previously. The pattern of aDISCl localisation is in contrast to this; the
longer DISCI isoforms are detected within the cytoplasm and strongly at the
centrosome. Due to its multiple interaction partners DISCI is considered likely to be
a molecular scaffold protein. These data support this and suggest that DISCI may
perform isoform specific interactions in specific sub-cellular compartments.
Subsequent experiments have attempted to confirm (and define) the existence of
centrosomal DISCI isoforms by sub-cellular fractionation.
4.3 The Long DISC1 isoform is abundant in fractions of isolated
centrosomes
Sub-cellular fractionation protocols to recover PI (nuclear) and P2 (mitochondria
enriched) fractions are well established in the laboratory. Isolation of centrosomes
required a new technique and was modified from Moudjou and Bornens, 1998.
Protocol details can be found in chapter 2 and the isolation process is depicted in
diagram 2.10.
4.3.1 Enrichment of 100kDa DISC1 in fractions of isolated
centrosomes
4.3.1.1 The isolated centrosome fraction is distinct in protein
composition from total cell lysate and P2 fractions
Centrosomal lysates were processed alongside SH-SY5Y total cell lysate and a
mitochondrion enriched (P2) lysate by SDS-PAGE. These lysates were subsequently
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analysed by western blotting to examine the proteins present in each fraction.
Gamma tubulin was initially used as a marker of centrosomal identity and the
mitochondrial protein cytochrome C was used to demonstrate mitochondrion
enrichment of the P2 fraction. Figure 4.3.A shows western blotting for y-tubulin in
all three fractions. This figure demonstrates that y-tubulin is present in the total cell
lysate, P2 and centrosomal lysate. Although y-tubulin is an important centrosomal
component and a reliable marker of centrosomal position using fluorescence
microscopy, it does exhibit a wide cellular distribution pattern. It has been reported
that at least 80% of total cellular y-tubulin is present in the cytosol (Moudjou et al.
1996) therefore it is not surprising that y-tubulin is present in the total cell lysate and
the P2 fraction in addition to the centrosomal fraction. This is also consistent with the
immunofluorescence data presented here, which demonstrates y-tubulin at the
centrosome and additionally in a diffuse pattern within the cytoplasm (for examples
see figures 4.2.A and 4.2.B). Furthermore, it is likely that only a small proportion of
the y-tubulin pool associated with the centrosome is examined in this centrosome
fraction. In these experiments y-tubulin was solubilised from centrosome fractions
using 40mM Tris pH 8.0 with 0.3% SDS. Subsequent reading suggests that more
stringent buffers may be required to release y-tubulin from the centrosome (Moudjou
et al. 1996). Using the current conditions it is likely that less than 60% of y-tubulin
associated with the centrosome has been released. The difficulties encountered
solubilising y-tubulin should not affect our ability to examine DISCI associated with
the centrosome as DISCI is likely to be more loosely associated with the centrosome
than y-tubulin. DISCI constructs that lack the ability to localise at the centrosome do
not affect y-tubulin itself, the core component of the centrosome, suggesting that
DISCI does not function to keep y-tubulin at the centrosome and is likely to have a
looser association with the centrosome (Kamiya et al. 2005).
The centrosomal fraction was further demonstrated to be distinct from total and P2
lysates using the mitochondrial marker cytochrome C. Using this antibody
cytochrome C is detected in the total cell lysate and enriched in the P2 fraction but
there is no cytochrome C present in the centrosome fraction as expected (Figure
4.3.B).
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It can be concluded from these western blotting experiments that the centrosome
fractionation procedure has produced a fraction distinct from total cell lysate and
mitochondrial enriched fractions that contains the centrosomal protein y-tubulin. It
would be desirable to confirm the success of the fractionation procedure with another
centrosomal protein; however none of the additional centrosomal antibodies tested
were suitable for immunoblotting.
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Gamma Tubulin
Figure 4.3.A SDS-PAGE followed by western blotting demonstrates the
presence of y-tubulin in all three SH-SY5Y fractions.
Figure 4.3.B. Cytochrome C is present within total and P2 fractions from
SH-SY5Y cells but not within the centrosome fraction.
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4.3.1.2 A 100kDa DISC1 isoform is enriched at the centrosome
SH-SY5Y total cell lysate, P2 lysate and centrosomal lysates were processed by
SDS-PAGE followed by immunoblotting for DISCI. Using the DISCI N-terminal
antibody R47 it was shown that distinct DISCI isoforms are enriched in the P2 and
centrosome fractions. The 71kDa DISCI isoform was seen to be enriched within the
mitochondrial P2 fraction as previously published (James et al. 2004 and figure
4.3.C). In concordance with the immunofluorescence data a DISCI isoform of
approximately lOOkDa in size is enriched within the centrosome fraction (Figure
4.3.C). This is consistent with the presence of either the L or Lv DISCI isoform at
the centrosome.
Surprisingly, 75kDa and 80kDa DISCI isoforms were also detected within the
centrosome fraction (Figure 4.3.C). Previously, sub-cellular fractionation has
localised these DISCI isoforms to the post-mitochondrial supernatant which contains
cytosolic and membranous cellular components (.James et al. 2004). It is intriguing
that these isoforms also appear to be enriched at the centrosome and that DISCI may
have a more prominent presence at the centrosome than previously thought.
Using the C-terminal aDISCl antibody a DISCI doublet comprising the L and Lv
isoforms is present within the total cell lysate and the P2 fraction (Figure 4.3.D). As
the P2 fraction is not a pure mitochondrial fraction these isoforms in the P2 lysate are
likely to represent cytoplasmic DISCI forms as this antibody does not detect
mitochondrial DISCI isoforms by immunofluorescence. Using this antibody a
lOOkDa DISCI isoform is indeed present within the centrosome fraction however
only one band of the DISCI doublet is detected (Figure 4.3.D). Unfortunately the
same enrichment of DISCI is not seen using this antibody as with the N-terminal
R47 antibody, however as only one of the DISCI long isoforms appears to be present
at the centrosome the DISCI pool is already reduced within the centrosome fraction.
The presence of only one band within the centrosome fraction indicates that either
the L or Lv DISCI isoform is present at the centrosome, while both are located in the
cytoplasm. It is difficult to determine which of these DISCI isoforms is present at the
centrosome as this isoform appears to have a slight band shift in the centrosomal
142
fraction. This could be due to a modification of this isoform at the centrosome or
more simply this could be due to use of a different buffer to solubilise the
centrosomal pellet causing the isoforms to migrate at a slightly altered molecular
weight. Due its size it is most likely that this isoform represents the L DISCI
isoform.
In summary, analysis of total, P2 and centrosomal lysates from SH-SY5Y cells
demonstrated that the 71kDa DISCI isoform is present in the mitochondrial enriched
fraction as previously published. These new data demonstrate the absence of this
isoform and preferential enrichment of DISCI lOOkDa, 75kDa and 80kDa isoforms
within the centrosome fraction. This is consistent with the immunofluorescence data








Figure 4.3.C. 20pg of each lysate was processed by SDS-PAGE followed by
immunoblotting for DISCI. Using DISC1 N-terminal antibody R47 an
enrichment of 100kDa DISC1 is seen within the centrosome fraction of SH-




Figure 4.3.D. 25pg of each lysate was processed by SDS-PAGE followed by
immunoblotting for DISCI The aDISCI C-terminal antibody detects a DISC1
doublet at 100kDa in total and P2 lysates, representing the Long and Long
variant DISC1 isoforms. In contrast, only one DISC1 isoform is detected in the
centrosome fraction indicating that either the L or Lv isoform is present at the
centrosome but not both. Due to the size it is most likely that this isoform
represents the DISC1 L isoform.
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4.4 DISC1 is localised to the poles of the mitotic spindle
throughout the cell cycle
As DISCI assumes a centrosomal location and the centrosome is an important
organelle for progress through mitosis I was interested to examine the localisation of
DISCI throughout mitosis in mammalian cells. I utilised COS 7 African Green
Monkey cells and performed immunofluorescent staining for a-tubulin (to locate the
mitotic spindle) and DISCI. In non-dividing (interphase) cells, aDISCl
immunoreactivity co-localised with a-tubulin at the site of microtubule nucleation
which is equivalent to the position of the centrosome (Figure 4.4.A (A-D)). DISCI
was present as one or quite often two bright centrosomal puncta (Figure 4.4.A (E-J)).
These paired puncta are likely to correspond to the two centrioles which comprise
each mammalian centrosome. Interestingly DISCI exhibits asymmetric staining at
the centrioles with one centriole staining more prominently than the other (Figures
4.4.A (E-J)).
DISCI was found to localise to the poles of the mitotic spindle throughout cell
division (Figures 4.4.B). Figure 4.4.B, images A-D, represent a cell in prophase
which has just duplicated its centrosome, which can be seen migrating towards the
opposite side of the cell. Images E-H of this figure show a late stage prophase cell
where this replicated centrosome has assumed its position at the opposite pole of the
cell and the mitotic spindle is beginning to form. Images I-L show the condensed
chromosomes aligning on the pro-metaphase spindle and migrating towards the
metaphase plate.
Figure 4.4.C shows the later mitotic stages of metaphase and anaphase during which
DISCI is still localised to the poles of the mitotic spindle. Figure 4.4.D depicts cells
approaching the completion of mitosis (telophase). The chromosomes have migrated
to opposite ends of the spindle and the cells are beginning to separate into two
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4.5 Discussion
The sub-cellular distribution of DISCI is complex and the subject of much debate
within the field. It is clear from many studies that DISCI assumes multiple locations
within the cell and that distinct isoforms occupy different sub-cellular locations. My
experiments have confirmed that the 71kDa DISCI isoform is mitochondrially
located as previously published (James et al. 2004).
Using immunofluorescence the L (~100kDa) and Lv (~98kDa) DISCI isoforms are
shown to be present as discrete puncta within the cytoplasm and also clearly evident
at the centrosome as demonstrated by co-localisation with two centrosomal proteins
y-tubulin and AKAP450. Immunoblotting DISCI from isolated centrosome fractions
further confirms this and suggests that it is most likely the DISC 1 L isoform present
at this location whilst both the L and Lv are located in the cytoplasm. Additionally
these sub-cellular fractionation experiments have demonstrated 75kDa and 80kDa
DISCI isoforms within the centrosome fraction. Unfortunately there are currently no
antibodies which specifically detect these isoforms such that this may be confirmed
by immunofluorescence.
This data raises the interesting question of whether DISCI performs isoform specific
interactions at distinct sub-cellular locations. As DISCI has the capacity to interact
with multiple proteins it is considered a molecular scaffold protein. Theoretically
individual DISCI isoforms could perform distinct protein-protein interactions and/or
traffic specific proteins to their required sub-cellular locations
One example of this has recently been published whereby the 71kDa DISCI isoform
has been shown to interact with Phosphodiesterase type 4B1 (PDE4B1). Both of
these protein isoforms are enriched within the mitochondrial fraction indicating that
this is where the interaction occurs (.Millar et al. 2005b). However the ability of
DISCI to bind type 4 phosphodiesterases is not limited to the 4B family although
this is the only interaction which has been studied in detail. Indeed DISCI can also
bind to PDE4A, PDE4C and PDE4D isoforms (.Millar et al. 2005b). Interestingly a
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member of the PDE4D family, PDE4D3, has previously been documented to exist at
the centrosome and has recently been shown to interact with AKAP450 and PKA
(Tasken et al. 2001, McCahill et al. 2005). As previously mentioned AKAP450 is a
putative DISCI interactor and these data demonstrate lOOkDa DISCI and AKAP450
co-localisation at the centrosome. This provides further support for a potential
DISC1-AKAP450 interaction and highlights the potential for a DISC1-AKAP450-
PKA-PDE4D interaction at the centrosome. Confirmation of the DISC1-AKAP450
interaction is needed to substantiate this hypothesis but it is an intriguing hypothesis
considering DISC Is already established role in cAMP signal transduction at the
mitochondria.
This chapter also examined the localisation of DISCI at the centrosome in the
context of mitosis and cell cycle progression. The centrosome is an important
organelle for cell cycle progression and disruption of centrosome function hampers
progress through the cell cycle and mitosis (Doxsey et al. 2005). Numerous
regulatory proteins necessary for cell cycle progression accumulate at the
centrosome, including Kendrin/Pericentrin B, which has been reported to be
important for DISCI localisation at the centrosome (Miyoshi et al. 2004). DISCI was
seen to be localised at the site of microtubule nucleation in interphase cells as
demonstrated by co-localisation with a-tubulin. At early stages of mitosis DISCI
expression was persistent at the centrosome even after centrosome duplication and
during centrosome migration. DISCI remained localised to the poles of the mitotic
spindle throughout cell division. This suggests that DISCI is a core feature of the
centrosome which may be necessary for cell cycle progression. The effect of
silencing DISCI expression on cell cycle progression is examined in chapter 6.
Interestingly during interphase DISCI was present quite often as two bright puncta
within the centrosomal region indicating that DISCI may be a marker of mammalian
centrioles. Furthermore DISCI appeared to be preferentially localised to one of the
centrioles although both did possess DISCI immunoreactivity. It has been reported
that certain proteins localise preferentially to the mother (older) centriole in various
cell systems and it is possible that DISCI is preferentially localised to one centriole
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in a similar manner. Both centrioles possess the ability to nucleate microtubules;
however only the mother centriole possesses a microtubule anchoring capability,
with proteins involved in anchoring of microtubules preferentially localising to the
mother centriole (Delgehyr et al. 2005). Ninein is a mother centriole specific protein
that is involved in microtubule nucleation and anchoring (Delgehyr et al. 2005).
Interestingly NUDEL, a DISCI interacting protein, has also been shown to co-
localise with Ninein specifically at the mother centriole where it contributes to
microtubule anchoring (Guo et al. 2006). DISCI may localise preferentially to the
mother centriole due to an excess of DISCI interacting proteins such as NUDEL at
the mother centriole. This scenario is depicted in figure 4.5.A below (adapted from
Badano et al. 2005). It will be interesting to further examine this asymmetry of
DISCI localisation at the centrioles and determine if DISCI possesses a role in
microtubule nucleation and/or anchoring, perhaps via its known interaction with




Figure 4.5.A. DISC1 localisation to the mammalian centrioles. DISC1 interacts with many
centriolar proteins, some of which preferentially localise to the mother centriole, indicated by
the arrow.
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In summary, DISC 1 was found to exhibit isoform specific localisation, with 1 OOkDa,
75kDa and 80kDa isoforms localising to the centrosome. This 1 OOkDa isoform
further appeared to be asymmetrically localised to the centrioles. DISCI is also
shown to be present at the poles of the mitotic spindle where it may perform









Figure 4.5.B. This figure depicts the isoform specific sub-cellular localisation profile of
DISCI. 71kDa DISC1 is predominantly associated with the mitochondrion whereas the
10OkDa isoform is mainly localised to the centrosome and can be seen at the poles of the
mitotic spindle during cell division. DISC1 isoforms of 80kDa and 75kDa are also localised




Optimising RNA interference to knock down DISC1
5.1 Preface
The gold standard for elucidating the function of an unknown gene is to create a loss
of function mutation and examine the resulting phenotype. To elucidate the functions
of DISCI at the cellular level, RNA interference has been employed to selectively
knock down DISCI expression. RNA interference is a powerful technique which can
be used to knock down expression of specified genes via double stranded RNA
(dsRNA) technology. Short interfering RNAs (siRNAs) are 21 nucleotide dsRNA
molecules which elicit gene silencing via the RNA interference pathway in mammals
(.Hannon, 2002). Under normal circumstances gene silencing is triggered by dsRNAs
present within the cell. These dsRNA precursors are processed by a ribonuclease
(RNase III) enzyme called Dicer to produce siRNAs. These siRNAs are then
unwound and one strand is incorporated into an RNA-inducing silencing complex
(RISC) which targets homologous transcripts for degradation (Hannon, 2002). To
date the enzyme responsible for cleaving the homologous mRNA transcripts, termed
'slicer', remains unidentified (Ketting and Plasterk, 2004). By using chemically
synthesised siRNAs we can take advantage of the RNAi pathway and artificially
induce gene knock down.
As the predicted disease model operating within the t( 1; 11) family is one of
haploinsufficiency for DISCI, RNAi will enable us to mimic the effects of the
translocation by artificially knocking down DISCI expression. Hopefully this will
not only give insights into the mechanism of disease pathogenesis in the t( 1; 11)
family but will also provide crucial clues to the normal functions of this novel
protein at the cellular level.
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5.2 DISC1 siRNA oligonucleotides knock down exogenous DISC1
protein
5.2.1 DISC1 siRNA oligonucleotides
The success of RNA interference depends on the choice of siRNA oligonucleotides
used to target the required gene. Although siRNAs may be designed by eye there are
various algorithms which can be employed to aid their design thus giving the optimal
chance of achieving gene knockdown. SiRNA oligonucleotides targeting the 5'
region of the target gene have been found to be effective in many cases. It is
suggested that 5' and 3' UTR regions are best avoided to evade interference by
regulatory proteins in these regions however there is no firm evidence that such
proteins hinder siRNA binding (Tuschl et al. siRNA user guide, 2004). In fact this
can be a useful region to target as resulting RNAi phenotypes can be rescued by
transfection of the target gene with an alternative 3'UTR sequence that will not be
targeted for knockdown (McManus and Sharp, 2002).
For my experiments I chose silencer pre-designed siRNA oligonucleotides which
were synthesised commercially by Ambion. These oligonucleotides were chosen
because the company guarantee silencing effects of greater than 70%. The
oligonucleotides were supplied pre-annealed and HPLC purified.
SiRNA oligonucleotides were chosen to target multiple regions along the DISCI
gene. Figure 5.2.A depicts the position of the oligonucleotides chosen for these
experiments. In brief, oligonucleotides were designed to target exons 2, 5, 6, 8 and
the 3'UTR region of DISCI. The oligonucleotides were given numerical identities as
detailed in figure 5.2.A.
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DISC1 genomic structure and siRNA target regions
1 23456 78 9 10 11/12 13 3'UTR
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Identifier: #5 #3 #1 #4 #2
Figure 5.2.A This figure depicts the exonic structure of the DISC1 gene and the location
of siRNAs designed to target the gene. Oligonucleotides were given numerical
identifiers. Unlabelled oligonucleotides are shown in black, FAM labelled
oligonucleotides are shown in green and Cy3 labelled oligonucleotides are shown in
red. Fluorescently labelled oligonucleotides were used to asses RNAi phenotypes by
fluorescent microscopy.
5.2.2 DISC1 siRNA oligonucleotides induce efficient knockdown of
exogenous FLAG-DISC1 protein
In addition to siRNA oligonucleotide sequence, RNAi induced knockdown is
dependent on efficient delivery (transfection) of the siRNA oligonucleotides into the
target cell. To assess the efficacy of these oligonucleotides for knocking down
DISCI, human embryonic kidney cells (HEK 293) and African green monkey kidney
cells (COS7) were used initially as established protocols exist for transfection of
these cell lines. Despite this it was necessary to determine the optimal transfection
reagent and the optimal concentration of siRNA oligonucleotides needed to knock
down gene expression. The siRNA oligonucleotides used here are guaranteed to
knockdown gene expression to the level of 70% or greater when used at a
concentration of lOOnM, with target gene expression analysed after 48 hours.
However excess siRNA can have non-specific toxic effects on the cell, therefore
DISCI siRNA oligonucleotides were initially tested at concentrations of lOnM and
50nM. Gene expression was analysed at 24 hours post transfection. Two chemical
transfection reagents were chosen to deliver the oligonucleotides, siPORT Amine
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and Lipofectamine 2000. Transfections were performed in 12 well tissue culture
plates, details of which can be found in chapter 2.
FLAG-DISCI and DISCI siRNAs were co-transfected into COS7 and HEK293 cells.
FLAG-DISCI expression was analysed by SDS-PAGE followed by western blotting.
A FLAG antibody and a DISCI (N-terminal R47) antibody were used to detect
DISCI protein expression levels post transfection. Using siPORT and Lipofectamine,
siRNA oligonucleotides for DISCI dramatically knocked down protein expression at
both lOnM and 50nM concentrations. Figure 5.2.B shows knockdown of exogenous
FLAG-DISCI induced by a 50nM concentration of oligonucleotides #1, #2 and #3 at
24 hours post transfection using siPORT in HEK293 and COS7 cell lines.
This figure suggests that when delivered using siPORT oligonucleotides #1, #2 and
#3 knock down exogenous DISCI with the same efficacy. However, delivery of
these oligonucleotides into HEK293 cells using lipofectamine suggests that
oligonucleotide #2 knocks down FLAG-DISCI expression to the greatest extent and
also that pooling individual siRNAs may have a synergistic effect on knockdown of
DISCI (figure 5.2.C).
These oligonucleotides were subsequently tested for knock down of endogenous
DISCI. Two additional oligonucleotides (#4 and #5) were also acquired at a later
date, due to an improvement in algorithm design at this point. Oligonucleotides #4
and #5 were not tested for knockdown at the level of exogenous DISCI but directly
tested for knockdown of endogenous DISCI.
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siPORT FLAG-D1SC1 ;siRNA (50nM) co-transfections at 24 hours
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Figure 5.2.B. This figure shows SDS-PAGE followed by western blotting to analyse
siRNA induced DISC1 knock down 24 hours post transfection using a 50nM
concentration of siRNA oligonucleotides. COS-7 cells were probed with DISC1 N-
terminal antibody (R47-15) and HEK293 cells were probed using a FLAG antibody.
Loadings were controlled by probing with alpha tubulin.








in x— c c c c
-—' v— o o o o
CO CO LO LO X— X—
+ + —1 N—»' v—^






Figure 5.2.C. This figure shows western blot analysis of FLAG-DISC1 expression 24
hours post transfection using lipofectamine. All oligonucleotides show good knockdown of
expression with the #2 + #3 oligonucleotide pool producing the most prominent
knockdown.
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5.3 DISC1 siRNA oligonucleotides knock down endogenous
DISC1 at the level of mRNA and protein
5.3.1 Real-Time PCR demonstrates RNAi induced knockdown of
DISC1 mRNA
To analyse endogenous DISCI knockdown siPORT was initially chosen to deliver
the siRNA oligonucleotides into HEK293 cells. RNA levels were analysed at 48 and
72 hours post transfection. Transfections were carried out in 12 well tissue culture
plates. Cells were harvested, RNA extracted and cDNA prepared as described in
chapter 2. Quantitative Real-Time SYBR green PCR (qRT-PCR) was used to
determine DISCI relative expression between treatment groups. DISCI primers for
qRT-PCR were designed to exon 2 ofDISCI. Oligonucleotides #1, #2, #3, #4 and #5
were tested for their ability to knock down DISCI by qRT-PCR. DISCI expression
levels are graphed as relative values compared to a mock or scrambled siRNA
control group. When compared to mock transfected cells, oligonucleotides #1 and #2
induced DISCI knockdown at 48 hours using a 50nM siRNA concentration.
Oligonucleotide #3 demonstrated inconsistent knockdown and was excluded from
further testing (Figure 5.3.A). Of the remaining two oligonucleotides #2 showed the
most pronounced levels of DISCI knockdown. This oligonucleotide was further
tested at concentrations of 50 and lOOnM at 48 and 72 hour time points. A lOOnM
concentration of oligonucleotide #2 did not produce further knockdown in
comparison to a 50nM concentration of this oligonucleotide and knockdown at 72
hours did not appear more pronounced in comparison to knockdown at 48 hours,
although DISCI mRNA levels are still reduced at this time point (figure 5.3.B).
Oligonucleotide #2 was then tested alongside two new oligonucleotides (#4 and #5)
for knockdown in comparison to mock treated controls. Oligonucleotide #2 again
consistently knocked down DISCI expression. Oligonucleotide #4 did not appear to
induce DISCI knockdown whereas oligonucleotide #5 was seen to induce
knockdown consistently and to a greater extent than oligonucleotide #2 (figure
5.3.C).
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At this point non-targeting negative control siRNA oligonucleotides were employed
to control for non-specific knock down of gene expression. Negative control siRNA
oligonucleotides were provided by Ambion and consisted of a 21 bp scrambled
sequences that should not target any human gene. DISCI oligonucleotides #2 and #5
were taken forward for further testing.
5.3.2 DISC1 oligonucleotides #2 and #5 demonstrate RNAi
induced knockdown of both RNA and Protein
Oligonucleotides #2 and #5 were transfected into HEK293 cells using siPORT.
Transfections were carried out in 6 well plates and upon harvesting cells were split
into two groups to allow for analysis of knockdown at the RNA and protein level.
SiRNA oligonucleotides (DISCI oligonucleotides #2 and #5 and non-targeting
negative control oligonucleotide) were transfected to achieve a final concentration of
50nM. DISCI mRNA levels were examined by qRT-PCR using primers designed to
exon 2 of DISCI. QRT-PCR samples were normalised using Glyceraldehyde -6-
phosphate dehydrogenase (GAPDH) and Phosphofructokinase (hPFK). DISCI
protein levels were analysed by SDS-PAGE followed by western blotting using
DISCI R47 N-terminal antibody. Relative protein levels were determined using the
Image J densitometry software package. Protein values were normalised using a-
tubulin or P-actin. This experiment was performed three times independently.
Non-targeting negative control oligonucleotides were not seen to reduce DISCI
expression levels in comparison to mock treated controls. Using oligonucleotides #2
and #5 these transfection conditions produced the most pronounced DISCI mRNA
knockdown at 72 hours post transfection in comparison to a non-targeting siRNA
control group (figure 5.3.D.). Although these oligonucleotides continually produced
DISCI knockdown it did not seem as consistent as previous experiments. It may be
possible that oligonucleotide delivery was compromised due to reagent instability or
oligonucleotide degradation although this was not formally tested.
Only one of the three experiments showed good correlation between mRNA levels
and protein levels. For experiment one, RNA and protein levels correlated well at
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both 48 hours and 72 hours, showing knockdown at both time points. Experiment
two produced RNA knockdown only at 72 hours and protein knockdown was not
apparent. Experiment three produced more prominent protein knockdown than RNA
knockdown at 48 hours whereas at 72 hours RNA knockdown was very prominent
but protein knock down was not. These discrepancies may be due to difficulties in
normalising the data. Also it is unknown how stable the DISCI protein is and
therefore at what point post RNA knockdown protein levels will diminish. For future
experiments protein turnover could be estimated by combining the use of translation
inhibitors and immunoblotting for DISCI to give an estimation of when RNAi
induced knockdown may be seen.
In summary, the negative control non-targeting siRNA oligonucleotide did not knock
down DISCI expression. DISCI siRNA #2 and #5 produced knockdown of DISCI
RNA and protein at either 48 or 72 hour time points. Unfortunately the levels of
mRNA and protein did not correlate well in all experiments. This could potentially
be a result of difficulties in normalisation and reliability of software used to
determine the relative expression levels; however it has been shown retrospectively
that the aliquot ofN-terminal R47 DISCI antibody used in these experiments has lost
its affinity for endogenous DISCI and this is likely to be a major contributing factor.
The most critical test for these oligonucleotides is the observation of knockdown of
DISCI protein post transfection. As the protein knockdown in these experiments was
seen to be variable it is also possible that the siRNA oligonucleotides have been
partially degraded or oligonucleotide delivery has been compromised resulting in
low transfection efficiency. Under these circumstances optimal knock down would
not be attainable. To continue analysing protein knockdown using these
oligonucleotides new batches were purchased ofDISCI siRNA #2 and #5 and also of
the non-targeting negative control siRNA. These oligonucleotides were purchased
conjugated to a fluorescent FAM or Cy3 label to allow analysis of transfection
efficiency and protein knockdown by immunofluorescence microscopy. A further
DISCI antibody (a-DISCl) designed to the C-terminus of DISCI was also employed
to analyse protein knockdown.
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Figure 5.3.A-D. These graphs show data representative of RNAi induced DISC1 mRNA
knockdown in HEK293 cells. Using 50nM siRNA, 48 hours post transfection, DISC1
siRNAs #1 and #2 produced approximately 50% reduction in DISC1 mRNA levels
whereas siRNA #3 inconsistently knocked down DISC1 expression (A). 100nM of
siRNA oligo #2 did not produce more pronounced knockdown than 50nM siRNA (B).
DISC1 siRNA #4 failed to induce DISC1 knockdown however siRNA #5 knocked down
DISC1 levels efficiently (C). DISC1 siRNAs #2 and #5 were further shown to induce
DISC1 mRNA knockdown in comparison to a non-targeting (NT) negative control siRNA
(D). This knockdown was statistically significant as determined by Anova with post hoc
Newman-keuls test, *p<0.05 (GraphPad prism).
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5.4 Fluorescently labelled DISC1 siRNA oligonucleotides knock
down endogenous DISC1 protein
5.4.1 FAM and Cy3 labelled DISC1 oligonucleotides knock down
endogenous DISC1 protein
Oligonucleotides #2 and #5 were conjugated to FAM (green) or Cy3 (red)
fluorescent tags to allow visualisation of oligonucleotides in transfected cells. Using
this method it is possible to track transfected cells and examine individual cellular
phenotypes in addition to examining whole cell populations. The lipofectamine 2000
reagent was used to deliver the oligonucleotides to HEK293 cells. It was decided to
change from the siPORT transfection reagent as oligonucleotides were more visible
by fluorescent microscopy after transfection using the lipofectamine reagent. This is
most likely due to the mechanism of delivery of the oligonucleotides into the cell
(see section 5.4.2).
Before immunofluorescent analysis was carried out, SDS-PAGE followed by
western blotting was used to analyse the ability of the labelled oligonucleotides to
induce protein knockdown following transfection with lipofectamine. It was shown
previously that the oligonucleotide #2 (unlabelled) was capable of inducing
exogenous FLAG-DISCI knockdown using lipofectamine, however this
oligonucleotide had not been tested for endogenous DISCI knockdown using this
reagent and oligonucleotide #5 had not previously been tested using lipofectamine
for delivery.
Transfections were carried out in 12 well plates as previously described. Cells were
transfected with an siRNA pool consisting ofDISCI oligonucleotides #2 and #5 but
a 50nM final transfection concentration was maintained. A DISCI C-terminal
antibody (a-DISCl) was used to determine knock down of the endogenous protein.
This antibody was chosen as existing aliquots of the N-terminal antibody (R47) had
lost affinity for the endogenous DISCI protein. This C-terminal antibody detects full
length DISCI and long variant DISCI at approximately 90-100kDa (Ogawa et al.
2005).
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Cy3 labelled DISCI oligonucleotides #2 and #5 clearly induced DISCI protein
knockdown at 24, 48 and 72 hour time points. At 48 hours post transfection, FAM
labelled oligonucleotides also showed clear knock down of DISCI (Figures 5.4.A
and B).
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Figure 5.4.A DISC1 siRNAs labelled with Cy3 fluorescent dye retain their ability to induce
DISC1 protein knockdown when delivered using lipofectamine (I). This protein expression
data is represented graphically using the Image J densitometry program. Samples are
normalised using a-tubulin and (3-actin and are scaled relative to the un-transfected control
lysate at 24 hours (II).
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Figure 5.4.B FAM labelled and Cy3 labelled DISC1 siRNAs reduce DISC1 expression at
48 hours post transfection using lipofectamine (I). Protein expression values were
quantified with the Image J densitometry program using a-tubulin and (3-actin to normalise
(II). This graph shows the average of two replicates in each column scaled relative to the
un-transfected control lysates.
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5.4.2 Fluorescent microscopy optimisation for analysis of siRNA
oligonucleotide delivery into HEK293 cells
To determine successful siRNA oligonucleotide delivery, cells were analysed by
fluorescent microscopy 24-48 hours post transfection. Cells were fixed using 4%
paraformaldehyde (PFA) and a FITC filter was used to excite the FAM label. Using
GAPDH FAM labelled control oligonucleotides, siPORT and lipofectamine
demonstrated the ability to deliver siRNA oligonucleotides successfully into
HEK293 cells at 24 hours post transfection. The oligonucleotides showed a very
different pattern of distribution depending on the transfection reagent used. Figure
5.4.C shows FAM labelled oligonucleotides within HEK293 cells 24 hours post
transfection using both transfection reagents. Lipofectamine results in a bright
punctate pattern of oligonucleotides within the transfected cells whereas siPORT
results in a more diffuse pattern of oligonucleotides within the cytoplasm. Although
both reagents resulted in successful delivery further analysis revealed that the
oligonucleotides were more clearly visible when delivered using lipofectamine. This
reagent also resulted in more consistent DISC 1 protein knockdown as determined by
SDS-PAGE and western blotting. Therefore, analysis of cellular RNAi phenotypes
using HEK293 cells was initially carried out by transfecting oligonucleotides with
lipofectamine at a concentration of 50nM for 48 hours. Fixation using PFA generally
resulted in better visualisation of the oligonucleotides as methanol quenches the
FAM signal. A cell number of 0.5 x 105 was determined as the optimal plating
conditions for a 12 well plate to allow analysis of individual cell phenotypes 48
hours post transfection.
Non-targeting control oligonucleotides were transfected in parallel to control for
non-specific phenotypes as a result of siRNA transfection. Unfortunately upon
microscopic analysis there was slight toxicity resulting from the transfection
procedure. Transfection reagent and siRNA concentrations were titrated further to
avoid non-specific phenotypes as a result of toxicity. A concentration of lOnM
DISCI siRNA was subsequently tested and deemed to be sufficient to induce DISCI
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protein knockdown (Figure 5.4.D.). This siRNA concentration was used for
subsequent transfections.
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GAPDH-FAM siRNA / a-tubulin
Lipofectamine 10pm siPORT
Figure 5.4.C. This figure shows imunofluorescent anaysis of siRNA delivery
into HEK293 cells. FAM labelled Gapdh siRNA is visualised using a FITC filter
(green) and cells were co-stained for Alpha Tubulin (red). Both lipofectamine
and siPORT are shown to deliver Gapdh siRNA into HEK293 cells. Images are
at 100 times magnification.
a-tubulin
R-Actin _
Figure 5.4.D. 10nM DISC1 siRNA is sufficient to induce protein knockdown 48 hours
post transfecting using lipofectamine.
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5.5 Discussion
This chapter describes the experimental procedures used to achieve optimal DISCI
knockdown via siRNA induced RNA interference. Five siRNA oligonucleotides
were designed along the length of the DISCI gene. Two of these oligonucleotides
successfully and consistently knocked down DISCI expression. Oligonucleotide #2
was designed to the 3'UTR ofDISCI and oligonucleotide #5 was designed to exon 2,
the largest exon of the DISCI gene. These oligonucleotides demonstrated successful
knock down of exogenous FLAG-DISCI protein and endogenous DISCI at the level
of mRNA and protein. These oligonucleotides produced prominent protein knock
down at 48-72 hours post transfection using concentrations of 10-50nM. These
experiments were controlled using a non-targeting scrambled siRNA oligonucleotide
which should not target any mammalian gene. This oligonucleotide did not show
reduction in DISCI gene expression below the levels of mock treated cells.
Classical RNAi results in reduced gene expression detectable at the mRNA and
protein level. Some siRNAs may also induce gene silencing by translational
repression only. Both DISCI siRNA oligonucleotides #2 and #5 possessed the ability
to knock down DISCI mRNA and protein levels and therefore the response elicited
by these oligonucleotides is a classical RNAi response.
One caveat to these experiments is that there were low levels of correlation between
mRNA and protein levels in some cases, with protein levels appearing to diminish
before mRNA levels in one case. This was however not a consistent finding and
therefore these discrepancies are considered to be due to difficulties in comparing
gene expression data that has been collected in different ways and also due a loss of
affinity of the R47 N-terminal DISCI antibody for endogenous DISCI.
The amount of siRNA used in RNAi interference experiments can vary greatly
depending on the gene being targeted. The oligonucleotides used in these
experiments were commercially available and came with a guarantee to knock down
gene expression greater than 70% if lOOnM concentrations were used and gene
expression was analysed at 48 hours post transfection. This is a huge
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oversimplification of the RNAi process because it is possible to saturate the siRNA
RISC complex (Hutvagner et al. 2004). Using a higher concentration of
oligonucleotides than is actually needed will not result in further reductions in gene
expression. Furthermore RNAi is a normal physiological process and 'hijacking' the
RNAi machinery using siRNAs may prevent normal cellular functioning thus
resulting in aberrant cellular phenotypes. Excess siRNA has been shown to have
many adverse effects such as off-target gene silencing, induction of the interferon
response and stimulation of non-specific RNA degradation (Barik, 2006). Moreover
over-saturation of the RNAi pathway has been shown to be lethal in adult mice
{Grimm et al. 2006). It is therefore desirable to titrate siRNA concentrations as much
as possible to reduce the likelihood of undesirable side-effects. Indeed DISCI siRNA
oligonucleotides were seen to produce good levels of knockdown when used at half
to one tenth the recommended concentration and using higher siRNA concentrations
did not increase the levels of DISCI knockdown. The phenotypic outcomes of
DISCI RNAi in mammalian cells are presented and discussed in chapter 6.
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Chapter 6
RNA interference for the DISC1 gene
6.1 Preface
This chapter describes pilot experiments analysing the effects of DISC l knockdown
in HEK cells using RNA interference. I have shown using quantitative Real-Time
PCR and polyacrylamide gel electrophoresis techniques that the most likely
mechanism of disease pathogenesis operating within the t( 1; 11) family is one of
haploinsufficiency for DISCI. To test the hypothesis that reductions in DISCI
expression may lead to cellular defects, I have utilised RNA interference technology
to artificially induce knockdown of DISCI gene expression. The optimisation
protocols for these experiments are detailed in chapter 5. Knocking down DISCI
gene expression by 50% should suffice to mimic the effect of the t( 1; 11)
translocation in the t( 1; 11) family. This RNA interference protocol knocks down
DISCI protein expression by 50% or more and hopefully will give essential clues as
to the normal functions ofDISCI at the cellular level.
During the course of these experiments there have been two published studies of
RNA interference for DISCI. Kamiya et at. 2005 used in utero electroporation to
deliver short hairpin RNAs into the developing mouse brain. The authors analysed
phenotypes of migrating neurons and found that knocking down DISCI expression
'virtually inhibited' neuronal migration. They also used an in vitro system in which
they over-expressed the hypothetical 'mutant' DISCI protein, that is predicted to
arise from DISCI truncation by the t( 1; 11) translocation. From these experiments
they drew the conclusion that the 'mutant' DISCI protein inhibits the interaction of
full length DISCI with NUDEL, LIS1 and pl50glued. These proteins are components
of a conserved nuclear migration pathway which is an important feature of neuronal
migration. The authors make the link between the effects of RNAi on neuronal
migration and the effects of the 'mutant' DISCI protein on the
LISl/NUDEL/pl50glllcd interaction, postulating that inhibition of neuronal migration
is a result of perturbations in this nuclear migration pathway. It is possible that these
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neuronal migration phenotypes do arise in this manner however, this study did not
analyse directly the effects of RNAi on these protein interactions but rather the
effects of the 'mutant' DISCI protein. As my experimental data have shown that this
'mutant' protein is undetectable in cells of t( 1; 11) patients it is still necessary to
demonstrate these defects using an RNA interference approach.
Hashimoto et al. 2006 examined the effects of reduced DISCI (by siRNA) in
primary rat neuronal cultures on ERK (Extracellular signal-related kinase) and Akt
(Protein kinase B) signalling as part of a study looking at DISCI in major depression.
The authors demonstrated a reduced abundance of the active phosphorylated form of
ERK and Akt in DISCI siRNA treated rodent neuronal cultures (.Hashimoto et al.
2006). This is an interesting finding as DISCI has recently been reported to be
involved in cAMP mediated signal transduction through direct interaction with the
Phosphodiesterase 4B and PDE4 activity is modulated by ERK signalling (.Millar et
al. 2005b, Houslay and Baillie 2003).
Confirmation of the existence of DISCI at the centrosome in chapter 4 opens up
many additional possibilities for the functional consequences of knocking down
DISCI. The centrosome has already been discussed in the context of neuronal
migration but it also has many other vital roles. The centrosome is the microtubule
organising centre of the cell and functions to generate and organise the a/p-tubulin
microtubule network (Doxsey 2001). The centrosome and microtubules are essential
for many aspects of cell survival including intracellular transport (of organelles and
molecules) and cell proliferation (Doxsey 2001, Doxsey et al. 2005). In addition to
localising to the centrosome DISCI has also been shown to be associated with
microtubules via either a direct or indirect interaction with a-tubulin, a component of
microtubules (.Morris et al. 2003, Brandon et al. 2004). Therefore RNA interference
for DISCI may have cellular consequences through the inhibition of DISCI function
at the centrosome or through interfering with interactions between DISCI and
microtubules.
172
DISCI is also localised to the mitochondria; however as discussed in chapter 4, the
specific isoforms of DISCI localised at the centrosome and the mitochondria appear
to differ. The mitochondrion is an important organelle as it drives cellular energy
production. The mitochondrion is an especially important organelle for brain
function as this organ has very high energy demands and mitochondrial dysfunction
has been implicated in many brain disorders (Wallace 1999, Schon 2000). The
mitochondrion is also critical for regulation of intracellular calcium levels and some
interesting interactions between DISCI and cAMP signalling molecules at the
mitochondria have been published recently (Babcock and Hille 1998, Millar et al.
2005b). One additional important function carried out by the mitochondria is
induction of apoptosis as a result of cellular insult (Green et al. 1998).
In this chapter I have examined the effects of reduced DISCI expression on cell
proliferation, cell cycle progression and microtubule network organisation which
may be hampered as a result of depletion of centrosomal DISCI. I have also
examined the effects of reduced DISCI expression on mitochondrial morphology,
apoptosis and cellular cAMP signalling. The functions of centrosomal DISCI and
mitochondrial DISCI are however not mutually exclusive and depletion of either
may impact on cAMP signalling and cell survival.
6.2 Analysis of DISC1 knockdown on cell cycle progression, cell
proliferation and apoptosis
6.2.1 Reduced DISC1 expression does not affect cell proliferation
as measured by BrdU incorporation
The percentage of dividing cells in a population was quantified by analysing the
incorporation of 5-bromo-2'-deoxyuridine (BrdU). BrdU is a thymidine analog that
can incorporate into the replicating DNA of actively dividing cells. This is then
coupled with immunodetection using a monoclonal anti-BrdU antibody for detection
of cells with labelled DNA. By pulsing cell populations for a short period of time
(typically 30 minutes to l hour) only cells that are within S phase of the cell cycle
will be labelled. I used a commercially available BrdU labelling kit which uses a
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fluorescein conjugated BrdU antibody for detection. After immunodetection of BrdU
the cell population was analysed by flow cytometry. The BrdU conjugated
fluorescein is excited at a wavelength of 488nm and this identifies the percentage of
actively dividing cells in the population. I used this technique to analyse both
lymphoblastoid cell lines derived from members of the t( 1; 11) translocation family
and cells with artificially induced DISCI knockdown. Protocol details can be found
in chapter 2.
6.2.1.1 Lymphoblastoid cell lines derived from t(1;11) family members
do not show reduced proliferation as a result of translocation
Lymphoblastoid cell lines were fed daily for three days before labelling with BrdU.
The cells were pulse labelled with BrdU for 40 minutes at 37°C using a final
concentration of 1 OpM BrdU. After 40 minutes the cells were spun down and washed
in fresh cell culture medium prior to the immunodetection procedure. After
immunodetection (detailed in chapter 2) cells were resuspended in PBS and analysed
by flow cytometry.
Two cell lines possessing a normal karyotype were analysed and three cells lines
possessing the t( 1; 11) translocation were analysed. This experiment was performed
twice independently. 10,000 cells were analysed for each cell line as depicted in the
sample dot plots shown in figure 6.2.A (A). This figure presents the flow cytometry
generated dot plots representing normal and translocation carrying cell lines. Non-
proliferating cells are coloured black and proliferating cells are coloured green.
Although there were differences in the percentage of dividing cells between the two
independent experiments there was no difference in the percentage of dividing cells
between translocation carrying cell lines and normal karyotype controls within each
experiment (Table 6.2.A (B)). The upper panel of table 6.2.A (B) shows
representative values of the number of dividing cells (S phase) in translocation and
non-translocation populations. The presence of the translocation does not appear to
alter the rate of proliferation of these cells.
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6.2.1.2 Artificially inducing DISC1 knockdown using RNA interference
does not reduce cell proliferation in HEK293 cells
HEK293 cells were transfected with a 50nM concentration of siRNA to knock down
the expression of DISCI (pooled oligonucleotides #2+#5). Each treatment group (i.e.
non-transfected, non-targeting siRNA transfected and DISCI siRNA transfected) was
performed 6 times in replicate. After 72 hours cells were pulse labelled with 10 pM
BrdU. Labelled cell populations were then pooled for each treatment group and
analysed by flow cytometry as described above. 10,000 cells in each treatment group
were counted and the proportion of BrdU positive cells deduced from this. Table
6.2.A (B) (bottom panel) shows the proportion of dividing cells in the non-targeting
(NT) siRNA transfected population and DISCI siRNA transfected population. The
reduction in DISC 1 expression was analysed by western blotting using a-tubulin and
P-actin to normalise protein loading. Figure 6.2.A (C) depicts the level of DISCI
knockdown achieved in this experiment. From this experiment we can deduce that a
high level of transfection efficiency was obtained and knockdown of DISCI at the
protein level is substantial but this does not lead to gross changes in the proportion of
proliferating cells. Although 6 replicates of each treatment group were used in this
experiment the protocol requires a high number of cells and therefore the replicates
were pooled for analysis. In order to perform statistical analyses this experiment
should be repeated. Furthermore it was noted that a high level of background was
present in the antibody only control group which did not receive BrdU and this may
have implications for the results of this experiment. For these reasons additional
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Figure 6.2.A. Analysis of BrdU incorporation by t( 1; 11) family member cell lines
demonstrated no significant difference between the rate of proliferation in translocation
carrying cell lines and normal karyotype controls (A + B). Furthermore artificially
inducing DISC1 knockdown does not produce gross abnormalities in cellular
proliferation (B + C).
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6.2.2 Analysis of cell cycle progression following siRNA induced
DISC1 knockdown
Analysis ofDNA content per cell is an established method for determining cell cycle
stage in a cycling population. This method uses fluorescent DNA intercalating agents
which when incorporated into DNA can give a measure of the total DNA content per
cell. In these experiments I used propidium iodide (P.I.), an analog of ethidium
bromide, which can intercalate with double stranded RNA and DNA. Detailed
protocols and references are documented in chapter 2. These experiments use flow
cytometry to analyse the amount of P.I. staining which is a direct reflection of the
amount of DNA per cell. Prior to mitosis cells in Gi phase are diploid (2N). Once
these cells enter S phase they replicate their DNA eventually possessing twice the
amount of DNA per cell (4N) before entering mitosis to produce two daughter cells
(2 x 2N). These properties of DNA content are used to determine the cycle stage of
each cell.
Using this method there is expected to be some overlap in the P.I. staining between
distinct phases. For example cells that have just begun S phase will be difficult to
distinguish from Gi phase cells as their DNA content will differ only slightly.
Similarly cells nearing completion of S phase will have almost the same DNA
content as cells in G2 phase and therefore some overlap occurs here also. MultiCycle
advanced DNA cell cycle analysis software was used to analyse the DNA histogram
plots produced by the flow cytometric measuring of P.I. staining and separate out the
distinct cycling populations.
HEK293 cells were transfected with 50nM of a non-targeting siRNA oligo or 50nM
DISCI siRNA (pooled oligos #2 + #5). Within one pilot experiment conducted each
treatment was carried out in duplicate and cells were harvested 48 hours post siRNA
transfection. After harvesting these cells were incubated in a hypotonic solution with
P.I. to stain total cellular DNA. This protocol incorporates a Ribonuclease A step
which removes dsRNA from the population being stained so we can be sure that only
the DNA is being measured. P.I. was measured by flow cytometry using the FL3
detector and histogram distributions representing DNA content per cell were
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generated. 10,000 cells were measured for each treatment group. This histogram plot
was exported to the DNA analysis software to determine the percentage of cells
within each phase of the cell cycle. Figure 6.2.B (A) depicts the histogram plot
generated by the flow cytometry program and (B) represents this same plot following
analysis to separate out each population. This histogram plot is from un-transfected
HEK293 cells which were processed alongside the experimental samples. The cell
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Western blots carried out on replicate samples demonstrated substantial reductions in
DISCI protein levels between non-targeting siRNA transfected groups (NT siRNA)
and DISCI siRNA transfected groups (Figure 6.2.C (A)). Values obtained from cell
cycle analysis of each sample are graphed in figure 6.2.C (B). Graphs are shown for
Gi, S and G2 stages of the cell cycle. Apoptosis was not measured in this analysis as
this experiment was performed separately. There were no substantial differences
between the un-transfected (unT) groups and NT siRNA or DISCI siRNA
transfected groups in any of the cell cycle phases. There does however appear to be a
small increase in the number of cells within the Gi phase in the DISCI siRNA
treated group in comparison to the NT siRNA transfected group. Although each
treatment was carried out in duplicate these values are from one pilot experiment,
thus not permitting statistical analysis. The number of DISCI siRNA transfected
cells within the S phase also appears to be slightly decreased in comparison to the
NT siRNA treated group which would be in concordance with an increased number
of cells stalled within the G| phase. Although these findings are potentially
interesting indicating that DISCI may play a role in regulation of the cell cycle
independent replication is required.
As western blotting from these lysates demonstrated a substantial reduction of
DISCI protein within the DISCI siRNA treatment groups differences in the cell
cycle profiles of these populations are likely to be a result of reduced levels of the
DISCI protein. The observed differences are however small and need to be
replicated in two additional independent experiments to confirm these results.
Furthermore, it is important to note that these cell populations are not synchronised
and have been analysed at 48 hours post transfection only. Analysis at longer time-
points and using synchronised cultures may lead to more apparent differences in the
cycling profiles and should be considered for future experiments.
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Figure 6.2.C. Data from one pilot experiment examining the cell cycle profile post siRNA
treatment. Western blotting of two replicate samples from each treatment group
determined substantial knockdown of DISC1 protein levels in comparison to un-
transfected cells and non-targeting siRNA transfected cells (NT siRNA) (A). This
knockdown of DISC1 resulted in small changes in the cell cycle profile of these treatment
groups (B). However these values are only from one representative experiment and need
to be repeated to confirm any changes that might occur.
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6.2.3 Analysis of apoptosis following DISC1 knockdown
Apoptosis is an essential physiological process required for development and to
eliminate abnormal cells from an otherwise healthy population. As the
mitochondrion is an important organelle for inducing apoptosis I was interested to
see if apoptosis was affected in DISCI siRNA treated cell populations. During
apoptotic cell death dying cells translocate the membrane phospholipid
phosphatidylserine (PS) to the outer leaflet of the cell membrane. Techniques which
analyse apoptosis generally take advantage of this by using the phospholipid binding
protein Annexin V that binds to PS on the membrane surface of apoptotic cells. I
used a commercially available kit that uses Annexin V conjugated to a FITC
fluorophore. Annexin V staining is usually combined with P.I. staining to identify
cells with a disrupted cell membrane i.e. late stage apoptotic or necrotic cells. P.I.
will not permeate early apoptotic cells. Therefore this technique allows the
identification of early apoptotic cells with Annexin V bound to PS on the outer
membrane, late stage apoptotic cells with Annexin V bound to PS that will also take
up the vital dye P.I., and necrotic or dead cells which will only take up P.I.
Three treatment groups were analysed, mock transfected, non-targeting siRNA
transfected (NT siRNA) and DISCI siRNA transfected, each of which was
performed in triplicate, within one pilot experiment. By this stage further
optimisation of the siRNA transfection process had demonstrated that lOnM siRNA
is sufficient to induce DISCI knockdown. For this experiment HEK293 cells were
treated with siRNA at a final concentration of lOnM and analysed 48 hours post
transfection. After harvesting cells were incubated with Annexin V-FITC and P.l. as
described in chapter 2 and were analysed by flow cytometry. Figure 6.2.D (A+B)
shows dot plots generated from the flow cytometry procedure. Un-stained HEK293
cells were used to set detectors for the FL1 (Annexin V-FITC) and FL3 (propidium
iodide) channels. The dot plot in figure 6.2.D (A) shows these un-stained cells. All
cells sit within the bottom left quadrant (A3) and represent healthy cells. The dot plot
in figure 6.2.D (B) depicts a mock transfected cell population stained with Annexin
V-FITC and propidium iodide. Quadrant A1 detects red stained cells only (i.e.
necrotic or dead cells), quadrant A4 detects green cells only (i.e. early apoptotic
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cells) and quadrant A2 detects cells which are both green and red (i.e. late apoptotic
cells). Green or red detection is indicated by either red or green shapes surrounding
the cell populations in each quadrant.
20,000 cells were counted by flow cytometry for Annexin V-FITC and P.I. staining
in each group and the quadrant statistics were analysed to determine whether there
were any differences in the number of dying cells, or indeed the progress of
apoptosis between the treatment groups. The first thing that was apparent from this
experiment was that a lot of cell death had occurred in the mock transfected cell
population indicating either an unhealthy cell population to begin with or a highly
toxic transfection procedure. For the purposes of further experimentation the amount
of transfect agent used was titrated further to avoid possible toxicity. The data from
the individual quadrants was used to create graphs representing the number of viable
cells, early apoptotic cells and late apoptotic cells. These graphs are shown in figure
6.2.D (C, D and E). Within this pilot experiment there were no significant differences
between the replicate values (n=3) for the mock transfected group and the NT siRNA
transfected group in either the percentage of viable, early apoptotic or late apoptotic
cells. However there were significant differences in all three categories between the
replicate values from the NT siRNA transfected cells and DISCI siRNA transfected
cells. Within the DISCI siRNA transfected cell populations there were significantly
more viable cells in addition to significantly reduced numbers of early and late
apoptotic cells in comparison to the NT siRNA cell populations (two-tailed t-test, *p
< 0.05). The extent of DISCI protein knockdown was determined by western
blotting and densitometry analysis (Figure 6.2.E (A+B)). Although there was
variability in the DISCI levels within triplicates of a given treatment group, the mean
value of DISCI in the DISCI siRNA transfection group is far reduced in comparison
to the NT siRNA transfected controls. All three DISCI siRNA treated replicates had
a higher percentage of viable cells and a lower percentage of both early apoptotic and
late apoptotic cells. However, these are within experiment replicates and independent
replications of this experiment need to be conducted. These results suggest that
DISCI may have a role in apoptotic signalling and that knock down of DISCI may
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Figure 6.2.D. This figure shows data from one pilot experiment (N=1) analysing apoptosis
post DISC1 siRNA treatment (n=3 per treatment group). Un-stained cells were used to set
the baseline FL1 and FL3 levels (A). Mock transfected cells are shown as an example of a
positively stained population (B). The percentage of cells within each quadrant is graphed
in figures C-E. Graphs show the mean and SEM of three replicates. DISC1 siRNA
transfection resulted in an increase in the number of viable cells (C) and a decrease in the
number of both early and late stage apoptotic cells (D and E). These differences were
deemed to be statistically significant in comparison to the negative (neg) control (non-
targeting siRNA) treated group (two-tailed t-test, *p<0.05). These values represent
statistical analysis within one pilot experiment only and need to be replicated
independently.
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Figure 6.2.E. A decrease in the levels of DISC1 protein is apparent by western blotting of
NT siRNA and DISC1 siRNA lysates (A). Protein loading was not equal between the
individual lysates so densitometry analysis was performed to determine DISC1 protein
levels. The mean and SEM values for the two groups are graphed (B, n=3 for each
column). There is a large reduction in the mean value of DISC1 protein present within the
DISC1 siRNA treated samples. However there is variation between the replicates and this
reduction does not reach statistical significance.
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6.3 Reduction of DISC1 levels via RNAi has implications for
cellular cAMP signalling
It has recently been published that DISCI interacts with Phosphodiesterase type 4B
(.Millar et al. 2005b). Phosphodiesterases (PDEs) are the only means of quenching
cAMP signalling within the cell (Houslay and Adams 2003). DISCI is hypothesised
to bind a low-activity un-phosphorylated form of PDE4B, which is then released
upon phosphorylation by Protein Kinase A in response to elevated cAMP production
(Millar et al. 2005b). As such I was interested to examine whether reductions in the
levels of the DISCI protein induced by DISCI siRNA would alter PDE4 specific
hydrolysis of cAMP. To examine this I induced DISCI knockdown in HEK293 cells
using lOnM siRNA (pooled siRNAs #2 and #5) and measured the ability of PDE4 to
hydrolyse cAMP 48 hours post transfection.
To do this I used tritium labelled cAMP (H3-cAMP) which was incubated with fresh
cell lysates containing endogenous phosphodiesterase activity. Active
phosphodiesterases will hydrolyse the H -cAMP substrate to produce H -5'AMP,
which is subsequently de-phosphorylated. The non-hydrolysed H3-cAMP is then
removed using a Dowex ion exchange resin by virtue of its negative charge so that
only the hydrolysed H '-AMP remains in the lysate. The level of hydrolysed H3-AMP
is then measured using a scintillation counter. For details of the assay protocol refer
to chapter 2.
For this pilot experiment each treatment group was performed three times in
replicate. Cells were plated in a 6 well tissue culture plate at a density of 1 x 105 and
transfected 36 hours after plating. Cells were transfected using either lOnM of a non-
targeting siRNA (NT siRNA) or lOnM of DISCI siRNA. 48 hours post transfection
cells were harvested. Replicates for each group were pooled and the protein
concentration was determined by taking the average of three optical density readings.
lOpg of protein was used to assay the levels of cAMP hydrolysis in each
experimental group. 10-20pg of protein was determined as the optimum lysate
concentration from a PDE4 activity standard curve (data not shown) carried out on
this cell type. The assay was performed in triplicate for each experimental group. A
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control group which contained no lysate was included to estimate the background
readings from the assay. For each experimental group and the control group cAMP
hydrolysis was measured in both the presence and absence of rolipram (a specific
PDE4 inhibitor). This enables us to determine the amount of cAMP hydrolysis
resulting from PDE4 activity in comparison to total PDE activity within the cell.
The RNAi for DISCI in the DISCI siRNA treatments groups was deemed successful
by SDS-PAGE followed by immunoblotting (Figure 6.3.A (A)). Using this
hydrolysis assay it was determined firstly that most of the phosphodiesterase activity
in this cell type was due to members of the PDE4 family as rolipram reduced PDE
activity to background levels (Figure 6.3.A (B)). Secondly transfection of DISCI
siRNA resulted in dowregulation of PDE4 activity in comparison to non-targeting
siRNA oligos (Figure 6.3.A (C)). This reduction was such that the levels of
hydrolysis were comparable to the control groups. Figure 6.3.A, graph (D) shows
PDE4 activity expressed as a percentage of activity seen in the NT siRNA treatment
groups, using the highest value as 100%. PDE4 activity is reduced in the DISCI
siRNA treated group. It is noted that these analyses use only two values from the NT
siRNA group as the PDE4 assay was not successfully completed for one sample. It is
necessary to repeat this experiment to confirm these results.
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Figure 6.3.A. This figure represents data from one pilot experiment analysing PDE4
activity levels post DISC1 siRNA treatment. DISC1 protein levels are reduced 48 hours
post RNAi (A). PDE4 hydrolysis assays performed on these lysates demonstrate that
PDE4 is the main phosphodiesterase activity present in HEK293 cells (B). The mean
level of cAMP hydrolysis is far lower in the DISC1 siRNA treated assay samples (n=3)
compared to NT siRNA treated samples (n=2) (C). This reduction appears to be a result
of decreased PDE4B activity (D). Graphs show the mean or average of replicates for
each group.
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6.4 Examination of cellular phenotypes by fluorescence
microscopy following DISC1 RNA interference
Studies of DISCI knockdown by RNA interference have reported defects in
localisation of various interacting proteins suggesting that DISCI may have a role in
anchoring or trafficking of certain cellular proteins. In particular Kamiya et al. 2005
reported that reducing DISCI expression by RNA interference resulted in defective
neuronal migration and imply that this is a result of disruption of LIS 1 and NUDEL
and pl50glued localisation at the centrosome. This implication is made on the basis
that RNAi for DISCI hampers neuronal migration and that over-expression of the
'mutant' DISCI protein results in failure of LIS1, NUDEL and pl50glued to
accumulate at the centrosome and hinders neuronal migration (Kamiya et al. 2005,
Ozeki et al. 2003). The authors did not however examine directly the localisation of
these proteins in cells treated with shRNA for DISCI. This mutant protein was also
shown to disrupt the P-tubulin microtubule network which may have further
implications for cell morphology and neuronal migration. The effect of DISCI on
localisation of proteins important for neuronal migration is a particularly important
aspect of DISCI function considering the developmental hypotheses surrounding
schizophrenia that involve hampered neuronal migration and aborization (Harrison
and Weingerber 2005). For these reasons I have revisited some of these areas to
assess the effects of reduced DISCI on cell morphology of the microtubule network
and centrosome structure.
As introduced previously mitochondrial dysfunction is also a feature of
schizophrenia and considering DISCl's localisation to the mitochondrion I wished to
examine the morphology and distribution of mitochondria in cells with reduced
DISCI protein. Furthermore the morphology of mitochondria has been shown to be
altered in cells over-expressing DISCI suggesting that DISCI may play a role in
mitochondrial fission and fusion {Millar et al. 2005a).
Except where stated all siRNA transfections were carried out using a final
concentration of lOnM of either a non-targeting siRNA control oligonucleotide or
pooled DISCI siRNA oligonucleotides #2 and #5.
189
6.4.1 Detection of DISC1 by fluorescence microscopy in RNAi
treated cells
FLAG-DISCI localises to a perinuclear location likely to correspond to the
centrosome when over-expressed in SH-SY5Y cells. Localisation of exogenous
FLAG-DISCI was examined in SH-SY5Y cells transfected with FLAG-DISCI alone
or cells co-transfected with FLAG-DISCI and DISCI siRNA #2 or #5. 72 hours post
transfection cells were fixed and processed by immunofluorescence for FLAG-
DISCI. Cells were examined by fluorescence microscopy. Four or five randomly
chosen regions from each coverslip were counted for FLAG-DISCI
immunoreactivity at the centrosome. Of the cells transfected there was approximately
50% less cells possessing FLAG-DISCI immunoreactivity at the centrosome in cells
co-transfected with FLAG-DISCI and siRNA for DISCI (Figure 6.4.A). As co-
transfected cells that received FLAG-DISCI should also have received the siRNA
for DISCI it can be inferred that these siRNA oligonucleotides reduce exogenous
DISCI accumulation at the centrosome.
Further to this it is necessary to determine whether reductions in endogenous DISCI
are also apparent following siRNA transfection and that this is specific to DISCI
siRNA and due not to siRNA or transfection in general. These experiments were
carried out in HEK293 cells as these are the cells for which protein knockdown has
been optimised (see chapter 5). In order to examine DISCI knockdown in transfected
cells it was first necessary to determine which cells have been transfected with the
siRNA oligos. Most research of this type is carried out by co-transfection with GFP
to detect transfected cells however it is possible that GFP itself may produce effects
post transfection. Therefore I chose FAM labelled siRNA oligos which can be
visualised by fluorescent microscopy to track transfected cells. These labelled
oligonucleotides function just as efficiently as the unlabelled siRNA oligonucleotides
and are visualised as bright green spots within the cytoplasm or at a perinuclear
location (see chapter 5). 48 hours post siRNA transfection cells were processed for
immunofluorescence using the aDISCl C-terminal antibody as this successfully
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detected DISCI knockdown at the protein level by immunoblotting. Initially it was
decidedly difficult to detect knockdown of DISCI by immunofluorescence as a high
number of cells were transfected and the amount of siRNA oligonucleotide was such
that it was difficult to find non-transfected cells which could be used for comparison
of DISCI expression levels. In order to overcome this problem I used a lower
volume of lipofectamine/siRNA complexes to transfect the cells. This produced a
much lower transfection level and allowed examination ofpositively transfected cells
and non-transfected cells on the same coverslip.
With this lower transfection efficiency it was possible to detect DISCI knockdown in
cells that received DISCI siRNA in comparison to adjacent cells that had not been
transfected (Figures 6.4.B and C). In some cells this reduction was seen as a less
intense or absent perinuclear dense spot likely to correspond to DISCI centrosomal
staining (Figure 6.4.B); in other cells a general reduction in expression was seen
(Figure 6.4.C). There were however some cells which received siRNA but which did
not apparently have reduced DISCI levels therefore any phenotypic abnormalities
observed as a result of siRNA transfection will have to be subject to cell counting
and statistical analysis to determine the relationship between transfection of siRNA
and the observed phenotype. DISCI knockdown was also detectable using the
DISCI R47 N-terminal antibody. Figure 6.4.D depicts HEK293 cells transfected
with 50nM DISCI siRNA 72 hours post transfection. The two cells containing
DISCI siRNA clearly have negligible DISCI staining in comparison to the non-
transfected cells.
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Cells counted per group
FLAG-DISC1 173
FLAG-DISC1 + #2 259
FLAG-DSIC1 + #5 218
B %of cells possessing centrosomal DISC1 staining
Figure 6.4.A. This figure shows a pilot experiment demonstrating exogenous DISC1
knockdown by immunofluorescent staining post siRNA treatment with DISC1 siRNAs #2
and #5. The percentage of cells possessing exogenous FLAG-DISC1 staining at the
centrosome was determined by counting 4-5 fields of view on each coverslip. These
values are depicted as a dot plot (A). Using these values a significant reduction in the
number of cells containing FLAG-DISC1 at the centrosome was observed in DISC1 siRNA
co-transfected populations (one-tailed t-test, **p<0.01, n>3 for each column) (B). Graph B
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6.4.2. DISC1 siRNA is not associated with disruption of the a/(S-
tubulin microtubule network
48 hours post transfection of DISCI siRNA, cells were processed by
immunofluorescence with an antibody against a-tubulin to detect the microtubule
network of the cell. DISCI has been reportedly associated directly and indirectly
with a-tubulin (.Morris et al. 2003, Brandon et al. 2004) therefore we might expect to
see some abnormalities in the microtubule network. Again transfected and non-
transfected cells from the same coverslip were examined simultaneously for
alterations in the microtubule structure that may be associated with siRNA
transfection. No gross changes in the a-tubulin microtubule network were seen to be
associated with DISCI siRNA in comparison to non-targeting siRNA controls
(Figure 6.4.E). Furthermore the microtubule nucleating centre is still clearly visible
in the DISCI siRNA transfected cells as indicated by an arrow in figure 6.4.E.
Similar results were obtained using p-tubulin to detect the microtubule network.
From these experiments it is clear that reduction of DISCI does not grossly alter the
microtubule network.
6.4.3 DISC1 siRNA is not associated with abnormalities in
mitochondrial morphology
As in previous experiments cells were processed by immunofluorescence 48 hours
post transfection. An antibody to mitochondrial cytochrome oxidase subunit II
(MTC02) was used to examine the morphology of mitochondria in transfected
versus non-transfected cells from the same coverslip. Examination of MTC02
revealed no apparent abnormalities in the morphology of the mitochondria in
transfected versus non-transfected cells (Figure 6.4.F). Although the number of
mitochondria per cell was not formally counted there were no obvious differences in
the distribution or intensity of MTC02 staining between transfected and non-
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6.5 Discussion
This chapter details pilot RNA interference experiments for the DISCI gene and
serves as a taster for the different phenotypes that may arise as a result of depletion
of DISCI. In all experiments DISCI protein levels were substantially reduced and
this correlated with a number of phenotypes. An altered cell cycle profde was
observed in DISCI siRNA transfected populations, producing a small increase in the
number of cells within Gi phase and a small decrease in the number of cells within S
phase. This alteration may arise as a result of reduced DISCI at the centrosome.
Exogenous FLAG-DISCI immunoreactivity was shown to be reduced at the
centrosome in cells co-transfected with DISCI siRNA and endogenous DISCI
staining was also seen to be reduced using two DISCI antisera (aDISCl and DISC-
R47). The centrosome is important for cell cycle regulation and has been shown to be
important for the Gi to S phase transition (.Hinchcliffe et al. 2001, Doxsey et al.
2005). This is in concordance with the differences observed in these experiments.
However, the data form these experiments comprises one pilot experiment with
replicates. Furthermore, these experiments did not use synchronised cultures and
only examined one time-point of 48 hours. Additional independent experiments
including synchronisation studies at extended time-points are required to confirm the
differences in the cycling profiles ofDISCI siRNA treated populations.
Another caveat to these experiments is that the BrdU incorporation experiment to
measure actively dividing cells did not find differences in the levels of proliferation
in DISCI siRNA transfected and non-targeting siRNA transfected populations. This
protocol was complex; it required a high cell number such that 6 replicates of each
treatment group were pooled for analysis. Furthermore the protocol required multiple
rounds of centrifugation and resuspension of cell pellets resulting in a high number
of cells being lost, hence the high starting number. The monoclonal BrdU antibody
also produced a very high level of background staining compared to un-stained
populations. Therefore, for reasons of high cell loss and high background staining the
results from this experiment may not be entirely accurate, although attempts were
made to exclude background as much as possible. It is my opinion that the DNA
content analysis is a more reliable procedure as it requires a smaller number of cells
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and the cells are only spun down once at the time of harvesting so no cells are lost
during the procedure. Furthermore the analysis of DNA content and conversion into
cell cycle data is carried out using computer analysis software which accounts for
overlap between stages and is likely to be more accurate than manually setting
thresholds in the presence of high background staining.
Interestingly, LIS 1, a DISCI interactor has also been shown to be actively involved
in mitosis. Over-expression of LIS 1 and RNAi mediated depletion of LIS 1 results in
an increase in the mitotic index of transfected cell populations. Various mitotic
defects were reported in these populations including delayed chromosomal alignment
resulting in delayed onset of anaphase, loss of chromosomes from the metaphase
plate and misorientation of the spindle axis {Faulkner et al. 2000). There was some
indication from my preliminary siRNA experiments that reduced DISCI may result
in additional cell cycle defects, including chromosome alignment and cytokinesis
defects. Future work will incorporate an in depth analysis to try and confirm this.
Some examples are shown in figure 6.5.A. Figure 6.5.A images A and B-C show two
cells from the same coverslip one of which has been successfully transfected with
DISCI siRNA. The positively transfected cell appears to have either a lagging
chromosome or a chromosome that has been lost from the metaphase plate (image C
is the same as B but with more intense DAPI staining). This is in contrast to the non-
transfected cell in which all chromosomes have aligned at the metaphase plate.
Images D-F in this figure depict cells at anaphase/cytokinesis. The mitotic spindle
has been detected using a-tubulin. Images D, E and F depict a cell which has
received DISCI siRNA and images G and H depict an un-transfected cell (not from
the same coverslip). Again in the cell that has received DISCI siRNA there may be
some DNA lagging behind after midbody formation in preparation for cytokinesis
(image F is the same as image E but with more intense DAPI staining). The un-
transfected cell is shown for comparison however this cell is at a slightly later stage
of mitosis. These figures are merely examples and synchronisation of cultures will be
necessary to determine the nature of any abnormalities that may arise. Time-lapse
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Given the large amount of mitochondrially localised DISCI and the role of the
mitochondrion in apoptosis I decided to measure the levels of cell death in siRNA
treated populations. Unfortunately Annexin-V FITC and propidium iodide staining
revealed that either the transfection procedure was highly toxic or the cell population
used in this experiment was unhealthy prior to transfection. The latter is considered
more likely as cell death of this magnitude was not apparent in other independent
experiments. Although this was a disappointing finding it serendipitously revealed
that cell populations transfected with DISCI siRNA had a higher number of viable
cells and lower number of apoptotic cells in comparison to mock transfected and NT
siRNA transfected populations. These differences were again small, percentage wise
and require independent replication. These findings suggest that reduced DISCI may
have a protective effect against apoptosis under toxic or stressful conditions. DISCI
has been implicated in the cellular stress response via interactions with the
eukaryotic translation initiation factor 3 (eIF3) (Ogawa et al. 2005). Ogawa et al.
demonstrated that over-expression of DISCI resulted in accumulation of eIF3 and
DISCI within stress granules in human neuroblastoma cells (Ogawa et al. 2005).
The specific role of DISCI at the mitochondrion or how DISCI participates in the
cellular stress response is not currently known. Previous studies have shown that
mitochondrially associated DISCI is resistant to trypsin digestion suggesting that
DISCI is localised within the mitochondrion or the mitochondrial membrane and
work to define its exact location in ongoing within the lab {James et al. 2004). At
this point in time we can only speculate about what role DISCI may have in
facilitating apoptosis induction and hypothesise that it may be as a result of altered
DISCI protein levels at/in the mitochondrion. Induction of apoptosis is an
intrinsically complex process involving alterations in mitochondrial membrane
potential, cytochrome c release and caspase activation {Smith et al. 2005, Hill et al.
2003). It is possible that DISCI may facilitate these signalling events in some
manner. Interestingly it has recently been reported that high levels of PDE4B2 limits
apoptosis in B lymphocytes {Smith et al. 2005). High levels of PDE4B in this cell
type appear to quench the effects of cAMP induced apoptosis via inhibition of the
AKT pathway. These events are independent of PKA, the normal cellular cAMP
effector kinase {Smith et al. 2005). This in an intriguing finding considering the
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recent report of DISC1-PDE4B interaction at the mitochondria (.Millar et al. 2005b).
The main difference between these studies is the isoform of PDE4B implicated.
71kDa DISCI, the mitochondrially localised isoform, has been shown to bind
PDE4B1 and is hypothesised to regulate its cAMP hydrolysing activity in a negative
manner. It is possible therefore that the absence of DISCI (via siRNA depletion)
may alter the activity of PDE4B1 affecting cAMP signalling and hence the induction
of apoptosis in HEK293 cells under stressful conditions. One other crucial difference
between these two studies is that that the DISC1-PDE4B interaction is PKA sensitive
and up-regulation of PKA culminates in release of DISCI from PDE4B1 (.Millar et
al. 2005b), whilst Smith et al. 2005 reports a PICA independent mechanism for
cAMP induction of apoptosis in B lymphocytes. Together these two studies in
combination with data generated from these siRNA experiments suggest a role for
DISCI and PDE4B and most likely DISC1-PDE4B interactions in mediating cAMP
induced apoptosis via the mitochondrial apoptosome, however the underlying
mechanism in HEK293 cells is unclear and likely to differ from that of B
lymphocytes. Intriguingly mitochondrial associated apoptosis is a critical feature of
normal brain development {Roth and D 'Sa, 2001).
One piece of convergent evidence is provided by a recent study by Hashimoto et al.
2006 which reported that siRNA mediated depletion of DISCI in rodent neuronal
cultures results in a decrease in the phosphorylation of AKT. The authors did not
examine any phenotypic abnormalities associated with cell death, however these data
suggest that DISCI may be involved in both PKA and AKT mediation of cAMP
signalling.
Continuing along the signalling theme, I also examined the effect of DISCI siRNA
on levels of cAMP hydrolysis by the type 4 phosphodiesterases. This follows on
from the recent work demonstrating an interaction between PDE4B and DISCI with
implications for cAMP signalling (.Millar et al. 2005b). This work demonstrated that
DISCI was associated with PDE4B1 in its non-phosphorylated form. This is a
dynamic interaction which appears to be disrupted by up-regulation of PKA
signalling and cAMP production. This previous work hypothesised that DISCI may
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inhibit the hydrolysis of cAMP by PDE4B1 until such time as cAMP levels are
increased and PDE4B1 activity is needed. My pilot experiment demonstrated that
reduction in DISCI by siRNA actually decreased the level of hydrolysis of cAMP by
PDE4s (in comparison to NT siRNA) which seems counterintuitive to the current
hypothesis. This is perplexing finding, if replicable, as it suggests that the presence
of DISCI is so vital that in its absence virtually no cAMP hydrolysis occurs. In order
for this to happen, DISCI must either have a direct effect on expression of PDE4s or
must have a far greater role in cAMP signalling than originally thought.
Modification ofPKA signalling has been shown to be important for progress from Gi
into S phase of the cell cycle in thyroid cells (Feliciello et al. 2000). Depression of
the cAMP pathway and cellular translocation of PICA is required for progress into S
phase in this cell type. Activation of cAMP signalling (and PKA) via addition of 8-
Br-cAMP and phosphodiesterase inhibitor (IBMX) resulted in failure to progress
from Gi to S phase (Feliciello et al. 2000). From my siRNA experiment cAMP
hydrolysis is dramatically reduced following DISCI depletion comparable to that of
phosphodiesterase inhibition which may account for the previously discussed delay
in Gi to S phase progression in these cells.
Knockdown of DISCI was also examined by fluorescence microscopy in transfected
cells. FAM labelled siRNA was utilised to allow individual transfected cells to be
identified. Transfection efficiencies were purposely low to allow examination of
positively transfected and negatively transfected cells within the same experiment.
DISCI siRNA successfully knocked down expression of both the exogenous and
endogenous DISCI protein.
The P-tubulin network has previously been reportedly disrupted by over-expression
of the 'mutant' DISCI protein (Kamiya et al. 2005). The authors demonstrate that
over-expression of 'mutant' DISCI disrupts the normal cellular distribution of full
length DISCI and imply that this is the root cause of these abnormalities. It follows
therefore that analysis of the tubulin network following siRNA mediated depletion of
DISCI may produce similar defects. In the case of these experiments analysis of the
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a/p-tubulin microtubule network did not yield any gross abnormalities in comparison
to non-targeting siRNA controls. It may be the case that knockdown is not sufficient
to induce defects; however the levels of DISCI knockdown observed by SDS-PAGE
and immunoblotting were such that I would expect to see a defect if DISCI is
involved in microtubule nucleation or stabilisation. It is possible that these methods
are not sensitive enough to detect very minor abnormalities however it is also
possible that in the Kamiya et al. 2005 study the 'mutant' DISCI protein is altering
the microtubule network by having additional effects and is not directly related to
disruption of full length DISCI. Furthermore work from this laboratory does not
support the finding that over-expression of'mutant' DISCI disrupts the microtubule
network (unpublished observation) and Ogawa et al. 2005 has shown that over-
expression of DISCI results in the formation of stress granules in transfected cells.
Therefore aberrant expression of DISCI or 'mutant' DISCI may result in cellular
stress that could cause alterations in the tubulin network as seen by Kamiya et al.
2005
It was also demonstrated by Kamiya et al. 2005 that 'mutant' DISCI causes re¬
distribution of LIS 1, NUDEL and pl50s'ued from their normal centrosomal location.
Unfortunately at the time of these experiments antibodies suitable for
immunodetection of these proteins were not available to me and these experiments
will be carried out in the future.
Examination ofmitochondrial morphology was also carried out as previous work has
demonstrated altered mitochondrial morphology following DISCI over-expression
(.Millar et al. 2005a). In this study a mitochondrial ring phenotype was observed
following DISCI over-expression suggesting that DISCI may play a role in
mitochondrial fission and fusion. Elowever using mitochondrial cytochrome oxidase
subunit II there were no obvious defects associated with the mitochondria in DISCI
siRNA transfected cells. Although no physical abnormalities are observed upon
DISCI knockdown there may be underlying defects in mitochondrial respiration or
signalling, which is possible considering the apoptosis defects seen in these studies.
Future plans will aim to study and characterise any defects in mitochondrial
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respiration in terms of ATP production post RNAi and any signalling defects that
may be associated with the apoptotic RNAi phenotype.
In summary, pilot experiments of DISCI depletion using siRNA have resulted in
various abnormalities in cell cycle progression, apoptosis and cAMP signalling (see
figure 6.5.B). Multiple independent experiments failed to detect abnormalities
associated with mitochondrial morphology or the microtubule network although
defects in these have previously been reported following DISCI over-expression and
'mutant' DISCI over-expression respectively {Millar et al. 2005a, Kamiya et al.
2005). The siRNA pilot experiments performed in this chapter serve as a taster for
some of the effects reduced DISCI might have in affected cells. Repeat experiments
including rescue experiments are yet to be performed to confirm the specificity of
these findings. Furthermore, these experiments are restricted to one cell type and it is
conceivable that DISCI may function differently in different cell types and also at
different times during development as DISCI has been shown to be developmentally
regulated (Schurov et al. 2004, Brandon et al. 2004). Considering its potential roles
in apoptosis and cell cycle progression reductions in DISCI expression as a result of
the t( 1; 11) translocation may have implications for cell division during the early
stages of brain development and also for selective apoptosis during later
developmental stages {Morilak et al. 2000, Roth and D 'Sa 2001). This may help to
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Figure 6.5.B. DISC1 knockdown using RNAi may result in disruption of diverse




DISC1 expression is dynamically regulated in human
embryonic stem cell neuronal progenitors
7.1 Preface
Stem cells derived from isolated human embryos or foetal tissues possess the ability
to regenerate all the various cell types in the human body. The study of mouse and
human embryonic stem (ES) cells is an invaluable resource for uncovering the
intricacies of neuronal differentiation. Using current technologies it is possible to
generate specific neuronal populations which will be valuable for examining the
specificities of gene transcription and regulation that culminate in neuronal
differentiation of a particular subset of neurons. Neurons generated in this manner
exhibit functionality in vitro possessing the capacity to produce GABA, glutamate
and dopamine neurotransmitters (Li et al. 1998, Perrier et al. 2004, Park et al.
2005).
There is particular interest in studying human ES cells with the aim of utilising
derived neurons in cell replacement therapy for neurodegenerative diseases.
Unfortunately although it is possible to generate specific neuronal populations, for
example midbrain dopaminergic neurons which are destroyed in Parkinson's disease,
there have been no successful attempts to re-integrate these neurons such that they
exhibit functionality in vivo (Park et al. 2005). With respect to schizophrenia, cell
replacement therapy is not currently a viable research area as there is no cell type
specific neuronal loss associated with schizophrenia; however the use of neural stem
cells for investigating the mechanisms of neuronal specification and differentiation is
important considering the likely neurodevelopmental nature of this disorder.
A number of functional studies have implicated DISCI in neuronal migration and
neurite outgrowth (Ozeki et al. 2003, Miyoshi et al. 2003). Of particular importance,
DISCI has been shown to perform developmentally regulated protein interactions
that may be important for neuronal migration (Brandon et al. 2004) and shRNA
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mediated depletion ofDISCI results in aberrant neuronal migration in the developing
mouse cortex (Kamiya et al. 2005). For these reasons I have undertaken a pilot study
of DISCI expression in hES cell neuronal progenitors. DISCI levels were measured
by quantitative Real-Time PCR in hES cells at various stages of neuronal
differentiation, however none of the hES cells in this study have reached a stage of
terminal differentiation and remain capable of differentiation into multiple neuronal
lineages. This study therefore indicates whether DISCI may be dynamically
regulated during neuronal differentiation but does not specify a role for DISCI in
terminal differentiation of particular subtypes of neurons.
7.2 DISC1 is dynamically regulated during neuronal differentiation
Human embryonic stem cell RNA for this study was provided by Dr. Wei Cui
(Roslin Institute, Edinburgh, UK). RNA was extracted in the laboratory of Dr. Cui
from three hES cell lines that had been differentiated down a neuronal lineage. This
RNA was extracted at various stages of the neuronal differentiation process. Three
hES cell lines were used in this study, HI (male), H7 (female) and T5 (derived from
the HI line). This RNA was reverse transcribed to produce cDNA which was used
for analysis ofDISCI expression by quantitative Real-Time PCR. Two housekeeping
genes, Glyceraldehyde-3-phosphate dehydrogenase (GAPDSP) and Glucose-6-
phosphate dehydrogenase (G6PD) were used to normalise DISCI expression. DISCI
expression was measured using primers spanning exons 4-6 of the DISCI gene. All
primer pairs amplified specific products from the hES cell cDNAs and produced
primer efficiencies within the recommended 90-110% range (Figure 7.2.A and
7.2.B). DISCI expression was normalised using each of the housekeeping genes
individually to examine the expression profile during neuronal differentiation.
Normalisation using either of these housekeeping genes indicated a dynamic
regulation ofDISCI expression during neuronal differentiation (Figures 7.2.C, D and
E). DISCI expression varied over time in all three hES cell lines with statistically
significant differences between some neuronally differentiated groups compared to
the un-differentiated samples (*p<0.05, ANOVA with post hoc Newman-Keuls test,
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see graphs in figures 7.2.C-E). Statistical analysis was performed using the GraphPad
Prism software.
These expression analyses were carried out on actively differentiating cell lines,
therefore it is possible that housekeeping gene expression may be altered throughout
the differentiation process. If changes in DISCI expression were as a result of
changing reference gene expression we would expect to see inverse correlations in
the expression patterns of DISCI and the reference gene. For example, increasing
expression of a reference gene will affect the normalisation of DISCI gene
expression such that the expression would appear lower. To rule out an effect of
alterations in reference gene expression, I compared the gene expression patterns of
GAPDH and DISCI throughout the differentiation process. The expression of each
gene was normalised using the second reference gene G6PD. For each cell line
expression is graphed as the relative fold change in expression relative to day 0 (un¬
differentiated), see figures 7.2.F,G and H. From these graphs it is clear that GAPDH
expression fluctuates slightly throughout the differentiation procedure. However,
these changes in GAPDH cannot account for the changes in DISCI gene expression
as the patterns are not identical and the fold changes in DISCI expression are much
more pronounced than those for GAPDH.
Unfortunately the quantities of RNA received to carry out these experiments meant
that three independent amplifications were carried out for the DISCI normalised to
GAPDH only. DISCI normalised to G6PD was carried out in duplicate however only
on one occasion were both reference genes included in the same experiment.
Therefore the graphs comparing the expression profiles of DISCI and GAPDH
normalised to G6PD contain only one GAPDH expression value for each sample.
Further replicates therefore may be needed to further validate the reference genes;
however the fact that a similar DISCI expression profile is generated using both
genes independently suggests that these genes are reliable in this instance.
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Real-Time PCR standard curves, pooled hES cell cDNA
Figure 7.2.A. Standard curves for each housekeeping gene and DISC1 primers were
carried out on pooled hES cell cDNA. Four point dilution curves were constructed
using neat, 1-10, 1-100 and 1-1000 dilutions of cDNA. This figure shows the product
specificity of each primer pair by running end point PCR products on a 1% TAE
agarose gel.
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Figure 7.2.B. This figure shows representative standard curves to determine primer
efficiencies on hES cell cDNA. All primer efficiencies should ideally fall between 90%
and 110% with correlation coefficients greater than 0.995
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GAPDH normalised DISC1 expression (H1)
Days Differentiated
(Mean and SEM)
G6PD normalised DISC1 expression (H1)
0 15 28 38 53 104
Days Differentiated
(Average of two values)
Figure 7.2.C. This figure graphically represents pilot DISC1 expression data from the H1
hES cell line. DISC1 is seen to be dynamically regulated throughout neuronal differentiation.
Normalisation using GAPDH and G6PD produce similar patterns of DISC1 expression.
DISC1 normalised to GAPDH was shown to be significantly altered at day 104 of the
differentiation process compared to day 0 (ANOVA with post hoc Newman-keuls test
**p<0.01, n = 3 for each column). G6PD normalised data was from only 2 independent
experiments thus the average values are shown and statistical analysis not carried out.
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G6PD normalised DISC1 expression (H7)
Days Differentiated
(Average of two values)
Figure 7.2.D, This figure graphically represents pilot DISC1 expression data from the H7
hES cell line. DISC1 is seen to be dynamically regulated throughout neuronal
differentiation. Normalisation using GAPDH and G6PD produce similar patterns of DISC1
expression. DISC1 normalised to GAPDH was shown to be significantly altered at days 60
and 67 of the differentiation process compared to day 0 (ANOVA with post hoc Newman-
Keuls test, Day 60 **p<0.01, Day 67 *p<0.05, n = 3 for each column). G6PD normalised
data was from only 2 independent experiments thus the average values are shown and
statistical analysis not carried out.
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G6PD normalised DISC1 expression (T5)
Days Differentiated
(Average of two values)
Figure 7.2.E. This figure graphically represents DISC1 pilot expression data from the T5
hES cell line. DISC1 expression is seen to be dynamically regulated throughout
neuronal differentiation. The pattern of DISC1 expression is similar using both GAPDH
and G6PD housekeeping genes. DISC1 expression normalised to GAPDH was
significantly different at days 60 and 67 of the differentiation process in comparison to
day 0 (ANOVA with post hoc Newman-Keuls test **p<0.01, n = 3 for each column).
G6PD normalised data was from only 2 independent experiments thus the average
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7.3 Discussion
This chapter has examined the expression profile ofDISCI at the RNA level in three
hES cells lines at various stages of differentiation along a neuronal pathway. In the
HI and T5 cells lines DISCI expression appeared to be up-regulated in hES cells that
had reached a neuronal progenitor state in comparison to undifferentiated cells of the
same line. For the T5 cell line there are only three time-points of differentiation, time
0 (undifferentiated) and time-points 60 and 67 days post-differentiation by which
time cells have been treated to acquire a neuronal progenitor fate. As this T5 cell line
was originally derived from the HI line it is interesting to examine similar time-
points during differentiation of the HI line. The nearest time-points in the HI cell
line are day 0 (undifferentiated) and day 53 post-differentiation. The relative DISCI
expression values at these time points are in concordance with each other in both cell
lines with DISCI being approximately 3-4 times more abundant at days 60-67 in the
T5 line and day 53 in the HI line relative to day 0 in either cell line. Despite the
limited number of time-points from the T5 line, it appears that DISCI is up-regulated
following neuronal differentiation, however examination of intermediate and later
time-points in the HI line reveal that DISCI levels oscillate and exhibit a more
complex expression pattern than would have been deduced from the T5 line.
Examination of DISCI levels in the same manner in the H7 line reveals smaller
oscillations in DISCI levels during differentiation. DISCI expression appears to drop
between day 50 and day 60 following neuronal differentiation however by day 67
DISCI levels are on the increase again. It would be interesting to examine further
time-points to deduce whether expression levels continue to rise in this cell line as in
the HI line.
It must be noted that the DISCI expression values in these experiments are 'relative'
to other time-points from the same cell line and are not comparable between cell
lines. These are not a measure of actual DISCI levels. For example, even though
there is a less apparent increase in DISCI in the H7 cell line than in the HI cell line it
does not mean that the HI cell line possesses more DISCI than the H7 cell line. It
may be the case that the H7 line naturally expresses DISCI at a higher level and
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therefore a less dramatic increase in expression levels is seen following neuronal
differentiation, although this is purely speculative. Furthermore, the T5 subclone of
HI is suspected to carry a duplication of the lq region of chromosome 1 harbouring
the DISC locus and therefore may already have augmented DISCI expression in
comparison to the other cell lines examined. Despite this, there still appears to be a
dynamic change in DISCI expression throughout the differentiation procedure.
From these experiments it appears that DISCI is a dynamic factor involved in (or in
response to) neuronal differentiation. To confirm or refute this hypothesis it is
necessary to examine DISCI expression in more detail using additional cells lines
and later time-points. In particular it would be interesting to examine DISCI
expression during differentiation of particular neuronal populations e.g.
dopaminergic neurons. It would be desirable also to examine the cell morphology at
each stage of differentiation and compare the DISCI expression levels such that
specific stages of development may be correlated with increasing or decreasing
DISCI levels. It will also be interesting to examine if changes in the levels of DISCI





The DISC2 gene is directly disrupted by the t(l;l 1) translocation and was identified
from expressed sequence tags (ESTs) surrounding the chromosome 1 breakpoint
region (.Millar et. al 2000). DISC2 represents a large polyadenylated transcript of
unknown size that is transcribed in the reverse orientation to DISCI. RACE PCR
(Rapid Amplification of cDNA ends) successfully identified 15kb of DISC2
sequence and located the 3' end ofDISC2 within intron 8 of the DISCI gene {Millar
et. al 2000). The 5' end of DISC2 remained to be identified; however it was
hypothesised to lie within intron 9 of the DISCI gene. Interestingly this intron 9
region is very large encompassing approximately 150kb of genomic DNA in
humans, 50kb in mouse and 4kb in pufferfish (Fugu rubipes) {Millar et al. 2001, Ma
et al. 2002, Taylor et al., 2003). Similar to the human and mouse DISCI genes,
intron 9 is the largest intron of pufferfish DISCI suggesting that some functional
importance may be attributable to this intron.
Analysis of the known DISC2 sequence demonstrated the absence of significant open
reading frames (ORF) {Taylor, M. unpublished, 2001). As a result of this DISC2 is
hypothesised to represent a non-coding RNA gene partially anti-sense to DISCI.
However, the remaining gene sequence must be identified in order to substantiate
this hypothesis.
With an ever expanding body of evidence suggesting a role for non-coding RNAs in
the regulation of sense gene expression it is plausible that DISC2 may regulate the
expression ofDISCI. This chapter describes my efforts to identify the 5' end of the
DISC2 gene and to establish the transcriptional activity of this gene in cell lines
derived from t(l; 11) family members. The normal functions of this gene may be
affected by the translocation. For this reason I was also interested to determine
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whether DISC2 was expressed from both the non-translocated and derived DISC2
alleles in translocation carrying cell lines.
8.2 DISC2 is transcribed in cell lines derived from t(1; 11) family
members
8.2.1. DISC2 is a low abundance transcript expressed in
lymphoblastoid cell lines from t(1;11) family members
In order to assess the effects of the translocation on DISC2 it was necessary to
determine whether this antisense gene is expressed in cell lines derived from the
t(l;ll) family. Reverse transcriptase PCR (RT-PCR) was carried out using primers
designed within the region of known DISC2 sequence (AF222981). This sequence
encompasses DISCI exon 9 and some DISCI intronic sequence flanking this exon.
DISC2 primers were designed within the intronic region to avoid amplification of
DISCI cDNA sequences. Moreover expression analysis was carried out using cDNA
produced from polyadenylated RNA to avoid contamination with heterogeneous
nuclear RNA (hnRNA) which may contain unprocessed or partially processed DISCI
mRNAs.
Analysis of t( 1; 11) cell lines demonstrated that DISC2 was indeed transcribed
however, it is a low abundance transcript as nested PCR was required to detect a
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Figure 8.2.A. DISC2 expression is detected by nested PCR in
t( 1; 11) cell lines possessing the translocation (T) and in normal
karyotype controls (N).
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8.2.2 DISC2 transcripts are produced from the translocated DISC2
allele
I next assessed t( 1; 11) cell lines for evidence of DISC2 transcription occurring from
the normal and derived chromosome 11 DISC2 allele. To do this it was necessary to
identify a single nucleotide polymorphism (SNP) which could discriminate between
transcription from the two alleles. An intronic SNP rs 1535530, within the DISC2
known sequence, was chosen and genotyped in t(l;l 1) cell lines in the same manner
as for DISCI (chapter 3). This SNP is located distal to the translocation breakpoint
located just outside of exon 9 region (within intron 9) of DISCI (SNP rsl535530
position chrl 228989432). The translocated DISC2 allele was found to be
represented by the A allele of SNP rs 1535530 and the normal allele is represented by
the G allele of this SNP.
Transcription from the normal and derived DISC2 alleles was determined using
nested allele specific PCR. Allele specific PCR primers were designed and optimised
using gradient PCR to ensure specificity for the individual alleles of SNP rs 1535530
(Figure 8.2.B (I)). This specificity was further confirmed using allele specific PCR
on genomic DNA controls (where the genotype of this SNP was known) performed
alongside allele specific RT-PCR on t(l; 11) cell line cDNAs (Figure 8.2.B(II)). As
can be seen in figure 8.2.B (II) transcripts appear to be produced from both the non-
translocated and translocated DISC2 alleles. This is not necessarily surprising as the
translocated DISC2 allele should retain its 5' end. This data suggests that the region
of chromosome 11 harbouring the translocated DISC2 allele can support
transcription of this gene.
In figure 8.2.B (II) expression from the translocated (A) allele appears to be weaker
in the normal karyotype controls compared to translocation carriers. Although this is
a potentially interesting finding this allele-specific PCR is non-quantitative and no
definitive conclusions can be drawn from this.
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DISC2 allele specific PCR
ooooo ooo
Normal Allele (G) Translocated Allele (A)
Figure 8.2.B. PCR primers specific for the A allele of SNP rs1535530 were optimised by
gradient PCR (I). A working temperature of 66°C (indicated by arrow) was chosen as the
optimum temperature as primers amplify the A allele specifically at this temperature, with
no non-specific amplification of the G allele. G allele specific primes were optimized in a
similar manner. Known genomic controls were used to ensure primer specificity. Allele
specific PCR on t(1;11) cell lines demonstrated that both alleles produce a transcript in
translocation carriers (T) and normal karyotype controls (N) (II).-VE reactions indicate no
DNA controls.
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8.3 Identification of the DISC2 5' end
It is hypothesised that DISC2 represents a non-coding antisense transcript that may
regulate DISCI. To explore this hypothesis further I sought to identify the 5' end of
the DISC2 gene. To do this I initially employed a bioinformatics approach and used a
variety of transcription factor search engines and promoter prediction programs to
search for the 5' end within intron 9 of DISCI. To search for transcription factors I
used the TRANSFAC database and to search for promoters I utilised both GRAIL
and Genscan promoter prediction programs (see chapter 2 for program details). All
of these programs were designed with the intention of identifying protein coding
genes and their potential to find promoters for non-coding genes is unknown. As the
DISC2 5' end is thought to reside within DISCI intron 9, a very large intron of
approximately 150kb in size, it was initially decided to focus on predictions located
within conserved regions of the intron. Conservation was determined using the
UCSC genome browser; at this time only mouse and rat conservations were
available. Mouse syntenic regions were also examined independently for regulatory
elements. One caveat to this approach is that there is no evidence for DISC2
transcripts in mouse or rat however absence of evidence is not evidence of absence
and this seemed a sensible approach to identify potentially important regions within
the intron.
I initially searched for clusters of transcription factors which might point to the
transcriptional start site of DISC2. A large number of transcription factor binding
sites were identified; however there was no apparent clustering or conservation of
transcription factor binding sites. This approach therefore did not narrow down the
region likely to harbour the DISC2 5' end. The situation was similar for the promoter
prediction programs. Of the few good predictions, most did not reside within
conserved sequence and all other predictions were marginal. With the bioinformatics
approach not proving fruitful it was decided to proceed down a more direct
experimental route. Moreover any positive predictions acquired using bioinformatics
would also need to be confirmed experimentally. I therefore decided to attempt 5'
RACE to identify the 5' end ofDISC2.
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8.3.1 Identifying the 5' end of the DISC2 gene using Rapid
Amplification of cDNA Ends
RACE uses cDNA populations that have been ligated to 3' or 5' adaptor sequences
to identify full length cDNAs. Primers specific for these adaptor sequences in
combination with gene specific primers are used to extend the known sequence of a
transcript. DISC2 was originally extended to the 3' end using RACE. The 5' end was
not successfully identified using this method (.Millar et al. 2000). This is likely due
to the fact that DISC2 is a large transcript. Currently 15kb of DISC2 sequence has
been defined.
8.3.1.1 Narrowing down the DISC2 5' region using PCR
Before performing the RACE experiments it was decided to attempt to narrow down
the region that is likely to harbour the DISC2 5' end before continuing. To do this I
used a human heart cDNA population. PCR primers were designed throughout the
intron 9 region and used to amplify DISC2 by PCR (Figure 8.3.A). DISC2 transcripts
were only amplified using the first primer pair designed within intron 9 (Figure
8.3.A.). This sequence was confirmed as being DISC2 by amplification with two
additional sets of DISC2 primers. Contamination of DISCI sequence was ruled out
using an intronic primer pair located outside the region ofDISC2 (Figure 8.3.B.).
Unlike the t( 1; 11) cell lines, DISC2 amplified well within 36 PCR cycles indicating
its much higher expression level in heart. This suggests also that the RACE
procedure should successfully amplify DISC2 from a human heart cDNA library and
further indicates that the 5' end of DISC2 may be close to exon 9 of DISCI.
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Figure 8.3.A. This figure depicts the intron 9 region of DISC1 using the UCSC genome
browser. Intronic primers were designed adjacent to conserved sequences throughout
the intron as indicated by arrows 1-6. Primer pairs were used to amplify DISC2 from
human heart cDNA. Only primer pair 1, located closest to exon 9 of DISC1, detected
DISC2 transcription. -VE reactions correspond to no DNA controls.
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DISC2 primers (intron 8) DISC1 intron 10-11 DISC2 intron 8/9
Figure 8.3.B. This figure confirms that DISC2 sequence is transcribed from the intron 8
and intron 9 region of DISC1 (A and C). It further rules out the possibility that these
transcripts represent un-processed DISC1 using an intronic primer pair located outside
of the DISC2 known region (B).
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8.3.1.2 Amplification of the DISC2 5' end using RACE
RACE can be a frustrating procedure because cDNA libraries often contain truncated
transcripts especially if transcripts are long, like DISC2, or contain a high level of
secondary structure. Furthermore as RACE is a PCR-based technique, truncated
(smaller) cDNAs will be more efficiently amplified than full length transcripts (if
they exist) further reducing the chance of identifying the 5' end. However, since the
original study by Millar et al. 2000 there have been significant advances in the
available RACE technologies. For these experiments an RNA-ligase mediated RACE
system from Ambion was used. This particular RACE system is specifically
designed to identify 5' gene ends. This technique used a human heart cDNA library,
also from Ambion, which should only contain full length transcripts. Full length
mRNAs contain a cap structure at their 5' end. Prior to the RACE procedure the
cDNA library was treated using a calf intestinal phosphatase to remove the un¬
capped 5' phosphate group from truncated mRNAs in addition to rRNA, tRNA and
DNA which are subsequently degraded. Following this the cap structure is removed
from full length mRNAs and these are ligated to a specific 5' adapter sequence.
Primers for this adapter are then used in conjunction with gene specific primers to
amplify the gene (and hence locate the 5' end). A heart cDNA population was chosen
as DISC2 was seen to be highly expressed in heart by northern blotting (.Millar et al.
2000).
Considering that the 5' end of DISC2 is thought to lie somewhere within a 150kb
intronic region it has the potential to produce a very large transcript. The processivity
of the polymerase used to amplify the RACE products would be important if this
technique were to be successful. I therefore chose a highly processive enzyme for use
in these experiments (details can be obtained in chapter 2).
The 5' RACE protocol uses nested PCR; an outer 5' adapter primer is combined with
an outer gene specific primer and used to amplify the cDNA library; the resulting
PCR products are subsequently re-amplified using a second (inner) 5' adapter primer
and a second (inner) gene specific primer. For these RACE experiments I used the
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outer primer of primer pair 1 (see figure 8.3.A), which successfully amplified DISC2
from human heart cDNA and designed a new inner gene specific primer for the
nested PCR reaction.
The RACE was carried out twice and produced 3 RACE products each time, a
doublet at approximately 600bp and a single product at approximately 500bp (Figure
8.3.C (A1 and A2)). These products were gel purified and re-run to determine the
DNA concentration subsequent to sequencing (Figure 8.3.C (B)). The doublet at
approximately 600bp was run on a 3% TAE gel to try and separate the products
(figure 8.3.C (C)). These two products were again gel-purified followed by
sequencing. Both products from the upper doublet and the lower product were
sequenced twice. Sequences were subjected to blast searching and were found to
align to DISC2 and intronic DISCI sequence on chromosome 1 (Figure 8.3.D).
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Figure 8.3.C. This figure depicts two repeats of the RACE procedure for DISC2 using
human heart cDNA (A1 and A2). Products labelled 1 and 2 were gel-purified and re¬
run and the lower band excised for sequencing (B). Product 1 was re-run to resolve
the doublet and both bands were excised for sequencing (C). The -VE reactions
correspond to no DNA controls.
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DISC2 RACE product blast search
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qiI 10944139 IembIAL136171.17 | Human DNA sequence from clone RP. .. 3 67 CO011■lJ
Cfi 1 8163870 1 qb 1 AF222981. 11 AF222981 Homo sapiens 1 DISC2 dene, com 244 2e-61
gi 18163844 IqbIAF2 22 987.11AF2 22 987 Homo sapiens DISCI protein ... 244 2e-61
qi129788794 IqbIAC090842.3 I Homo sapiens chromosome 3 clone RP... 107 3e-20
qi1249428661qb1AC090940.2 I Homo sapiens chromosome 3 clone RP... 107 3e-20
qi1169728661embIAL35S877.25| Human DNA sequence from clone RP... 105 le-19
qil216290631qbIAC119038.4 I Homo sapiens 3 BAC RP11-508018 (Ro... 103 5e-19
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Figure 8.3.D. This figure depicts blast search results from representative DISC2 RACE
product sequence. This sequence aligns to the human BAC AL136171 which overlaps
intron 9 of DISC1. It also aligns to DISC2 and DISC1 sequence within intron 9.
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8.4 Analysis of RACE products
Blast searching reveals that the RACE products align to sequence within human
BAC AL136171, which overlaps the intron 9 region of DISCI. However these
alignments are not all from one region of this BAC. Alignments of all RACE
products revealed similar matches to two different regions of AL136171 separated by
almost 25Kb of sequence (Figure 8.4.A). It is possible that these RACE products
represent spliced DISC2 transcripts therefore the boundaries between the two regions
of alignment were analysed for splice site consensus sequences. A 5' splice site
contains the consensus sequence GT at the exon/intron boundary and the 3' splice
site contains AG at the intron/exon boundary with some conservation of sequence
surrounding these sites (Figure 8.4.B). The exon/intron boundaries of the DISC2
RACE products were compared to these consensus sequences. These comparisons
are shown in figure 8.4.B. Both 5' and 3' splice sites conform to the consensus with
only one base pair difference indicating that these are functional splice sites.
Therefore it appears that a new splice variant of DISC2, consisting of two novel
exons, has been identified using this RACE procedure.
On further examination of the DISC2 region using the UCSC genome browser newly
added spliced EST sequences were identified (DA536261, DA566884, DA562083,
figure 8.4.C). I examined these EST sequences and compared them to my RACE
products. The genomic structure and sequence of these ESTs was compared to
known DISC2 and the novel DISC2 RACE sequence (Figure 8.4.D). The most 5'
RACE exon matched the 5' exon of all three ESTs, and the second RACE exon
matched two of the ESTs; the third EST sequence lacked an exon at this position
(Figure 8.4.D). Furthermore all three spliced ESTs contained a third exon which was
within the known DISC2 sequence (AF222981). This exon was not detected using
my RACE primers as this exon is located further towards the 3' end ofDISC2. These
EST sequences were derived from 5' oligo capped human heart cDNA and were
cross referenced to Kimura et al. 2006. This paper was involved in examination of 5'
gene ends to identify alternative promoters for human genes. Considering the authors
particular effort to examine only 5' gene ends it is very likely that the 5' exon of
these ESTs and the DISC2 RACE product represents the true 5' end ofDISC2.
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Although this 5' exon is likely to represent the 5' end, the genomic structure of full
length DISC2 remains unknown. Some potential DISC2 transcripts are depicted in
figure 8.4.E but more experimental work is needed to elucidate the full genomic
potential of DISC2. My attempts to define the promoter region of DISC2 are
discussed in the subsequent section.
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RACE product (4) reverse complement








Sequence aligns AI136171 region 77021 -77205
Sequence aligns AM36171 region 101888 -102078
Figure 8.4.A. This figure depicts representative DISC2 RACE sequence and the
region of alignment to BAC AL136171. This RACE sequence aligns in two pieces
separated by ~25Kb of sequence.
5' consensus splice site sequence
A A G GTAAGT




3' consensus splice site sequence C A G




Figure 8.4.B. This figure depicts consensus 5' and 3' splice site sequences and
the corresponding DISC2 splice sites. The DISC2 RACE splice site sequences





Figure 8.4.C. 3 new spliced EST sequences were identified within the DISC2
region using the UCSC genome browser. DISC1 exon 9 is indicated with a blue
arrow and novel DISC2 exons are indicated with red arrows.
AF2229S1 DISC2 cDNA
Figure 8.4.D. DISC2 RACE sequence was compared to ESTs from the UCSC genome
browser. The most 5' exon of DISC2 aligns with all of the spliced EST sequences.
RACE exon 2 also aligns to two of the ESTs however the third EST lacks this exon.
Furthermore all three ESTs contain a novel exon within the known DISC2 sequence.
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Potential DISC2 transcripts
Figure 8.4.E. Some potential DISC2 transcripts are shown, in addition to the three
novel ESTs which possibly represent true DISC2 splice variants.
8.5 Searching for the DISC2 promoter
As the RACE procedure appears to have successfully located the 5' end of DISC2,
promoter searching began again to try and define the DISC2 promoter. Eukaryotic
promoters have many characteristic features including a TATA box (TATAAA),
Initiator sequence (PyPyAN(T/A)PyPy, see abbreviations), CAAT box (CCAAT),
GC box (GGGCGG) and E box (CACGTG). These elements can be distributed at
various positions throughout the promoter region and only a selection of these
elements are likely be present within any given promoter.
Using the FPROM and TSSG mammalian promoter prediction programs
(www.softberry.com) a putative promoter was identified overlapping the 5' RACE
region. This sequence consisted of a putative TATA box at start of the 5' exon of
DISC2 and an initiator sequence approximately 11 bases downstream (Promoter 1
figure 8.5.A). It is puzzling that the promoter elements in this case appear to be
within the cDNA sequence therefore this may not represent the real promoter region.
Alternatively the TATA box at the 5' end of the RACE sequence is also a good
consensus initiator sequence and therefore DISC2 could have a TATA-less promoter
and consist of an initiator sequence in addition to upstream transcription factor
binding sites (Promoter 2 figure 8.5.A).
This promoter prediction program also identified 3 additional putative promoters
within approximately 700bp of the 5' RACE sequence. Some of these promoter
predictions are likely to be false positives and therefore any prediction requires
experimental confirmation. Furthermore as DISC2 is a novel non-coding RNA gene,
for which the promoter characteristics are not well understood, it is possible that
these prediction programs are not applicable in this situation.
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5' DISC2 RACE sequence









Figure 8.5.A. This figure depicts promoter predictions for the DISC2 cDNA sequence.
Promoter prediction 1 was identified using the FPROM and TSSG mammalian
promoter prediction programs. However it was noted that the TATA box sequence of
this promoter is also a good initiator sequence (promoter prediction 2) and as such
DISC2 could potentially possess a TATA-less promoter.
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8.6 Discussion
Only 1.4% of the human genome consists of protein coding genes, of which we
possess approximately 20,000-25,000 (Szymanski and Barciszewski 2002,
International Human Genome Sequencing consortium 2004). This is far reduced in
comparison to that of lower eukaryotes and demonstrates that the complexity of a
human cannot be clearly linked to the number of protein coding genes we possess
(>Szymanski and Barciszewski 2002). This further suggests that an additional layer of
complexity may be present. Additional complexity is indeed provided by the non-
coding transcriptome and also by multifaceted use of protein-coding genes. It has
been estimated that more than 50% of all protein coding genes use alternative
splicing to produce multiple transcripts from the same genomic locus (.Lander et al.
2001 International Human Genome Sequencing Consortium). This is in addition to
approximately 52% of known genes which use alternative promoters to diversify the
range of transcripts produced by a single gene (Kimura et al. 2006). By considering
that many protein coding genes employ alternative splicing, alternative promoters or
both, we can begin to understand how a complex organism such as a human being
can be generated from a mere 25,000 protein coding genes. Add to this the additional
complexity of non-coding genes that can either regulate protein coding genes or
perform independent functions and we can begin to embrace the complex nature of
the human genome. These non-coding genes can be housekeeping genes such as
ribosomal RNA or transfer RNA but they may also be regulatory and impact on the
expression of their cognate sense gene products.
This chapter attempted to further characterise such a non-coding gene, DISC2, which
is disrupted by the t(l;l 1) translocation. IfDISC2 has a role in regulating expression
of its sense gene partner DISCI, then disruption by the t( 1; 11) translocation may
have effects on transcription from the DISCI gene. This is in addition to the
independent effects of the translocation on DISCI. DISC2 has been relatively
uncharacterised to date with one large exon identified by RACE sequencing but the
5' end remaining uncharacterised (.Millar et al. 2000).
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The experiments in this chapter have shown that DISC2 is a low abundance transcript
within lymphoblastoid cell lines derived from t( 1; 11) family members. Furthermore
translocation results in the production of abnormal transcripts in these cell lines with
preliminary evidence supporting potential up-regulation of DISC2 in translocation
carriers (Figure 8.2.B and exon 9 qRT-PCR data, chapter 3). However as the function
ofDISC2 is unknown we can only speculate that this may affect DISCI expression in
some manner.
I set out to attempt to identify the 5' end of this gene. As an initial bioinformatics
approach proved unfruitful a more direct experimental route was chosen. PCR was
used initially to narrow down the DISC2 gene region followed by RACE PCR to
identify the 5' end. The RACE procedure identified novel splicing of the DISC2 gene
with this new splice variant encompassing two novel exons. These novel exons are
separated by almost 25kb of genomic sequence. On examination of this genomic
region using the UCSC genome browser, three new EST sequences were identified
(DA536261, DA566884, DA562083). These EST sequences were in the same
orientation as DISC2 and on comparison of RACE and EST sequences it was noted
that the 5' exon of the RACE products corresponded to the 5' exon of all three ESTs.
The RACE products and the ESTs were all generated from heart cDNA libraries
enriched for 5' gene ends and therefore this 5' exon is likely to represent the true 5'
end of DISC2. These newly incorporated EST data also identified a third novel
DISC2 exon within the current known sequence.
Promoter prediction programs were employed to search for the promoter within the
5' region of the RACE sequence. These programs identified multiple promoters in
this region, highlighting the likely high false positive rate of promoter prediction
programs. The prediction nearest the 5' end suggested that a TATA box element is
present followed by an initiator sequence however these elements were present
within the cDNA sequence of the 5' exon and are unlikely to represent the real
promoter. It was noted that a good initiator sequence is present at the start of the 5'
exon and therefore it is possible that DISC2 possesses a TATA-less promoter which
is a common phenomenon. However these predictions need to be validated by
experimental data. It is important to note also that DISC2 is a putative non-coding
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gene and promoter elements for these genes are not well characterised. The
prediction programs used here search for promoter elements present within protein
coding genes and therefore they may not be applicable in this situation.
In summary, these data have presented evidence for the existence of the DISC2 5'
end some 22kb from the known sequence, making this gene approximately 37kb in
length. The majority of this novel sequence comprises a large intron, however the
RACE procedure identified two novel DISC2 exons and examination of new EST
data also identified a further novel exon within the known DISC2 sequence. Attempts
can now be made to characterise the genomic structure, coding potential and function





DISCI and DISC2 were originally identified as candidate genes for schizophrenia
and related affective disorders in a large multi-generation Scottish family. This
family possesses a balanced 1; 11 translocation disrupting the DISC locus, which
segregates in a statistically significant manner with major psychiatric illness
(.Blackwood et al. 2001, Millar et al. 2000). There now exists a large body of
independent genetic evidence implicating the DISC locus in psychiatric illness.
In recent years DISCI has come into the limelight as an important and functionally
relevant gene implicated in brain structure and function. The DISC2 gene however
has remained uncharacterised. Despite insights into the function of the DISCI
protein the disease mechanism operating within the t( 1; 11) family has been the
subject of much debate, with differing hypotheses regarding haploinsufficiency and
the presence of a 'mutant' DISCI protein. This PhD thesis aimed to shed light on the
pathogenesis of illness within this family by investigating the effects of the t( 1; 11)
translocation on the expression and function of the DISC locus.
9.2 Discussion and future work
From the mRNA and protein expression experiments in chapter 3 it is relatively clear
that there is no truncated DISCI protein produced as a result of the t( 1; 11)
translocation. Therefore the most likely disease mechanism operating within this
family is one of haploinsufficiency. There are still some grey areas however
surrounding the effects of the t( 1; 11) translocation on transcription from the DISCI
and DISC2 genes. In particular Real-Time PCR using primers within the exon 9
region of DISCI appeared to show a less dramatic reduction or even increased
expression in some cell lines carrying the translocation. Whilst it is clear that this is
not due to an increase in DISCI expression, this region of chromosome 1 also
harbours the DISC2 gene. It is possible therefore that this apparent upregulation may
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be due to transcription of DISC2 from the derived chromosome 11 allele. In support
of this it has been shown that DISC2 is apparently transcribed from this derived
allele. It remains therefore to examine the expression levels of DISC2 in t(l;l 1) cell
lines carrying the translocation compared to karyotypically normal controls. If the
derived DISC2 allele is transcribed in cells of t( 1; 11) individuals it may have a
significant impact if, in concordance with the current hypothesis, DISC2 represents a
bone-fide functional non-coding RNA gene.
Experiments described in chapter 8 have successfully identified the 5' end of this
novel DISC2 gene providing a platform on which to take forward the functional
characterisation of this gene and to test the current hypothesis. The genomic structure
ofDISC2 has not yet been fully defined, however it appears to be more complex than
originally thought with multiple different splice variants. Further RACE experiments
may help to define the genomic structure and northern blotting is now possible to
define the number and sizes of transcripts produced from this gene. Hopefully
expression ofDISC2 constructs will shed light on whether this antisense non-coding
RNA gene acts as a riboregulator ofDISCI. It will be interesting also to examine the
expression profiles ofDISCI and DISC2 in high expressing tissue such as heart and
brain, however as DISC2 appears to be a human specific gene the availability of
appropriate tissue may prove a hindrance. Real-Time PCR data presented in chapter
7 provided evidence for a dynamic regulation of DISCI expression in human
embryonic stem cells during neuronal differentiation. These cells lines may also be
used to analyse DISC2 expression and determine a possible developmentally
correlated expression profile for this gene.
This work has provided support for the somewhat controversial localisation of
DISCI at the centrosome. It can be concluded from data presented in chapter 4 that
in fact specific DISCI isoforms are prominently associated with the centrosome, and
the centrioles in particular. DISCI also localises to the poles of the mitotic spindle, a
previously unknown location. The centrosome is a multifunctional organelle with
roles in nuclear migration, mitosis and protein degradation (Badano et al. 2005,
Doxsey et al. 2005). Considering the potential cell cycle defects reported following
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siRNA induced knockdown of DISCI, it will be interesting to examine the
centrosomal localisation of DISCI further. It has been shown that some proteins
involved in centrosome function to do not remain associated with this organelle
throughout the cell cycle. For example Chen et al. have reported that ninein, a
mother centriole protein, appears at the centrosome in interphase but disappears
during the mitotic phase and re-appears at telophase (Chen et al. 2003). From the
experiments thus far DISCI appears to remain associated with the centrosome
throughout the cell cycle. Time-lapse microscopy in combination with cell cycle
markers will be useful in clarifying this localisation of DISCI throughout mitosis.
Furthermore, DISCI centrosomal interactors, including NUDEL (Ndell), LIS1,
dynein and dynactin, have been shown to be localised to centrosomes, spindle
microtubules and kinetochores during mitosis and play an important role in spindle
formation, chromosome alignment and checkpoint control (.Faulkner et al. 2000,
Siller et al. 2005, Yan et al. 2003). It will be interesting therefore to examine whether
DISCI occupies similar additional locations or participates in similar functions
during mitosis.
As haploinsufficiency is the most likely disease model operating with the t( 1; 11)
family much of the future work will focus on the phenotypic abnormalities arising as
a result of DISCI knockdown using an RNAi interference approach. Phenotypes
assessed so far have shown that reduced DISCI may cause delays in progression
from Gi into S phase of the cell cycle. This would be consistent with localisation of
DISCI to the centrosome. Initially it will be necessary to carry out independent
repetitions of this experiment. Furthermore cell cultures should be synchronised to
allow exact comparisons of cell cycle stages between experimental populations. In
addition to using DNA content as a measure of cell cycle stage, additional strategies
should also be employed to define cell cycle progression. As the cell cycle is
basically a complex signalling cascade, it is possible to look at protein markers of
cell cycle progression. Moreover time-lapse microscopy of synchronised cultures
should be carried out to examine more specifically the delays in cell cycle
progression and the reasons for this. Using time-lapse microscopy it will be possible
to examine the formation of the bipolar spindle, chromosome segregation and
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chromosome alignment, the timing of the onset of anaphase and also cytokinesis
which will hopefully yield important information regarding the reasons for cell
cycling defects that may result from DISCI knockdown.
Apoptosis is also an interesting area which will be explored in more detail. To further
analyse the apoptotic phenotype it will be necessary to first determine if this defect is
due to effects on mitochondrial DISCI and thus represents mitochondria elicited
apoptotic defects or defects in an alternative apoptotic signalling cascade. To do this
it is possible to examine mitochondrial membrane potential and protein markers of
apoptosis that are specifically associated with mitochondrial signalling. It is also
possible to specifically induce the apoptotic response via the mitochondrial
apoptosome. These experiments will hopefully shed light on the apoptotic defects
that are occurring as a result of DISCI knockdown. These experiments may also give
insights into the normal function of DISCI at the mitochondria. Additional
experiments to define this should include examination of mitochondrial respiration,
via ATP production, following DISCI knockdown as defects in mitochondrial
respiration have been implicated in schizophrenia (Ben-Shachar 2002).
DISCI already has a defined role in cAMP signalling via interactions with
phosphodiesterase type 4B (.Millar et al. 2005b). The RNAi experiments presented
here demonstrate further that the hydrolysing activity of PDE4 enzymes is
dramatically reduced when DISCI levels are reduced. This was not expected as the
Millar et al. 2005 study presented data showing DISC 1 to have an inhibitory effect
on PDE4B hydrolysing activity, which suggests that reduced DISCI levels should
result in increased PDE4 activity. The results from these experiments imply that
DISCI has a wider role in cAMP signalling and that this pathway is dramatically
affected by reductions in DISCI. It seems unlikely that this effect is occurring within
cells of t( 1; 11) patients as a complete block in hydrolysing cAMP would have
extremely deleterious effects. In this respect it is possible therefore that reducing
DISCI expression by RNAi is more useful in determining the normal functions of
DISCI rather than elucidating the exact effects of the t( 1; 11) translocation. It is
necessary to examine PDE4B activity directly in t( 1; 11) cell lines to deduce further
the effect of the translocation on cAMP signalling.
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The possibility that DISCI has a wider role in cAMP signalling than previously
appreciated is however becoming an exciting possibility considering its prominent
localisation to the centrosome. I have shown that DISCI co-localises with AKAP450
at the centrosome. This AKAP protein is involved in centrosomal targeting of PKA
and also in binding to phosphodiesterase type 4D, which also binds PKA at the
centrosome (McCahill et al. 2005, Tasken et al. 2001). AKAP450 is also a putative
DISCI interactor and therefore there is the possibility of an
AKAP450/PKA/PDE4D/DISC1 complex at the centrosome. It is also possible that
this may be extended to mitochondrial cAMP signalling where DISCI binds PDE4B
and that DISCI may be a general component of AKAP/PKA/PDE signalling
complexes. To substantiate this hypothesis it is necessary to examine the interaction
between DISCI and AKAP450 further and also to examine interactions between
DISC 1 and mitochondrial AKAP proteins.
Lastly it remains to be said that with much of the future work plans employing RNAi
mediated knockdown of DISCI it will be necessary to implement good controls to
minimise identification of non-specific phenotypic abnormalities as potentially
important. Despite the implementation of controls there is still some controversy
surrounding the use of siRNAs and their resulting off target effects, therefore DISCI
rescue experiments should be performed whilst bearing in mind that overexpression
experiments raise additional problems of their own. The phenotypes observed thus
far from RNAi mediated DISCI knockdown seem to correlate well with expected
phenotypes and with the localisation of DISCI within the cell and its suspected role
as a protein scaffold protein. Therefore although RNA interference is not a foolproof
science, "as with everything else in life, good planning and moderation are keys to
success" (Barik, 2006).
9.3 Final conclusions
DISCI haploinsufficiency is the most likely disease mechanism operating within the
t( 1; 11) family. Resulting decreases in DISCI may have wide implications for cell
biology including cell cycle progression, apoptosis and cAMP signalling. These are
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crucial processes which are integral to brain development and function. Perturbation
of DISCI at the centrosome may have implications for cell division or neuronal
differentiation during early stages of brain development and for selective apoptosis to
define the brain circuitry during later developmental stages. These defects in
combination with additional neuronal migratory abnormalities may contribute to
aberrant neuronal positioning and connectivity within the schizophrenic brain.
Perturbations in cAMP signalling may have implications for neurotransmission and
information processing within the brain and this in combination with subtle
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together with growth retardation and neurologi¬
cal abnormalities. This is consistent with the
expression pattern ofGtf2irdl in the developing
brain and craniofacial areas (23) and its ability
to regulate expression of goosecoid (Gsc) and
Hoxc8, genes that control craniofacial and skel¬
etal development (3, 4). Gsc-null mice die soon
after birth with craniofacial defects, rib fusions,
and sternum abnormalities (24); Hoxc8 EE~/_
mice, where temporal regulation of Hoxc8 is
altered but not abolished, have skeletal patholo¬
gies and signs of neurological dysfunction (25).
We used a short interfering RNA (siKNA) that
knocks down levels of endogenous GTF2IRD1
by ~60% to show regulation of GSC by
GTF2IRD1 in human embryonic kidney (HEK)
293T cells. In cotransfection experiments, the
GTF2IRD1 siRNA reduced expression of a
pGL3-G!>Cprom luciferase reporter construct
(Fig. 4), suggesting that GTF21RD1 influences
gene transcription at endogenous levels. To
date, few upstream regulators of Gsc have been
defined in vivo, even though its developmental
importance in Drosophila and humans is well
established. Misregulation of GSC expression
due to absence or lower levels of GTF2IRD1
probably contributes to the craniofacial pathol¬
ogies seen in WBS and Gtf2irdl-mil\ mice.
Of the other genes deleted in HR, CYLN2
probably contributes to, but is not solely respon¬
sible for, the neurological phenotype in WBS.
Although no human case of isolated haploinsuf-
ficiency for CYLN2 has been reported, Cyln2~'~
and Cyln2+'~ mice present with mild structural
brain abnormalities, hippocampal dysfunction,
and deficits in motor coordination, alongside
mild growth deficiency but no craniofacial
defects (26). However, haploinsufficiency for
CYLN2 and GTF2IRD1 alone cannot explain
all the clinical features of WBS, because HR
displays a milder clinical profile. The more
pronounced facial and cognitive/behavioral
phenotypes associated with the larger dele¬
tion implicate other telomeric genes in these
features, specifically GTF2I, which lies distal
to GTF2IRD1 and is deleted in classic WBS
cases. GTF2I and GTF2IRD1 share many
structural properties and are likely to have
overlapping functions; indeed, both have been
shown to regulate gene activity through a
common DNA element, DICE (27). This work
introduces members of the TFII-I gene family
as critical regulators of craniofacial and
neurological development.
Our findings allow us to compile a picture
of the molecular pathology of WBS, a clas¬
sical human microdeletion syndrome. No
single gene is responsible for the craniofacial
or cognitive features ofWBS. We suggest that
cumulative dosage of TFII-I-family genes ex¬
plains the main phenotypes. Gtf2irdl-null
mice and classic WBS individuals have two
functioning copies (in trans and cis, respec¬
tively), whereas HR has three functioning
genes of the GTF2IRDIIGTF21 cluster and
shows milder WBS phenotypes. Whether one
gene has more effect than the other or
whether the effects are additive or multiplica¬
tive remains to be determined. Haploinsuffi¬
ciency for other genes in the WBS critical
region explains the vascular features and may
contribute to the full syndrome, but it is not the
main cause. Because adjacent duplicated but
diverged genes are common in the human
genome, such cumulative dosage effects may
underlie the pathology of other chromosomal
syndromes where members of different gene
families are deleted or duplicated.
References and Notes
1. S. Alappat, Z. Y. Zhang, Y. P. Chen, Cell Res. 13, 429
(2003).
2. T. A. Hinsley, P. Cunliffe, H. J. Tipney, A. Brass, M.
Tassabehji, Protein Sci. 13, 2588 (2004).
3. C. Ring et a/., Genes Dev. 16, 820 (2002).
4. D. Bayarsaihan, F. H. Ruddle, Proc. Natl. Acad. Sci.
U.S.A. 97, 7342 (2000).
5. A. L. Roy et al., EMBO J. 16, 7091 (1997).
6. M. Tassabehji et al., Eur. J. Hum. Genet. 7, 737 (1999).
7. J. V. O'Mahoney et al.. Mol. Cell. Biol. 18, 6641 (1998).
8. H. J. Tipney, T. A. Hinsley, A. Brass, D. Donnai, M.
Tassabehji, Eur. J. Hum. Genet. 12, 551 (2004).
9. A. K. Ewart et al.. Nat. Genet. 5, 11 (1993).
10. C. A. Morris, S. A. Demsey, C. O. Leonard, C. Dilts,
B. L. Blackburn, J. Pediatr. 113, 318 (1988).
11. D. Donnai, A. Karmiloff-Smith, Am. J. Med. Genet.
97, 164 (2000).
12. A. Reiss, S. Eliez, S. J. E. Schmitt.J. Cogn. Neurosci. 12
(suppl.), 65 (2000).
13. M. Tassabehji, Hum. Mol. Genet. 15, 229 (2003).
14. M. Bayes, L. F. Magano, N. Rivera, R. Flores, L. A. Perez
Jurado, Am. J. Hum. Genet. 73, 131 (2003).
15. J. M. Frangiskakis et al.. Cell 86, 59 (1996).
16. M. Tassabehji etai., Am. J. Hum. Genet. 64,118(1999).
17. A. Botta et al.,]. Med. Genet. 36, 478 (1999).
18. R. Heller, A. Rauch, S. Luttgen, B. Schroder, A.
Winterpacht, J. Med. Genet. 40, E99 (2003).
19. A. Karmiloff-Smith et al., data not shown.
20. P. Hammond et al., Am. J. Med. Genet. A 126, 339
(2004).
21. P. Hammond et at., Am. J. Hum. Genet., in press.
22. M. E. Durkin, C. L. Keck-Waggoner, N. C. Popescu,
S. S. Thorgeirsson, Genomics 73, 20 (2001).
23. J. A. Rivera-Perez, M. Mallo, M. Gendron-Maguire, T.
Gridley, R. R. Behringer, Development 121, 3005 (1995).
24. A. H. Juan, F. H. Ruddle, Development 130, 4823 (2003).
25. D. Bayarsaihan etai, Gene Expr. Patterns 3, 579 (2003).
26. C. C. Hoogenraad et al., Nat. Genet. 32, 116 (2002).
27. D. Tantin, M. I. Tussie-Luna, A. L. Roy, P. A. Sharp,
J. Biol. Chem. 279, 5460 (2004).
28. Supported by Wellcome Trust grant 061183 (M.T.).
Scanners were funded by BDF NewLife (P.H.). Surfim
loaned specialist scanning equipment. We thank the
families and W. Fergusson, M. J. Carrette, and W.




Figs. SI to S4
References
15 June 2005; accepted 5 October 2005
Published online 3 November 2005;
10.1126/science.l 116142
Include this information when citing this paper.
DISC1 and PDE4B Are Interacting
Genetic Factors in Schizophrenia
That Regulate cAMP Signaling
J. Kirsty Millar,1*! Benjamin S. Pickard,1* Shaun Mackie,1
Rachel James,1 Sheila Christie,1 Sebastienne R. Buchanan,1
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The disrupted in schizophrenia 7 (DISCI) gene is a candidate susceptibility
factor for schizophrenia, but its mechanistic role in the disorder is unknown.
Here we report that the gene encoding phosphodiesterase 4B (PDE4B) is dis¬
rupted by a balanced translocation in a subject diagnosed with schizophrenia
and a relative with chronic psychiatric illness. The PDEs inactivate adenosine
3',5'-monophosphate (cAMP), a second messenger implicated in learning,
memory, and mood. We show that DISC1 interacts with the UCR2 domain of
PDE4B and that elevation of cellular cAMP leads to dissociation of PDE4B from
DISCI and an increase in PDE4B activity. We propose a mechanistic model
whereby DISC1 sequesters PDE4B in resting cells and releases it in an activated
state in response to elevated cAMP.
Schizophrenia and bipolar affective disorder are chromosomal translocation t( 1; 11 )(q42;q 14)
common, debilitating conditions that are deter- cosegregating with schizophrenia (7 cases),
mined in part by genetic factors. The DISCI bipolar affective disorder (1 case), and re-
gene (for disrupted in schizophrenia I) is a lated affective disorders (10 cases) in a large
candidate susceptibility factor for psychiatric Scottish family [maximum logarithm of the
illness with both genetic and biological plausi- odds ratio for linkage (lod score) = 7.1] (2, 3).
bility (I). DISCI is disrupted by a balanced Translocation carriers, even without a major









Fig. 1. Stn.icti.iri? and expression of the PDE4B gene in psychiatric patients. (A)
Genomic organization of PDE4B, showing positions of exons (vertical lines),
alternative transcript forms, a scale bar, and bacterial artificial chromosomes
(BACs; closed boxes) used as FISH probes to define the translocation break¬
point (dashed vertical line). Only the PDE4B1 form is directly disrupted. (B and
C) FISH with probes synthesized from BACs RP11-433N2 and RP11-442111,
respectively, on t(1;16) patient metaphase spreads. Arrows mark the normal
and derived chromosomes. (D) PDE4B1 expression in lymphoblastoid cells,
with (T) or without (N) the t(1;16), and with glyceraldehyde-3-phosphate
dehydrogenase (GAPDh) loading controls. (E) DISC1 expression in lympho¬
blastoid cells, with (T) or without (N) the t(1;11), and with GAPDH loading












psychiatric diagnosis, have reduced amplitudes
of the P300 event-related potential, consistent
with an underlying cognitive defect (3). A
number of independent genetic linkage and
association studies provide confirmatory evi¬
dence for involvement of the DISCI locus in
schizophrenia, schizoaffective disorder, and
bipolar affective disorder {1-4). DISCI is ex¬
pressed in regions of the brain implicated in
the genesis of psychiatric symptoms (5-7) and
binds diverse proteins in the central nervous
system, including the neurodevelopmental
proteins FEZ1 (5) and NUDEL (P, 10).
In ongoing studies of psychiatric patients
with chromosomal abnormalities, we identified
a proband with schizophrenia who carried a
balanced t(l;16)(p31.2;q21) translocation. The
subject had a history of repeated psychotic
episodes with auditory hallucinations and de¬
lusions and was treated with standard anti¬
psychotic medications. A cousin of the proband
who also carried the translocation had a psy¬
chotic illness with prolonged hospital admission
but was not available for interview {11). Using
fluorescence in situ hybridization (FISH) {11),
we showed that the translocation breakpoint on
chromosome 16 lies within an intron of the
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Fig. 2. Human DISC1 binds the PDE4B UCR2 domain in transfected cells. (A) Domain organization of
type 4 phosphodiesterases. The common structure of core regions forming the UCR1/UCR2 module
and the catalytic domain are indicated. Each PDE4 isoform contains a unique N terminus. (B) HEK293
cells were cotransfected with DISC1 and PDE4 expression vectors. FLAG epitope-tagged immuno-
precipitates from lysates prepared from HEK293 cells cotransfected with either empty vector or
FLAG-DISC1 and PDE4B1-B3 plasmids, probed by Western blot analysis with antibodies against FLAG
and pan-PDE4B. Markers are indicated in kilodaltons. (C) FLAG-tagged immunoprecipitates from
HEK293 cells cotransfected with DISCI and the indicated FLAG-PDE4B1 constructs (top) probed by
Western analysis with the R47 antibody to detect total DISC1 and PDE4B1-associated DISC1. For a
schematic representation of PDE4B1 constructs and expression of the corresponding FLAG-tagged
PDE4B1 proteins, see fig. S6. (D) Glutathione S-transferase (GST) pull-downs from lysates of HEK293
cells cotransfected with empty FLAG vector or FLAG-DISC1 and GST or GST-UCR2 plasmids, probed
with antibody against FLAG to detect total DISC1 and DISC1 that specifically interacts with the UCR2
domain. (E) Mapping the PDE4B binding site on DISC1. 35S-labeled NA D1SC1 fragments (depicted in
fig. S8) and FLAG-tagged, unlabeled PDE4B3 were synthesized by in vitro transcription-translation,
mixed, and incubated for 3 hours in a binding reaction before immunoprecipitation with antibody
against FLAG. Input DISC1 and PDE4B3-bound DISC1 were detected by SDS-polyacrylamide gel
electrophoresis (SDS-PAGE) followed by autoradiography. Equal capture of FLAG-tagged PDE4B3 was
determined by Western analysis with antibody against FLAG (lower). Input signal represents 1/50 of
total binding reaction. Markers are indicated in kilodaltons.
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Cadherin 8 (CDH8) gene (fig. SI) and that
the 1 p31.2 translocation breakpoint disrupts
the B1 isoform of the phosphodiesterase 4B
(PDE4B) gene (Fig. 1, A to C). CDH8 is a cell
adhesion molecule that potentially has a
neuronal function (11), but we focused on
PDE4B for the following reasons: (i) PDE
action is the sole means of inactivating intra¬
cellular adenosine 3',5'-monophosphate (cAMP),
a key second messenger involved in learning,
memory, and mood (12-14). (ii) Mutations in
the fruit fly Drosophila dunce gene, which
encodes an ortholog of mammalian PDE4,
cause learning and memory deficits (13). (iii)
Mice deficient in PDE4D behave as if they are
taking antidepressants (15). (iv) Rolipram, an
antidepressant, is a selective inhibitor of PDE4
(16). And (v), most intriguingly, we found
c DISC1 PDE4B DISC1/PDE4B/DAPI
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Fig. 3. Interaction of endogenous DISC1 and PDE4B in human SH-SY5Y cells. (A) Control
immunoglobulin IgG and DISC1 immunoprecipitates (R47) from lysates of SH-SY5Y cell were probed
by Western blot analysis to detect DISC1 (R47) and PDE4B1 (top), and PDE4B immunoprecipitates
(pan-PDE4B) from SH-SY5Y cell extracts were probed for PDE4B (pan-PDE4B) and DISCI (bottom).
The DISC1 71-kD isoform is indicated with an arrow. (B) Protein extracts from SH-SY5Y subcellular
fractions were probed by Western analysis with antibodies against DISCI, PDE4B1, and cytochrome c
(as labeled). PI, nuclear fraction plus whole-cell debris; P2, predominantly mitochondrial; P3, other
membrane elements; C, cytosolic. The DISC1 71-kD isoform is indicated with an arrow. (C)
Immunofluorescence in SH-SY5Y human neuroblastoma cells. (Left) DISC1 (R47 antibody); middle,
PDE4B (antibody against pan-PDE4B); (right) merged signal plus DAPI (nuclear DNA) stain (See also
fig. S11). (D) Confocal immunofluorescence in differentiated SH-SY5Y human neuroblastoma cells,
left to right as in (C). (Inset) Highlighted region enlarged 2.5 times. (E) Immunofluorescence in
hippocampal primary cells, neuron and undifferentiated cell, left to right as in (C), except (left), DISC1
(C2 antibody) (See also fig. S11). Neurons were identified by using an antibody against NeuN.
PDE4B (but not CDH8) to interact robustly
with DISCI in a large-scale yeast two-hybrid
screen using full-length DISCI as bait (9).
To determine the effect of the t( 1; 16) and
t( 1; 11) translocations on PDE4B and DISCI
expression respectively, we analyzed patient-
derived lymphoblastoid cell lines. Cell lines
derived from family members with or without
the t( 1; 16) translocation revealed that PDE4B1
protein expression was reduced by ~50% in
the presence of the t( 1; 16) translocation (Fig.
ID; fig. S2). In the case of the t( 1; 11) trans¬
location, we demonstrated transcription of
DISCI from the derived chromosome 1 (fig.
S3A). However, DISCI transcript levels are re¬
duced overall, and when we used antibody R47,
which is specific for an epitope within the N
terminus of DISCI (7), we found no evidence
[fig. S3, B to D, and (11)} for a putative C-
terminally truncated protein (8, 9). Expression
of all DISCI species was consistently reduced
to about half normal levels in each of five
t(l;l 1) cell lines from different individuals (Fig.
IE; fig. S2). These are the same DISCI species
that are detectable in human brain tissue (7),
which indicates that proportionate reduction of
DISCI expression in brain is the most likely
consequence of inheriting the translocation.
The reduction in DISCI is specific, as we see
no change in the relative level of TRAX,
which maps immediately 5' of DISCI (fig. S4,
A and B). Haploinsufficiency for DISCI in the
t(l; 11) translocation cases and for PDE4B in
the t( 1; 16) translocation cases is therefore the
most likely mechanistic explanation for suscep¬
tibility to schizophrenia in these individuals.
PDE4 isoforms are classified as long, short,
or supershort (17), depending on the presence
of conserved regulatory regions (UCR1 and
UCR2) linked to the catalytic unit (Fig. 2A).
Long isoforms uniquely express UCR1, whose
phosphorylation by protein kinase A (PKA) trig¬
gers a conformational change in the UCR1 and
2 module, leading to increased catalytic activity
(17). To determine which of the many known
PDE4 isoforms could interact with DISCI, we
transfected expression constructs into HEK293
cells (11). We analyzed the long PDE4B1 and
PDE4B3 isoforms, which each contain UCR1,
as well as the short PDE4B2 isoform, which
does not. All three of these human isoforms co-
immunoprecipitate with DISCI (Fig. 2B), which
shows that binding is not specific to one par¬
ticular isoform. Indeed, DISCI binds represent¬
ative long isoforms from all four PDE4 genes
(fig. S5). Removal of UCR2 abolished PDE4B1
binding to DISCI (Fig. 2C; fig. S6). Moreover,
the UCR2 domain alone was capable of binding
DISCI (Fig. 2D), which suggests that UCR2 is
a specific DISCI interaction domain.
To identify the site of PDE4 binding on
DISCI, we performed binding assays after
expression of DISCI and PDE4B by in vitro
transcription-translation. Full-length DISCI
(1 to 854), a C-terminal truncated DISCI (1 to
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Fig. 4. Effects of cAMP on DISC1 and PDE4B. SH-SYSY
cells were mock-treated or treated with (A) IBMX and
forskolin, (B) 8-bromo-cAMP, (C) IBMX and forskolin
with or without H89 for 30 min. Immunoprecipitates
from a PDE4B-specific antibody were prepared and
analyzed by Western blot analysis with the antibodies
against PDE4B or the R47 antibody for DISCI. The
DISCI 71-kD isoform is indicated with an arrow. (D)
Relative coimmunoprecipitation of DISC1 in treated
versus untreated cells (plotted as means + SEM of at
least three independent tests). (E and F) SH-SY5Y cells
were either untreated (Ctr) or challenged for 30 min
with a mixture of either IBMX and forskolin or IBMX and
forskolin plus H89. Immunoprecipitates from PDE4B-
specific antibody were prepared from lysates for either
(E) PDE4 activity assays by measurement of cAMP hydrolyzing activity, or (F) Western blot analysis with a PDE4B-specific antibody or with an antiserum
specific for the single PKA phosphorylation site in UCR1. Methods for obtaining these data are available online [refs. S8, S9, S13, S14, and S21 in (7 7)].
a-pUCR1
I+F+H89
597), and the N-terminal "head" domain of
DISCI (1 to 358) were tested for their ability to
bind 35S-labeled PDE4B3 in vitro. All three
V5-tagged DISCI protein fragments efficiently
coimmunoprecipitated PDE4B3 (fig. S7),
which indicated that PDE4B binding to DISCI
is direct and that the DISC 1 N-terminal domain
is required for the interaction. We next gen¬
erated a series of constructs that progressively
delete amino acids from the N terminus of
DISC 1 (Fig. 2E; fig. S8) and showed that ami¬
no acids 219 to 283 are required for binding to
PDE4B. DISCI binding was restored by amino
acids 180 to 250 (fig. S9).
To determine whether and where endogenous
DISCI and PDE4B interact, we performed co¬
immunoprecipitation and colocalization studies
using conventional and confocal microscopy in
the human neuroblastoma-derived cell lines
SH-SY5Y and LAN5 and in primary rat hippo-
campal cells. DISC 1 antiserum (R47) coprecip-
itates PDE4B1 from SH-SY5Y extracts (Fig.
3A, top), whereas pan-PDE4B, an antibody that
recognizes all PDE4B isoforms, specifically
coimmunoprecipitates the 71 -kD DISC 1 isoform
(Fig. 3A, bottom). Thus, isoform PDE4B1 as¬
sociates with the 71-kD isoform of DISCI. In
cell fractionation studies, the PDE4B1 isoform
was most abundant in the mitochondria-enriched
fraction P2 (Fig. 3B), as was the 71-kD isoform
of DISCI, which is also predominantly mito¬
chondrial (7). PDE4B partially colocalizes with
DISCI in the mitochondria of SH-SY5Y (Fig.
3, C and D; fig. S10 and SI 1) and LAN5 (fig.
S10) cells. In rat hippocampal primary cultures,
DISCI and PDE4B expression overlap substan¬
tially in both neurons and proliferating non-
neuronal cells (Fig. 3E; fig. S10 and Sll).
To further investigate DISC 1-PDE4 binding,
we determined the effect of elevated cAMP.
Overexpression studies show that long PDE4
isoforms are activated by PKA in response to
increased intracellular cAMP and, thereby,
provide part of the cellular desensitization sys¬
tem for cAMP signaling (18, 19). PKA phos¬
phorylation of UCR1 induces conformational
changes that concomitantly affect enzymatic
activity and the interaction between UCR1 and
UCR2 (20). To increase cAMP production
and simultaneously to block its hydrolysis,
SH-SY5Y cells were treated with forskolin plus
the nonspecific phosphodiesterase inhibitor 3-
isobutyl-l-methylxanthine (IBMX). This dra¬
matically decreased the amount of DISCI
coprecipitating with PDE4B (Fig. 4, A and D).
When cAMP levels were raised by using the
cell permeable cAMP analog 8-bromo-cAMP,
we similarly observed a reduction in PDE4B-
DISC1 binding (Fig. 4, B and D). The action
of forskolin plus IBMX was ablated when we
added the PKA-specific inhibitor H89 (Fig. 4,
C and D). These data indicate that the in¬
teraction between PDE4B and DISCI is dy¬
namic and directly influenced by altered cAMP
levels through the action ofPKA. Our data also
indicate that DISCI binds predominantly to the
dephosphorylated, low-activity form ofPDE4B,
consistent with a model whereby PKA phos¬
phorylation leads to release, from DISCI, of an
activated population of PDE4B in response to
elevated cAMP levels (fig. S12). To test this, we
measured PDE4B cAMP hydrolyzing activity
in SII-SY5Y cells and observed a 48% increase
over controls, in the presence of IBMX and
forskolin, that was inhibited by H89, consistent
with PKA mediation of this increase (Fig. 4E).
This increase in PDE4B activity is due to ac¬
tivation of UCR1-containing long PDE4B iso¬
forms, because the short isoform PDE4B2 was
not immunoprecipitated from SH-SY5Y cells
(Fig. 4F). Using an antibody specific for the
PKA-phosphorylated forms of PDE4 (18, 21),
we identified a 104-kD PDE4B immunore-
active species in PDE4B immunoprecipitates
from cells treated with IBMX and forskolin
(Fig. 4F) that is not seen in control cells, con¬
sistent with PKA phosphorylation of UCR1 as
the mechanism of PDE4B activation.
Our study provides primary evidence for
PDE4B as a genetic susceptibility factor for
schizophrenia. We show that DISCI, an estab¬
lished candidate, interacts with PDE4B in a
compartmentalized fashion. This interaction is
dynamic and is cAMP- and PKA-dependent.
We speculate that functional variation in DISCI
and/or PDE4 will modulate their interaction and
affect mitochondrial cAMP catabolism with a
concomitant physiological and psychiatric out¬
come. A unifying link between schizophrenia
and bipolar affective disorder, and between
DISCI and PDE4, may occur at the cognitive
level of learning and memory and at the mo¬
lecular level of cAMP signaling.
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Altered TCR Signaling from
Geometrically Repatterned
Immunological Synapses
Kaspar D. Mossman,1,2,3 Cabriele Campi,4 Jay T. Groves,1-2'3*
Michael L. Dustin4*
The immunological synapse is a specialized cell-cell junction that is defined by
large-scale spatial patterns of receptors and signaling molecules yet remains
largely enigmatic in terms of formation and function. We used supported bilayer
membranes and nanometer-scale structures fabricated onto the underlying
substrate to impose geometric constraints on immunological synapse formation.
Analysis of the resulting alternatively patterned synapses revealed a causal
relation between the radial position of T cell receptors (TCRs) and signaling
activity, with prolonged signaling from TCR microclusters that had been
mechanically trapped in the peripheral regions of the synapse. These results are
consistent with a model of the synapse in which spatial translocation of TCRs
represents a direct mechanism of signal regulation.
Antigen recognition by T cells requires inter¬
actions between TCRs and antigenic peptides
bound to major histocompatibility complex
molecules (pMHCs) on antigen-presenting cells
(APCs) (7). A coordinated recognition process
ensues in which surface proteins on the T cell,
along with their respective ligands, become
organized into micron-scale, spatially patterned
motifs known as immunological synapses (ISs)
(2, i). TCRs and pMHCs occupy a region des¬
ignated the central supramolecular activation
cluster (c-SMAC). This is surrounded by a ring
of interactions between leukocyte function-
associated antigen-1 (LFA-1) on the T cell
and intercellular adhesion molecule-1 (ICAM-1)
on the APC, termed the peripheral supramolecular
activation cluster (p-SMAC). Ultimately, an
elaborate collage of adhesion, costimulatory,
and signaling molecules, along with cytoskeletal
attachments (4, 5) and lipid rafts (6-8), orga¬
nizes to sustain signaling over the hours required
for full T cell activation. Although previous
observations have suggested that the spatial
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face engage their respective ligands in the
bilayer, they become subject to the geometrical
restrictions on mobility imposed by the chro¬
mium lines. T cell blasts expressing the cloned
AND TCR, specific for moth cytochrome c
(MCC) 88-103 peptide bound to I-Ek (pMHC),
were used in all IS formation experiments. In
control experiments with nonactivating peptide,
T cells failed to form IS patterns on substrates
with chromium lines, confirming specificity of
the system (fig. SI). Under conditions of spe¬
cific antigen recognition, a series of IS patterns,
formed under different geometries of constraint
patterns, were compared with the unrestricted
IS patterns (Fig. 2A). Arrays of parallel lines
were found to restrict protein mobility in one
dimension and skew the synaptic pattern from a
circular to a rectangular shape in which a central
band of TCR-pMHC is flanked by two bands of
LFA-l-ICAM-1 (Fig. 2B). Multifocal ISs were
observed to form in response to grid constraint
organization of the c-SMAC is directly involved
both in increasing and extinguishing TCR
signaling (9, 10), a direct causal relation be¬
tween changes in the synaptic pattern and
signaling remains to be established.
We have developed an experimental plat¬
form that enables direct manipulation of IS
patterns in living T cells. A supported mem¬
brane, consisting of a continuous and fluid lipid
bilayer coating a silica substrate (11), is used
to create an artificial APC surface (12). In¬
clusion of glycosylphosphatidylinositol (GPI)-
linked pMFIC and ICAM-1 into the supported
membrane is sufficient to enable IS formation
between a T cell and the synthetic surface
(13). This hybrid live cell-synthetic bilayer IS
is illustrated schematically in Fig. 1. Fluidity
is a characteristic property of supported bi-
layers and distinguishes them from solid and
polymeric substrates. Movement within the
bilayer, however, can be manipulated by fabri¬
cating geometrically defined patterns of solid-
state structures on the substrate (Fig. 1) (14).
We posited that such substrate-imposed con¬
straints might be used to guide molecular
motion in the supported bilayer and linked
cell-surface receptors to generate alternatively
patterned synapses.
Silica substrates displaying various config¬
urations of chromium lines (100 nm wide and
5 nm high) were fabricated using electron-beam
lithography (15). Supported proteolipid mem¬
branes were assembled on these substrates by
vesicle fusion. As receptors on the T cell sur-
J|tCR ^ pMHC LFA-1 0 ICAM-1
Fig. 1. Diagram of a hybrid live T cell-supported
membrane junction. Receptors on the cell surface
engage cognate ligands in the supported mem¬
brane and become subject to constraints on
mobility imposed by physical barriers. The cyto-
skeleton is represented schematically to reflect
the active source of central organization observed
in our experiments.
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Investigation of the existence of a theoretical C-terminally truncated DISCI
protein species in lymphoblastoid cells carrying the t(l; 11)
To look for biallelic transcription of DISCI in translocation-carrying cell lines,
polyadenylated RNA was prepared from a cell line heterozygous for exonic SNP
rs2492367. RT-PCR products were sequenced and both SNP alleles were detected (fig.
S3A), demonstrating that DISCI is transcribed from both the normal and the
translocated alleles in this cell line. To quantify DISCI transcript levels, primers
specific for exon 2 (the same as those used to amplify rs2492367, above) were used in
quantitative RT-PCR experiments. DISCI transcripts were found to be present at
reduced levels in cells carrying the translocation (fig. S3B). Because exon 2 is located
proximal to the translocation breakpoint, the primers used for quantitative RT-PCR
should amplify truncated transcripts as well as normal transcripts. Detection of similar
transcript levels between normal and translocation cell lines using these primers would
therefore have indicated that truncated transcripts are present at normal levels. Detection
of reduced transcript levels however, most likely indicates a reduction in truncated
transcript abundance.
DISCI-specific antibody R47 was raised to an epitope within the N-terminus
(SI). To confirm the ability of this antibody to detect C-terminally truncated forms of
DISCI, COS7 cells were transfected with plasmids designed to express DISCI amino
acids 1-358 (essentially the head domain only) or 1-597 (up to the position of the
translocation breakpoint) with a C-terminal V5 peptide tag. Two forms of C-terminal
truncation were used since the extent of any putative truncated protein will depend upon
the utilisation of an unknown cryptic transcription stop site, polyadenylation site and
translation stop codon. These may occur within either chromosome 1 or 11 sequence,
and it is therefore not possible to predict how large a theoretical truncated protein
produced from the derived chromosome 1 would be. Expression of these proteins was
confirmed using antiserum specific for the V5 peptide tag (fig. S3C) and antibody R47
clearly detected each exogenous protein against the background endogenous bands (fig.
S3C). The larger of the two exogenous proteins migrates at a size similar to, but
distinguishable from, that of the endogenous protein (fig. S3C). Thus using this
antibody there is no positive evidence for a hypothetical truncated protein in t( 1; 11)
cells and certainly no evidence for overexpression of such a protein. There is a
theoretical possibility that a low level of truncated protein may be present in
lymphoblastoid cell lines, but undetectable due to masking by the endogenous protein.
In overexpression experiments artificial C-terminally truncated forms of DISCI
adopt a quantitatively different subcellular localization than the full-length protein in
many cells, with full-length DISCI appearing mainly punctate in association with
mitochondria in HeLa cells while truncated DISCI is mainly diffuse within the
cytoplasm (S2, S3). In COS7 mitochondrial localization is maintained regardless of C-
terminal truncation, but truncated DISCI occupies additional diffuse cytoplasmic and
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strong nuclear localizations (S4) and displays an altered fractionation profile (S5). We
therefore examined subcellular fractions of t( 1; 11) lymphoblastoid cells to look for
evidence of an aberrant C-terminally truncated DISCI species. Fractionation profiles of
normal cells and cells carrying the t(l;l 1) were found to be indistinguishable (fig. S3D),
providing further evidence against the presence of a truncated DISCI species.
Finally, it is worth noting that linkage and association studies point to a general
effect of DISCI variation on vulnerability to psychiatric illness. There is no evidence to
suggest that these variants produce truncated proteins of dominant-negative effect. The
weight of evidence from the t( 1; 11) family is for haploinsufficiency. This and other
mechanisms, including qualitative or quantitative effects on protein-protein interactions,
may explain these generalized effects.
1(1; 16) disruption of the CDH8 gene
The t( 1; 16) translocation results in the formation of two fusion genes. On the der(16),
the PDE4B promoter and exon la are juxtaposed to exon 2 of the CDH8 gene. The
translocation breaks before the PDE4B translation start site, so no productive protein is
expected. On the der(l), the fusion of CDH8 with PDE4 is out of frame, introduces
multiple stop codons immediately after the translocation break and thus is not expected
to produce active PDE4B. In support of this, we have found no evidence from t( 1; 16)
proband Western blots for a truncated or fusion PDE4B peptide.
We have not investigated CDH8 further, but for completeness, we note that it is
a member of the Type II, or atypical, cadherins, cell adhesion molecules which are
defined by the lack of an extracellular tripeptide motif, HAV, possibly involved in the
binding specificity of Type I cadherins (S6). The cytoplasmic tail is thought to signal
the presence of interactions to the intracellular compartment by mediating receptor
clustering through interaction with the proteins such as a-catenin, (l-catenin and,
eventually, the cytoskeletal proteins, actin and a-actinin. In this way, adhesion to
adjacent cells can affect the cytoarchitecture of the cell and may even play a role in cell
motility. The two principal roles of neuronal cadherins are thought to be in the
mediation of certain developmental pathways in the brain and the regulation of synaptic
function. CDH8 proteins preferentially bind to each other prompting the hypothesis that
cadherins are responsible for the aggregation or interconnection of similar cells within
an organ. In the brain, CDF18 expression is restricted to particular sub-regions and
neuronal patches (S7).
Materials and Methods
The t(l; 16) proband
The proband carrying the t( 1; 16) had onset of mental illness in his mid twenties, and
index admission three years after first presentation. There was clear evidence for
development of a schizophrenic illness with persistent second person auditory
hallucinations and persecutory delusions. Treatment was with routine phenothiazines
with evidence for remission of symptoms. Flowever, over the next 20 years, there were
a series of relapses again with clear auditory hallucinations and persecutory delusion
requiring inpatient treatment. DSM-IV criteria for chronic schizophrenia were fully met
using evidence gathered by a structured SADS-L interview of the proband and case-note
review. A cousin of the proband who also carried the translocation was found on review
2
of hospital notes to have had a psychotic illness with prolonged hospital admission, but
was not accessible for the present study.
Plasmids
Plasmids encoding untagged or FLAG-DISCI in pcDNA3.1, PDE4 isoforms PDE4B1,
B2, B3, PDE4A10, PDE4C2, PDE4D5 and pEBG plasmids expressing GST or a GST-
UCR2 domain of PDE4D have been described previously (SI, S2, S8-S11). PDE4B1
and PDE4B3 open reading frames (ORFs) were amplified by PCR and cloned into
pCMV4A (Invitrogen, Paisley, UK) to generate carboxyl-terminal FLAG-tagged
proteins. The DISCI ORF and progressive amino-terminal deletions were generated by
nested PCR amplification and cloning into pcDNA6 (Invitrogen). The DISCI ORF and
specific deletion fragments were amplified by PCR and cloned into pcDNA-DEST40
(V5 tag) or pcDNA6 (both Invitrogen). DISCI ORF fragments spanning amino acids 1-
180, 1-250 and 1-300 were generated by PCR using DISCI specific 3' primers and a
primer 5' to the T7 promoter in pcDNA DISCI and used directly as a DNA template for
IVTT. All plasmid inserts were confirmed by DNA sequencing.
Preparation of rat hippocampal primary cultures
Hippocampi were isolated from day 18 rat embryos, and cells dissociated in trypsin then
plated on poly L-Lysine (Sigma, Gillingham, UK) coated glass coverslips at a density of
1 x 103 cells/ml in neurobasal medium/10% fetal bovine serum/0.5 mM L-glutamine.
After 24 hours, the medium was removed and replaced with neurobasal medium/1%
B27/penicillin-streptomycin. All media were supplied by Invitrogen. Cells were grown
for 5 days prior to fixation.
Antibodies
DISCI-specific antibodies R47, R1443/1, pan-PDE4B and a PDE4B1-specific antibody
(PDE4B-228), as well as sera specific for PDE4A, C & D have been described
previously (SI, S12-S14). DISCI-specific antibody C2 (SI 5) was provided by Akira
Sawa (The Johns Hopkin University). Anti-V5 antibody was obtained from Invitrogen,
anti-FLAG M2 from Sigma and anti-cytochrome c from Clontech, Basingstoke, UK.
Mitochondria were detected using antibody ab3298 (Abeam, Cambridge, UK) or an
antibody specific for mitochondrial Hsp70 (Abeam). Neuronal cell types in primary
cultures were identified using an antibody to NeuN (Abeam).
Yeast two-hybrid screening
DISCI full-length bait sequence in a Gal4-based N-terminal plasmid (pB23) was
screened against an adult human brain library as previously described (S2). In total, 64
proteins of interest were identified, 16 of which are considered high confidence
interactions based upon a method (SI 6, SI 7) that takes account of whether the clone
matches known ORFs, the number of clones identified for a given gene, and whether a
protein is promiscuous, that is, identified in several independent yeast-two hybrid
screens. From this screen we have previously reported the interaction of DISCI with
NUDE and Nudel (S2). Amongst the high confidence interactors, three independent
PDE4B clones were identified all corresponding to approximately the same portion of
PDE4B (amino acids 187-361 of isoform PDE4B1, accession number Q07343).
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Fluorescence In Situ Hybridization mapping of the t(l: 16) breakpoint
Fluorescence in situ hybridization was conducted as previously described using labelled
YAC and BAC clones (SI8). Breakpoint-spanning YACs were identified by
fluorescence in situ hybridization (FISH), and BAC clones corresponding to positive
YAC regions were arranged into contigs by consulting Washington University FPC
(S19) and the UCSC Human Genome Browser (S20). BAC positions at breakpoints
were determined using FISH. The mapping of the chromosome 1 breakpoint to PDE4B
with bacterial artificial chromosome clones RP11-433N2 and RP11-442111 is shown in
Fig. 1. For completeness, we show in fig. SI that on the derived chromosome 16, BACs
RP11-875E12 and RP11-685M21 flank the other breakpoint. This lies within a second
gene, Cadherin 8 (CDH8), demonstrating that this gene is also disrupted.
Fluorescence Imaging
Images were captured on a Zeiss Axioskop 2 MOT epifluorescence microsocope, using
SmartCapture 2 version 2.3.1 (Digital Scientific Ltd, Cambridge UK).
Immunofluorescence
Cells on glass coverslips were probed with antibodies using standard methods. Primary
antibodies were detected using AlexaFluor 488 or 594-conjugated secondary antibodies
(Molecular Probes, Paisley, UK).
Confocal microscopy
Human SH-SY5Y cells were probed with a pan4B antibody and DISCI antibody R47,
labeled with alexa 594 and alexa 488 respectively and observed
using a Zeiss Pascal laser scanning microscope. The images shown are of a slice
through the centre of the cell.
Cell fractionation
Cells were fractionated as described previously (SI). The fractions correspond to: PI;
nuclei, plus whole-cell debris, P2; predominantly mitochondrial, P3; other membrane
elements, and C; cytosolic.
Transfection
HEK293 cells were maintained at 37°C with 5% CO2 in DMEM (Sigma) with 10% FBS
and transfected with lipofectamine 2000 (Invitrogen) at 90% confluence, 15-24 hours
after removal of antibiotics.
Immunoprecipitation
Cells were lysed in ice-cold PBS containing 1% Triton X-100/1 mM DTT/2 mM
PMSF/10 mM sodium fluoride/5 mM pyrophosphate/protease inhibitor cocktail
(Roche). Lysates were solubilized by incubation for 1 hr at 4°C on a rotary wheel and
centrifuged at 13,000 rpm for 30 min. Lysates were pre-cleared by incubation with
protein G-Sepharose (Sigma) for 15 min. Indicated antibody was added to the
supernatant, incubated for 3 hours or overnight, protein G was added to capture immune




Cells were lysed as for immunoprecipitation and GST-protein complexes captured by
overnight incubation with glutathione-sepharose. Beads were then washed five times in
PBS/1% Triton X-100 with NaCl added to a final concentration of 0.5 M plus protease
inhibitors.
Protein synthesis in vitro
T7,T3 or SP6-coupled reticulocyte lysate system (TNT, Promega, Southampton, UK)
was used to synthesize proteins. For in vitro binding assays equivalent amounts of [35S]-
labelled and unlabelled lysates were mixed and diluted to a final buffer concentration of
lx PBS/1% Triton X-100 in 600 pi reaction volume. After 3 hours at 4°C protein
complexes were isolated by addition of anti-V5 or anti-FLAGM2 antibody plus protein
G sepharose. Immune complexes were washed five times in the above buffer.
PDE4B phosphorylation assay
SF1-SY5Y cells were either untreated (Ctr) or challenged for 30 min with a mixture of
either IBMX + Forskolin (I/F) or IBMX + Forskolin (I/F) + H89 (I/F/H89) at the
concentrations used for expts described in Fig 4A. The selective immunoprecipitation of
PDE4B from SYH-SY5Y cells was done using a specific antibody targeted to the
unique C-terminal region of this sub-family through a procedure performed exactly as
described previously (SI3, S21). The immunoprecipitated PDE4B was then analysed as
previously described by (i) immunoblotting with a PDE4B specific antiserum (S8, SI 4),
(ii) immunoblotting with an antiserum specific for the single PKA phosphorylation site
in UCR1 (S2, S9) and (iii) assayed for cAMP hydrolysing PDE4 activity (SI3, S21).
Activity measurements are means ± SD for n=3 separate experiments.
Cell culture
Cell lines SH-SY5Y, LAN5, COS7 and HEK293 were cultured in DMEM/10% fetal
bovine serum. Lymphoblastoid cell lines established from t( 1; 11), t( 1; 16) subject and
karyoptypically normal controls were cultured in RPMI/10% fetal bovine serum (all
media supplied by Invitrogen). Forskolin, IBMX, H-89 and 8-bromo-cAMP (all Sigma)
were added to cultures at 100 pM, 20 pM, 10 pM and 100 pM respectively, and
incubated at 37°C for 30 min prior to harvesting of cells. To differentiate SH-SY5Y
cells, retinoic acid was added to the medium at a final concentration of 1 pM for 5 days.
Immunoblotting
Proteins separated by SDS-PAGE were transferred to Hybond-P (Amersham
Biosciences, Little Chalfont, UK) or Invitrolon (Invitrogen) membranes. Primary
antibodies were detected using horseradish peroxidase-conjugated secondary antibodies
(Sigma) and proteins visualized using ECL-Plus (Amersham Biosciences).
Densitometry
Densities of protein bands visualised on photographic film were determined using
UVIDoc software (UVITech, Cambridge, UK). Immunoreactivity was expressed as the
ratio of DISCI :GAPDH or PDE4B:GAPDH. To allow for between-gel comparisons all
values from translocation cell lines are given as % of expression in a cell line derived
from a karyotypically normal relative measured from the same gel.
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Biallelic transcription of DISCI in t(l; 11) cell line
SNP rs2492367 ([tctctctcG/Agcccttca] within exon 2, proximal to the translocation
breakpoint) was used to distinguish between the normal and translocated alleles of
DISCI. A t( 1; 11) translocation-carrying lymphoblastoid cell line heterozygous for
rs2492367 was studied. Previous family genotyping had demonstrated that the A allele
is located on the derived (translocated) chromosome. Random-primed cDNA (First
Strand cDNA synthesis kit; Roche, Lewes, UK) was prepared from polyA RNA
extracted from this cell line (PolyA Pure mRNA purification kit; Ambion, Huntingdon,
UK). Oligonucleotides corresponding to the SNP region were designed (Forward
Primer:gaacgtggagaagcagaagg, ReversePrimer: cagagaactggaggagccag). Thermostart
Taq Polymerase (Abgene, Epsom, UK) was used to amplify this region and the resulting
products were directly sequenced (Big Dye version 3.1, Applied Biosytems,
Warrington, UK) to determine (nonquantitatively) if both alleles were represented.
Real-Time RT-PCR
RNA was extracted from Lymphoblastoid cell lines using the RNAeasy kit (Qiagen).
and treated to ensure no DNA contamination using Turbo DNA-fyee (Ambion). cDNA
was made using the First Strand cDNA synthesis Kit (Roche).
Primers for DISCI were designed using PRIMER3 software on the Biology Workbench
website (http://workbench.sdsc.edu/). Primers were designed in exon 2 ofDISCI and
should detect all known spliced variants. Relative quantification ofDISCI was
determined using the MyiQ Real-Time PCR detection system and associated optical
software system version 1.0 (Bio-Rad Laboratories, Ltd). Real-Time PCR was carried
out in a final volume of 15 pi, containing 7.5 pi of iQ SYBR Green Supermix (Bio-Rad
Laboratories Ltd.), 150 ng primers (Forward and Reverse) and 1 pi of reverse
transcribed cDNA. Reference genes, glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) and human phosphofructokinase, muscle (PFKM), were amplified in parallel
and used to facilitate normalisation. The thermal profile included 95°C (3 min), then 40
cycles of 95°C (10 s), 66°C (30 s), 72°C (45 s). Double stranded product was measured
during the 72°C extension step using fluorescence emitted by incorporation of SYBR
green I into the product. Melt curve analysis was performed after PCR amplification to
ensure specificity of products. All reactions were carried out in duplicate and standard
curves for all primer sets were run in parallel to determine primer efficiencies.
Primers used are as follows;
DISCI Forward J14 5'-GAACGTGGAGAAGCAGAAGG-3'
Reverse J15 5'-CAGAGAACTGGAGGAGCCAG-3'
GAPDH Forward 5'- GGGAGCCAAAAGGGTCATCA-3'
Reverse 5' - GTGGCAGTGATGGCATGGAC-3'
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Fig. S1. Fluorescence in situ hybridization mapping of t(1:16): chromosome 16
breakpoint.
(A, B) FISH using BAC clone RP11-875E12 and RP11-685M21 probes,
respectively, on t(1;16) patient metaphase spreads. Arrows mark FISH signals
on the normal and derived chromosome 16.
(C) CDH8 genomic organisation showing positions of exons (vertical lines) and
BAC clones (closed boxes) used as probes to define the translocation
breakpoint (dotted line).
Fig. S2. Reduced PDE4B expression in the t( 1; 16) lymphoblastoid cell line and
reduced DISC1 expression in five independent lymphoblastoid cell lines (a-e)
carrying the t(1;11), compared to one and four cell lines, respectively, from
karyotypically normal relatives, all expressed as a percentage of normal levels
and relative to GAPDH. There was no reduction in the levels of TRAX (SOM
fig.S4) between t( 1; 11) carriers and karyotypically normal relatives.
Fig. S3. Detection of truncated DISC1 in lymphoblastoid cell lines.
(A) Biallelic DISC1 transcription in t( 1; 11) lymphoblastoid cell lines determined
by sequencing across heterozygous SNP rs2492367.
(B) Quantitative RT-PCR using DISC1-specific primers designed from exon 2
sequence (translocation breakpoint proximal) in lymphoblastoid cells with (Ta,
Tb) or without (Na, Nb) the t(1 ;11). Each cell line was assayed four times.
(C) Detection of C-terminally truncated DISC1 species by DISC1-specific
antibody R47. COS7 cells were mock-transfected (mock) or transfected with
pDEST40 vectors expressing DISC1 amino acids 1-358 or 1-597 with a V5
peptide tag. Due to the variable intensity of the DISC1 endogenous bands it
should be noted that the mock transfection was carried out simultaneously with
the DISC1 (1-597) transfection and is therefore separate from the DISC1 (1-
358) transfection. These constructs were selected as they may mimic the
hypothetical truncated DISC1 protein resulting from the translocation.
Exogenous DISC1 detected with R47 antiserum or V5-specific antiserum is
indicated with arrows, other bands are due to recognition of endogenous DISC1
by R47. Markers are indicated in kiloDaltons.
(D) Subcellular fractionation profile of DISC1 in lymphoblastoid cells with (T) or
without (N) the t(1;11). This experiment should be interpreted in the context of
the previously reported altered subcellular distribution of C-terminally truncated
forms of DISC1. Loadings have been adjusted so that DISC1 levels are
comparable between cell lines. P1: nuclear fraction, plus whole-cell debris; P2:
predominantly mitochondrial; P3: other membrane elements; C: cytosolic.
Markers are in indicated kilodaltons.
Fig. S4. TRAX expression is not perturbed in t(1 ;11) lymphobastoid cells lines.
(A) Western blots of protein extracts from control and t(1 ;11) lymphoblastoid cell
lines were probed sequentially with a-TRAX and a-GAPDH antibodies.
(B) TRAX protein levels are plotted as the ratio of a-TRAX over a-GAPDH,
normalised with respect to the control cell line. The graph shows the mean
results of three independent Western blots.
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Fig. S5. Co-immunoprecipitation of PDE4A, B, C and D with DISC1.
Representative long PDE4 isoforms containing a UCR2 domain were assayed
for binding to DISCI. Anti-FLAG immunoprecipitates from iysates prepared from
HEK293 cells co-transfected with empty Flag vector (mock) or Flag-DISC1 and
PDE4C2 or PDE4D5 were probed by Western blot analysis with pan-PDE4C or
PDE4D antibodies (top). Anti-V5 immunoprecipitates from in vitro
transcribed/translated [35S]-PDE4B3 or PDE4A10 incubated with either V5
antibody or V5 antibody and V5-DISC1. Immune complexes were separated by
SDS-PAGE and visualised by autoradiography (bottom). Signals obtained by
Western blot analysis or autoradiography were consistent with the expected
MW of the PDE4 isoforms tested.
Fig. S6. Mapping the DISC1 binding site on PDE4B1
Minimal DISC1 binding regions 1 and 2 (top) were identified by yeast two-hybrid
screening and binding studies in mammalian cells, respectively. PDE4B1
deletion constructs used to map the DISC1 interaction domain (fig.2C) were
generated as in-frame C-terminal Flag tagged fusion proteins and expressed in
HEK293 cells. Amino acid residues which comprise the PDE4B1 truncations are
indicated (middle). Detection of expressed Flag tagged PDE4B1 protein
fragments was carried out by Western blot analysis of total cell lysates and the
position of individual fragments at the expected MW are indicated by an arrow
(bottom). Markers are indicated in kilodaltons.
Fig. S7. PDE4B binds the DISC1 amino terminus.
Anti-V5 immunoprecipitates from in vitro transcribed/translated [35S]-PDE4B3
incubated with V5-DISC1 fragments (DISC1 residues 1-854, 1-597 and 1-358)
were separated by SDS-PAGE and visualised by autoradiography (upper).
Labelled PDE4B3 input signal represents 1/50 of that present in the binding
reaction (bottom).
Fig. S8. Schematic of DISC1 N-terminal deletion constructs.
The indicated amino-terminal DISC1 deletion fragments (NA) were constructed
in plasmid pcDNA6Ato initially identify a PDE4B3 binding site (fig.2E). DNA
fragments encoding DISC1 amino acids 1-180, 1-250 and 1-300 were
generated to confirm the position of the PDE4B3 interaction site on DISC1
(fig.S9).
Fig. S9. Mapping the PDE4B binding site on DISC1.
[35S]-labeled amino-terminal DISC1 fragments were incubated with unlabelled
Flag tagged PDE4B3, immunoprecipitated with anti-Flag antibody and immune
complexes were resolved by SDS PAGE and detected by autoradiography.
Input DISC1 signal represents 1/50 of the total binding reaction (left). DISC1
fragments which specifically bind to PDE4B3 are indicated by arrows (right).
Markers are indicated in kilodaltons.
Fig. S12. A model for dynamic cAMP-responsive binding of PDE4B to DISC1.
(A) When cellular cAMP is low PDE4B activity is low, and PDE4B binds to
DISC1 via UCR2.
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(B) When cellular cAMP levels are high, UCR1 is phosphorylated by PKA,
causing a UCR1-UCR2 conformational change and dissociation of PDE4B from
DISCI, with subsequent catalytic unit conformation change and activation.
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Fig. S10. Additional images of native DISC1 and PDE4B co-expression (see
Fig. 3C, D, and E).
Upper, DISC1 (R47 or R1443/1 antibodies) and PDE4B (pan-PDE4B antibody)
expression in SH-SY5Y (rows 1 & 2, respectively) and LAN5 human
neuroblastoma cells (row 3). Nuclei were visualised with DAPI.
Lower, Hippocampal primary neuron probed with DISC1 (C2) and PDE4B (pan-
PDE4B). Neurons were identified using an antibody to NeuN. Nuclei were
visualised with DAPI.
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Fig. S11. DISC1 and PDE4B co-localize with mitochondrial markers.
Top, Mitochondria (Hsp70 antibody) and PDE4B (pan-PDE4B antibody) in an
undifferentiated hippocampal cell (row 1) and a hippocampal neuron (row 2).
Neurons were identified using an antibody to NeuN. Nuclei were visualised with
DAP I.
Bottom, DISC1 (R47 or R1443/1 antibodies) and mitochondria (MTC02
antibody) in SH-SY5Y (row 1) and LAN5 (row 2) neuroblastoma cells. Nuclei
were visualized with DAPI.
12
Supplementary References
51. R. James etal., Mol. Cell. Neurosci. 26, 112 (2004).
52. N.J. Brandon et ai, Mol. Cell. Neurosci. 25, 42 (2004).
53. J.A. Morris et al., Hum. Mol. Genet. 12, 1591 (2003).
54. J.K. Millar etal., Biochem Biophys Res Commun. 311, 1019 (2003)
55. Y. Ozeki ef al., Proc Natl Acad Sci U S A. 100,289 (2003)
56. C. Redies, Prog Neurobiol. 61, 611 (2000)
57. K. Korematsu et al., Exp Neurol. 154, 531 (1998)
58. S.J. MacKenzie et al., Br. J. Pharmacology 136, 421 (2002).
59. E. Huston etal., Biochem. J. 328, 549 (1997).
510. G. Rena et al., Mol. Pharmacol. 59, 996 (2001).
511. G.B. Bolger etal., Biochem. J. 328, 539 (1997).
512. C. Sette, M. Conti, J. Biol. Chem. 271, 16526 (1996)
513. S.J. Mackenzie, M.D.Houslay, Biochem. J. 347, 571 (2000)
514. A. McCahill etal., Cell. Signal. 17, 1158-1173 (2005).
515. K. Miyoshi etal., Mol. Pyschiatry 8, 685 (2003).
516. J.C. Rain et al., Nature. 409, 211 (2001).
517. F. Colland etal., Genome Res., 14, 1324 (2004).
518. B.S. Pickard et al., Am J Med Gen (Neuropsy Gen) 136, 26 (2005)
519. Arizona Genomics Institute, http://www.qenome.arizona.edu/fpc/
520. UCSC Genome Bioinformatics, http://qenome.ucsc.edu/




This appendix provides details regarding preparation of the solutions indicated in
chapter 2. Some of the required reagents are listed along with suppliers in the
subsequent reagents section.
H3-cAMP
2pM (3pCi) cAMP solution is prepared in Tris/Mg2' buffer. Store at -20°C. Caution:
radioactive material, add in fume hood wearing double gloves.
Cell freezing medium
RPMI or DMEM depending on cell type
10% Fetal Bovine Serum
10% DMSO
Aliquot and store at -20°C.





Pepstatin A (5mg/ml) 40pl
Make up to 200mls in distilled water, store in 20ml aliquots at -20°C. Add 400pl of





Once dissolved add 50ml of tissue culture grade DMSO and adjust final volume to
1L. Adjust pH to 7.6. Store at -20°C.
Coomassie Brilliant Blue protein fix/stain
Coomassie stain 0.25g
Methanol;water (1; 1 v/v) 90ml
Glacial Acetic acid*NB 10ml
Filter solution and store at room temperature (RT).
*NB: Always add acid to water
Coomassie de-stain (MethanoEAcetic acid)
Glacial acetic acid 100ml
Methanol 300ml
Make to 1L with distilled water, store at RT.
Cytochalasin D
Add 5mg vial to 1ml DMSO, store in aliquots at -20°C. Protect from dark.
Dowex slurry
Dowex ion exchange resin is prepared 1:1 in water. Before use mix dowex:ethanol at
a ratio of 2:1. Store dowex at 4°C.
Ethanol fixative solution (BrdU incorporation assay)




Blocking buffer consists of a 10% solution of animal serum (in PBS/BSA .02%





Make up solution in a 250ml conical flask, cover in parafilm and incubate at RT
overnight.
Step 2. Add 50mls of Tris.HCL (0.2M, pH 8.5), mix and heat at 100°C for 20
minutes.
Step 3. Allow to cool and add 1.75g DABCO. Aliquot and store at -20°C long term
or 4°C short term.
Mowiol/DAPI
DAPI was added to Mowiol to achieve a final concentration of 250ng/ml.
Nocodazole
Add lOmg vial to 33.3mls DMSO, store in 1ml aliquots at -20°C.
10X Orange G loading buffer
Ficoll 400 3g (15%)
SDS (20% solution) 50pl (0.05%)
EDTA (0.5M) 800pl (20mM)
Orange G 0.125%
Make up to 20mls with distilled water, store at RT.
4% Paraformaldehyde
Dissolve paraformaldehyde powder in IX PBS (in fume hood, wear face mask) to
achieve a final concentration of 4%. Solution may need heating to dissolve. Aliquot
and store at minus 20°C.
PBS/BSA (.02%)





Store at RT; This stain is re-usable.
PBST blocking buffer (western blotting)
IX PBS, 5% semi-skimmed milk (MAVREL), 0.2% Tween20.
Propidium Iodide solution C
Propidium iodide 208mg
Spermine tetrahydrochloride 500mg
Adjust volume to 500mls with trisodium citrate/spermine stock solution. Adjust pH
to 7.6. Store at-20°C.
50X Protease inhibitors (Complete)
1 tablet dissolved in 1ml distilled water, aliquot and store at -20°C.











store at RT. Add lOOmM DTT
RIPA buffer
Tris(hydroxymethyl)-methylamine(lM, pH7.5) 2.5ml
Sodium Chloride (NaCl, 3M) 2.5ml
Igepal 500pl
Sodium Deoxycholate (10% solution) 2.5ml
Sodium Dodecyl Sulphate (20% solution) 250pl





20% Sodium Dodecyl Sulphate (0.04%) 2mls
Methanol (20%) 200mls
Make up to 1L using distilled water, store at 4°C.
Snake venom
1mg/ml in distilled water, store at -20°C. This is toxic wear double gloves and face
mask when adding to reactions.
IX TBST (Tris buffered saline with Tween20)
1M Tris, pH7.5 50ml
Sodium Chloride 8.75g
Make up to 1L with distilled water; add 1ml Tween20 (0.1%).
TBST blocking Buffer (Western blotting)
IX TBST plus 1% Marvel.
1.5M Tris pH 8.8 (for SDS-PAGE gel preparation)
181.5g of Tris(hydroxymethyl)-methylamine in 1L distilled water, pH using
Hydrochloric Acid (HCL), store at RT.
0.5M Tris pH 6.8 (for SDS-PAGE gel preparation)
60.5g of Tris(hydroxymethyl)-methylamine in 1L distilled water, pH using HCL,
store at RT.
PDE Tris buffer
20mM Tris-HCL buffer (2.42g of Tris.HCL in 1L of distilled water), pH to 7.4 using
HCL, store at 4°C.
Tris/Mg2+
20nM PDE Tris buffer plus lOmM MgCh.
50X Tris-Acetate electrophoresis buffer
Tris(hydroxymethyl )-methylamine 242g
Galcial Acetic Acid 57ml
EDTA (0.5M, pH 8.0) 100ml
Make up to 1L with distilled water, store at RT, dilute to IX before use.





Make up to 2 litres with distilled water and adjust pH to 7.6.
Trypsin solution A
15mg of trypsin dissolved in 500mls of trisodium citrate/spermine stock solution.
Adjust pH to 7.6. Store at -20°C.
Trypsin inhibitor/Ribonuclease A solution B
250mg Trypsin inhibitor
50mg Ribonuclease A (RNase A)
Make up to 500ml using trisodium citrate/spermine stock solution and adjust pH to
7.6. Store at -20°C.
3T3 Lysis buffer








8-H3 cAMP Amersham Biosciences
Cytochalasin D Sigma
DABCO Sigma





Sodium Dodecyl Sulphate (20% solution) Fischer Scientific
Spermine tetrahydrochloride Sigma
Trisodium citrate Sigma
Trypsin Sigma
Trypsin inhibitor Sigma
